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ABSTRACT 
 
In this thesis we explore innovation in general practices in Ireland. Drawing on an 
encompassing equilibrium, disequilibrium and learning-by-using model of adoption, 
we examine the influences of general practitioner (GP) and practice characteristics, 
strategic behaviour, learning and knowledge spillovers, and cumulative learning 
from previous adoption decisions on the perceived benefits of adopting and using 
innovations in general practices. Ours is the first application of this theoretical 
framework to timing of adoption, multiple technology adoption and intensity of 
adoption decision-making in a health care setting. Our examination focuses on three 
innovations, prescription drugs, medical equipment and Information and 
Communications Technology (ICT). 
  
Our analysis is based on two data sources, a secondary dataset which brings together 
GPs prescribing history over a 4½ year time period with information on the 
characteristics of the 625 GPs themselves, and a cross-sectional primary dataset 
which provides us with information for 601 general practices concerning practice 
structure and use of medical equipment and ICT. Employing duration analysis, 
multivariate Probit and ordered Probit econometric techniques, we examine the 
adoption, use and intensity of use of prescription drugs, medical equipment and ICT 
respectively. 
 
Irish GPs exhibit notable innovative behaviour with respect to prescribing innovation 
and practice development. Our research demonstrates that Irish GPs respond to 
informational stimuli with respect to adoption and use of new prescription drugs, 
medical equipment and ICT. Furthermore, Irish GPs are incentivised by commercial 
and market considerations. In addition, we find the extent which a practice adopts 
technologies and learns from that experience influences both ensuing prescribing and 
investment decision-making. Our empirical findings support an economic approach 
to examining decision-making in a health care setting and the application of our 
encompassing theoretical model to examinations of adoption and use of innovations 
by health care professionals. 
1 
 
CHAPTER 1: ADOPTION OF INNOVATIONS IN  
IRISH GENERAL PRACTICES 
1.1 Introduction 
In this thesis we explore innovation in general practices in Ireland. It is widely 
accepted that the contribution of innovations to economic growth is only realised 
when innovations are widely adopted and used (Baptista, 1999; Hall and Khan, 
2003). Likewise, the contribution of innovations to health care provision and 
outcomes is realised when they are adopted and used within health care settings. The 
overall aim of this thesis is to examine the adoption and use of innovations in Irish 
general practices. Our examination focuses on three innovations, new prescription 
drugs, medical equipment and Information and Communication Technology (ICT), 
and specifically addresses the following research questions: 
(i) What are the determinants of timing of adoption of new prescription 
drugs by Irish GPs? 
 
(ii) What influences the use of medical equipment in Irish general practices? 
 
(iii) What factors influence the intensity of ICT use in Irish general practices? 
 
The general practice environment in Ireland is slightly different to that in other 
countries, particularly in relation to the autonomy enjoyed by Irish GPs in the 
running of their practices, therefore, providing us with a unique context for this 
study. For instance, Irish GPs are self-employed private practitioners who compete 
2 
 
for customers, both public and private patients, similar to other professionals, such as 
architects, dentists, solicitors and engineers (Competition Authority, 2010). They 
also enjoy considerable autonomy in how they staff and equip their practices, and are 
not constrained by prescribing guidelines, such as the National Institute for Clinical 
Excellence (NICE) guidelines in the UK. These commercial and health care 
provision features of Irish general practice enables the novel application of economic 
approaches to examining the adoption of health care innovations. 
 
Previously, three complementary theoretical approaches have been used to explain 
the timing of innovation decisions. Disequilibrium models reflect the learning and 
informational influences on timing of adoption (Rogers, 2003). By contrast, 
equilibrium models take account of how organisational characteristics and strategic 
interactions influence timing of adoption (Karshenas and Stoneman, 1993). While 
learning-by-using models reflect how cumulative learning experience from previous 
adoption decisions influence timing of adoption (McWilliams and Zilbermanfr, 
1996). The disequilibrium approach has been used primarily to explain adoption by 
individuals, whereas the equilibrium and leaning-by-using approaches are generally 
used to explain adoption by firms. In addition to empirical examinations of timing of 
adoption, these theoretical models have also been extended to examinations of 
multiple technology adoption (Colombo and Mosconi, 1995; Stoneman and 
Toivanen, 1997) and intensity of adoption (Battisti and Stoneman, 2003; Hollenstein, 
2004; Battisti et al., 2007). This encompassing theoretical framework informs the 
empirical analyses of this thesis.  
 
3 
 
The data sources for our study include both a secondary dataset and a primary 
dataset. The secondary dataset brings together GPs prescribing history over a 4½ 
year time period with information on the characteristics of the 625 GPs themselves, 
and enables us to explore the factors which shape the timing of the first prescription 
of new drugs by GPs in Ireland. Primary survey data provides us with information 
relating to practice characteristics and use of medical equipment and ICT for a 
sample of 601 general practices in Ireland. This survey data allows us to examine the 
determinants of medical equipment use and intensity of ICT use by general practices 
in Ireland. Through the lens of our theoretical framework and using both datasets, we 
employ a number of econometric approaches to examine the adoption and use of 
prescription drugs, medical equipment and ICT by GPs. 
 
The rest of the chapter is organised as follows. Section 1.2 describes the general 
practice environment in Ireland. The motivation for this study and the contributions 
of this research are discussed in Section 1.3. Finally, Section 1.4 provides an 
overview of this thesis, briefly describing the content of each chapter.  
 
1.2 General Practice in Ireland 
The Irish government considers primary care to be the appropriate setting to meet 
90-95 per cent of all health and personal social service needs, with GPs central to its 
provision (Department of Health and Children, 2001). In fact, along with Denmark, 
the Netherlands and the UK, Ireland is identified as one of the European countries 
where GPs are predominately the first point of contact with health care services 
(Boerma and Dubois, 2006).  
4 
 
 
Irish GPs are by and large self-employed private practitioners who choose where 
they set up practice, who they employ and how much they charge for consultations 
and any additional services they provide (Department of Health and Children, 2001; 
Wren, 2003). The majority of Irish GPs treat private patients but also hold a contract 
with the government to treat those patients who qualify for a Medical Card. Medical 
card or General Medical Services (GMS) patients are public patients who are entitled 
to attend GPs free of charge.
1
 Approximately, one-third of the Irish population are 
entitled to these means-tested medical cards (Department of Health and Children, 
2010).
2
 The remainder of the Irish population are classed as private patients and they 
pay directly for each visit to a GP and for any additional services provided.
3
  
 
Irish GPs enjoy considerable autonomy with respect to prescribing and practice 
development decisions (Department of Health and Children, 2001; Wren, 2003). In 
Ireland, there are no explicit guidelines in relation to prescribing decisions. Once a 
                                                 
1
 GPs are remunerated for treating GMS patients on a capitation basis. The capitation fees are 
calculated based on the following factors: (1) a demographic factor designed to reflect differences in 
demands by various age and gender groups, and (2) a geographic factor designed to reflect the 
expenses incurred in visiting patients in various age/distance categories (Thomas and Layte, 2009). In 
2008, the average payment to a GP principal in Ireland with a GMS contract was €220,000. 
Approximately 70 per cent of this payment comprises fees for services provided to public patients; the 
remainder comprises allowances for secretarial/nursing support, locum hire to cover annual leave, and 
out-of-hours payments (24 per cent); superannuation (5 per cent); and „other‟ payments (2 per cent) 
(Competition Authority, 2010). This payment does not include fees received directly from private 
patients for care and treatment provided.    
2
 In 2009, 33.2 per cent of the population were entitled to medical cards. Those entitled to free GP 
care under the GMS scheme has been increasing in recent years. In 2007, 29.4 per cent of the 
population was entitled to a medical card, whereas in 2008, this figure had increased to 30.6 per cent. 
Approximately, 2.2 per cent of the population are entitled to GP Visit Card which also entitles the 
holder to free GP care. GP Visit Cards were introduced in 2005 as a graduated benefit to extend free 
GP care to individuals and families on moderate incomes (Department of Health and Children, 2010). 
3
 General practices are not obliged to display the price of a consultation, although an updated Guide to 
Professional Conduct and Ethics for Registered Medical Practitioners specifies that GPs may display 
prices.  In 2009, the Competition Authority estimated that the average cost of a GP visit for a private 
patient is approximately €50-55 in urban areas, with slightly lower charges in rural areas 
(Competition Authority, 2010). The National Consumer Agency also reported a wide range of prices 
for GP visits, averaging at €51, with a minimum of €35 and a maximum of €70 (Thomas and Layte, 
2009). 
5 
 
drug is approved for use by the Irish Medicines Board, GPs can prescribe it to their 
patients. Irish GPs also have considerable autonomy in how they equip their 
practices (Department of Health and Children, 2001; Wren, 2003), and there is 
evidence of considerable variation concerning the range of medical equipment 
(Boerma and Dubois, 2006; O'Dowd et al., 2006) and the extent of ICT use (Irish 
College of General Practitioners, 2003; Lordan and Normand, 2005; O'Dowd et al., 
2006; Dobrev et al., 2008; Meade et al., 2009) in Irish general practices. 
 
In Ireland, general practices also vary greatly in size and personal characteristics. 
Approximately one in four practices is a solo-practitioner practice. The majority of 
practices are two or three GP practices, although 12 per cent of practices have five or 
more GPs. Practices tend to be male GP dominated (Bourke and Bradley, 2010). Not 
all practices have nursing or administrative support. One in five practices does not 
employ a nurse and one in ten does not employ administrative support.
4
 In general, 
practices tend to be located in urban locations. General practices are regularly visited 
by pharmaceutical representatives, less so by suppliers of medical equipment and 
ICT. Many practices are involved in research projects (24 per cent), affiliated to 
academic institutions (38 per cent) and hold clinics delivered by other health care 
professionals (49 per cent). 29 per cent of practices are training practices (Bourke 
and Bradley, 2010). 
 
                                                 
4
 A survey report pertaining to the primary data collection of this thesis was published in the 
Department of Economics, University College Cork Working Paper Series (Bourke and Bradley, 
2010). This report provides a timely profile of Irish general practices. A comparison with previous 
surveys of general practices in Ireland reveals a move away from solo-practitioner practices, with 
practices more likely to employ support staff, in recent years. In 2005, 35 per cent of general practices 
in Ireland were solo-practitioner practices; 35 and 40 per cent of practices employed a full- and part-
time nurse respectively; and 70 per cent of practices employed full-time clerical assistance (O‟Dowd. 
et al., 2006) 
6 
 
In general, Irish GPs invest in a range of medical equipment (Bourke and Bradley, 
2010), in fact, to a greater extent than many of their European counterparts (Boerma 
and Dubois, 2006). Almost all Irish general practices are computerised, although 
there is variation in the ICT applications used (Bourke and Bradley, 2010; Meade et 
al., 2009). In a European context, Irish GPs  are considered „average‟ performers 
with respect to their use of ICT (Dobrev et al., 2008). It is worth noting that Ireland 
has a low number of GPs per capita in comparison with other EU countries. It is 
estimated Ireland has approximately 52-56 GPs per 100,000 of the population. 
Countries such as Austria, France and Germany have over 100 GPs per 100,000 
(Thomas and Layte, 2009).
5
  
 
It is important to discuss the different incentives Irish GPs may face in their adoption 
decision-making. Irish GPs incur no monetary cost in relation to their prescribing 
decisions. The cost of the prescription is borne by the patient or in the case of public 
patients by the State. Neither are Irish GPs constrained by prescribing budgets for 
their public patients.
6
 Therefore, GPs need not consider the price of drugs when 
prescribing them to their patients. Although, it is important to note that private 
patients who bear the cost of any drugs prescribed may request a less expensive drug 
if they consider the cost of a drug too high. However, for the most part, it is 
reasonable to assume that the cost of a new drug does not feature in GPs prescribing 
decisions, and such a decision is not influenced by commercial considerations.  
 
                                                 
5
 In fact, there are concerns in relation to the future supply of GPs in Ireland, due in part to the 
increased feminisation of the profession, accompanied by a rise in part-time working, among both 
male and female GPs, and a movement towards early retirement (Competition Authority, 2010).  
6
 The Indicative Budget Treatment Scheme (IDTS) was introduced in an attempt to contain public 
patient prescribing costs, and is discussed in Section 3.3. 
7 
 
On the other hand, Irish GPs do incur a monetary cost with respect to how they equip 
their practices. Therefore, when a practice invests in a new piece of equipment the 
GP(s) will consider the cost incurred from investing in such equipment because that 
cost is borne solely by the practice. It is also important to note that when judging the 
benefits of equipment investment decisions it is likely that Irish GPs consider the 
benefits to health care provision as well as commercial considerations from 
expanding the diagnostic and treatment capabilities of the practice. To reiterate, Irish 
GPs face different incentive structures with respect to their prescribing and practice 
investment decisions. Irish GPs incur no monetary cost from prescribing decisions 
and the benefits of such decision-making are bestowed solely to the patient. In 
contrast, Irish general practices incur a monetary cost, in some instances a substantial 
monetary cost, in the procurement of practice equipment; however the benefits of 
such investments may include business efficiencies as well as improved patient care.  
 
In addition, an interesting feature of the Irish health care system is the mobility that 
Irish patients enjoy with respect to registering with a GP. Public patients choose their 
GP from a panel of GPs who are part of the GMS scheme and, provided the GP is 
willing to accept them as patients, they register with that GP. It is relatively easy for 
public patients who wish to change GP to subsequently register with a different GP 
in their area if they so wish. At the present time, there is no register of private 
patients in Ireland. Consequently, private patients may not be registered with any 
practice or may be registered with more than one practice. It is reasonable to assume 
that Irish GPs are mindful of the mobility of their patients and potential patients in 
their adoption decision-making. GPs that are seen to be innovative may be more 
likely to attract both public and private patients.  
8 
 
 
In Ireland, general practice plays a pivotal role in health care provision. Given the 
independent nature of general practices in Ireland, decision-making concerning 
prescribing new drugs and investing in medical equipment and ICT is at a practice or 
individual GP level. Therefore, the general practice environment in Ireland provides 
us with a unique setting for examining the adoption of health care technologies by 
health care practitioners.  
 
1.3 Motivation and Contribution 
Primary care is the central focus of the Irish health system (Department of Health 
and Children, 2001). More than two-thirds of the Irish population attend their GP 
each year (Central Statistics Office, 2008) and, therefore, are directly affected by 
how their GP chooses to run their practice. As previously mentioned, GPs are 
independent contractors who decide what drugs to prescribe to their patients, what 
medical equipment they invest in, and for what purposes they use ICT. In fact, the 
innovation capabilities of Irish GPs are confined to these three areas of decision-
making.
7
 Therefore, our examination of the adoption and intensity of adoption of 
prescription medicines, medical equipment and ICT provides us with a holistic view 
of the innovativeness of Irish GPs. This section discusses the contribution to theory 
(1.3.1), knowledge (1.3.2) and policy (1.3.3) of this thesis. 
  
                                                 
7
 Interviews with GPs, described in Chapter 5, confirmed that decision-making concerning adoption 
and use of innovations comprise of these three areas. 
9 
 
1.3.1 Contribution to Theory 
The primary theoretical contribution of this thesis is the importance of experiential 
learning on adoption decision-making. In this thesis, we hypothesise that individual 
and corporate learning from previous adoption decisions influences subsequent 
decisions concerning uptake and use of technologies. Our empirical analysis clearly 
illustrates the influence of learning-by-using effects on the adoption and use of three 
innovations in a health care setting. In the innovation literature, measures of 
learning-by-using effects have focused on learning from the adoption of 
complementary technologies and earlier technology vintages (Colombo and 
Mosconi, 1995; Arvantis and Hollenstein, 2001). In our examination of the adoption 
and use of innovations by Irish GPs, we extend earlier conceptualisations of 
learning-by-using effects to capture learning from a range of similar and differing 
adoption decisions. Therefore, our variable measurements of learning-by-using 
effects include learning from an individual GP‟s portfolio of drugs, learning from a 
general practice‟s portfolio of medical equipment, and learning from ICT use for 
contrasting purposes. To date, in innovation studies learning-by-using models of 
adoption have been appended to the more established equilibrium and disequilibrium 
models of adoption as a means of understanding adoption decision-making. 
However, we would argue that our robust and consistent evidence of the influence of 
learning-by-using effects on adoption decision-making places these experiential 
learning effects at the centre of the theoretical debate. 
 
In addition, our empirical findings justify the application of the encompassing 
theoretical framework of learning-by-using, equilibrium and disequilibrium models 
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of adoption to adoption decision-making in a health care setting. Due to the 
commercial free-market elements of general practice in Ireland, we take an economic 
approach to our exploration of innovative decision-making in Irish general practices 
and examine the influence of practice heterogeneity and strategic behaviour of 
adoption decision-making. Our findings illustrate that decision-making in general 
practices is influenced by commercial and business motivations. Previous studies 
have implicitly drawn on the disequilibrium model of adoption to examine the 
adoption of health care innovations by health care professionals (Coleman et al., 
1966; Rogers, 2003). This thesis ascertains the influence of epidemic effects on 
timing of adoption, multiple technology adoption and intensity of adoption of 
innovations by GPs. Therefore, our empirical findings illustrate the need to consider 
the influence of commercial and business motivations, as well as learning and 
experiential stimuli, on adoption decision-making in general practices, and 
ultimately substantiate the application of an encompassing theoretical model 
incorporating the disequilibrium, equilibrium and learning-by-using approaches to 
adoption decision-making in a health care setting. 
 
This encompassing theoretical framework informs the empirical examinations on 
timing of adoption, multiple technology adoption and intensity of adoption of 
innovations by GPs. However, there is some variation in the application of this 
theoretical model to the three empirical exercises. This is discussed in detail in the 
relevant chapters. Table 1.1 summarises the application of the theoretical framework, 
as well as the data and econometric methodology employed, in the three empirical 
exercises. This thesis‟ contribution to knowledge is discussed in the following 
section.  
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Table 1.1: Summary of Application of Theoretical Framework, Data and Econometric Methodology in Empirical Analyses 
Research Focus Application of Theoretical Framework Dataset Econometric 
Methodology 
Chapter 
Timing of Adoption -  
New Prescription Drugs 
Equilibrium (rank, stock, and order effects) 
Disequilibrium (epidemic learning effects) 
Learning-by-Using (learning-by-using effects) 
Matched Dataset – 
GMS Prescribing and GP 
Characteristics Databases 
 
Duration Analysis 4 
Multiple Technology 
Adoption - 
Medical Equipment 
Equilibrium (rank and order effects)  
Disequilibrium (epidemic learning effects) 
Learning-by-Using (learning-by-using effects) 
Medical Equipment and IT 
in General Practice 
Survey Data 
 
Multivariate Probit 
Analysis 
6 
Intensity of Adoption - 
ICT use for Administrative 
and Patient Care functions 
Equilibrium (rank effects)  
Disequilibrium (epidemic learning effects) 
Learning-by-Using (learning-by-using effects) 
Medical Equipment and IT 
in General Practice 
Survey Data 
Ordered Probit 
Analysis 
7 
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1.3.2 Contribution to Knowledge 
This thesis provides us with a holistic picture of Irish GPs innovative behaviour. Our 
examination of Irish GP‟s prescribing and practice development decision-making 
points towards an innovative group of health care practitioners. Our empirical 
findings demonstrate that Irish GP‟s decision-making is influenced by informational 
and learning stimuli. In fact, they exhibit capabilities for accumulating knowledge 
and learning from experience with technologies which informs ensuing adoption 
decisions. Furthermore, our research reveals that Irish GPs respond to commercial 
and market incentives with respect to practice development and health care 
provision. 
 
Drawing on our encompassing theoretical model of adoption, we employ a number 
of econometric approaches and datasets in our empirical analyses of innovative 
decision-making in a health care setting.
8
 We employ duration models in our 
analysis of the adoption of drugs new to the Irish market by GPs. Duration analysis 
enables the application of timing of adoption models to prescribing behaviour, 
allowing us to examine equilibrium, disequilibrium and learning-by-using effects on 
the time of first prescription of new drugs by Irish GPs. To our knowledge, our study 
is the first to use duration analysis to examine prescribing innovation. 
 
Primary data was collected as part of this research process, with postal 
questionnaires distributed to the Irish general practice population in Spring 2010. 
601 general practices responded to the survey, providing us with a timely profile of 
                                                 
8
 The data analysis and statistical software package Stata 11 is used to conduct all statistical and 
econometric analysis (StataCorp 2009). 
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general practices in Ireland, along with information on decision-making concerning 
use of medical equipment and ICT.
9
  
 
As mentioned in Section 1.3.1, we extend our theoretical model to multiple 
technology and intensity of adoption decision-making. We use multivariate Probit 
analysis to examine the adoption of six items of medical equipment by general 
practices. Multivariate Probit analysis allows us to account for the unobservable 
factors that influence the adoption of all items of medical equipment (Greene, 2003). 
We understand that this is the first time such an econometric approach has been 
employed to medical equipment adoption. Therefore, this analysis contributes to our 
understanding of what determines adoption by controlling for unobservable 
individual-specific heterogeneity within a multiple technology adoption framework.  
 
In our empirical analysis of intensity of ICT adoption by general practices, our 
econometric technique is ordered Probit analysis, which allows us to identify the 
determinants of the probability of practices being intensive users of ICT. This 
econometric approach has been used in previous studies of intensity of ICT adoption 
(Hollenstein, 2004; Battisti et al., 2007). However, this is the first study where 
ordered Probit analysis has been used to examine intensity of ICT adoption by small 
health care organisations. This analysis deepens our understanding of what 
influences intensity of adoption, considered to be the more important element of the 
entire diffusion process. 
 
                                                 
9
 The survey report presents findings in relation to the structure of general practices in Ireland and 
highlights high levels of medical equipment and ICT use. It also reports findings by Health Service 
Executive (HSE) region; practice size and support staff (Bourke and Bradley, 2010). 
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In summation, this thesis contributes to our knowledge of Irish GPs and their 
prescribing and practice development decision-making. Furthermore, our research 
reveals how GPs are influenced by informational and learning stimuli, as well as 
commercial and market incentives. This thesis also broadens our understanding of 
timing of adoption, multiple technology adoption and intensity of adoption decision-
making.  
 
1.3.3 Contribution to Policy 
The objective of this thesis is to identify the determinants of the adoption and use of 
innovations by Irish GPs. It is expected that our research can contribute to Irish 
health care policy in relation to influencing the uptake of new drugs, the use of 
medical equipment, and the intensity of ICT use by GPs. As this study identifies 
factors and types of practices which influence adoption and use of health care 
technologies, we can also highlight possible areas for intervention to shorten the time 
to adoption and use of health care technologies. 
 
In Ireland, there exists a two-tier system with respect to primary care. Means-tested 
GMS patients are entitled to attend their GP free of charge, whereas the remainder of 
the population pay out-of-pocket for consultations and services provided. However, 
the Irish government, as part of a package of healthcare reforms, proposes to 
introduce Universal Primary Care in Ireland within a five year timeframe 
(Department of the Taoiseach, 2011). The proposed reforms, to be financed through 
social insurance, will affect the reimbursement of GPs. These changes may remove 
many of the market-based elements of general practice and consequently may affect 
GPs innovativeness behaviour. However, the move towards group practices with 
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more nursing support may increase learning and knowledge acquisition 
opportunities, and therefore positively influence innovative behaviour.  
 
Health care reforms in the UK include the establishment of GP-led commissioning 
consortia, which will be given budgets to commission health care on behalf of 
patients in their local communities (Barratt, 2011). While there are clear distinctions 
in the mandates of the GP-led commissioning consortia in the UK and general 
practices in Ireland, it may be possible to consider some of the potential implications 
of these reforms through the lens of this thesis. Consideration should be given to the 
fact that placing decision-making concerning health care resourcing in the hands of 
health care professionals may encourage innovative health care provision.   
 
In brief, we aspire to guide policy to support GPs innovation in Ireland and 
elsewhere, and also to identify the potential implications of policy reforms in 
international health care systems to innovative behaviour in general practice. The 
policy implications of this thesis, as well as our contributions to theory and 
knowledge, are discussed in detail in Chapter 8. 
 
1.4 Thesis Overview 
The rest of this thesis is structured as follows. In Chapter 2, the conceptual 
framework of the thesis is presented. Three complementary theoretical approaches 
have been used to explain the timing of adoption of innovation decisions. 
Disequilibrium models reflect the learning and informational influences on timing of 
adoption and generally have been used to examine innovation by individuals 
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(Rogers, 2003). Equilibrium models take account of how organisational 
characteristics (rank effects) and strategic interactions (stock and order effects) 
influence timing of adoption by firms (Karshenas and Stoneman, 1993). Learning-
by-using effects reflect how cumulative learning experience from previous adoption 
decisions influence timing of adoption (McWilliams and Zilbermanfr, 1996). 
Chapter 2 also discusses the extension of these models to multiple technology 
adoption and intensity of adoption. This encompassing theoretical framework 
informs the empirical exercises of Chapters 4, 6 and 7. The rationale for its‟ 
application to adoption and use of innovations in a health care setting, as well as 
previous empirical research on the adoption and use of new prescription drugs, 
medical equipment and ICTs by GPs, is discussed in the relevant empirical chapters.  
 
In Chapter 3, we introduce our secondary dataset, comprising of the GMS 
Prescribing and GP Characteristics Databases, which is used in the empirical 
investigation of the timing of first prescription of new drugs by Irish GPs in Chapter 
4. The GMS Prescribing Database provides us with data on GPs prescribing history 
over a 4½ year time period with information on the characteristics of the 625 GPs 
themselves. Diffusion curves are used to graphically illustrate prescribing patterns of 
the sample of 1,137 drugs. In general, three patterns emerge: a relatively constant 
proportion of GPs prescribing these drugs, an increase in the proportion of GPs 
prescribing these drugs, and a decrease in the proportion of GPs prescribing these 
drugs. In addition, the GP Characteristics Database, representing a third of all GPs 
who hold a contract to treat public GMS patients in Ireland, includes information on 
nursing and clerical support, location, and GP age. This matched dataset provides us 
with a rich source of data, and enables us to investigate the influence of 
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disequilibrium, equilibrium and learning-by-using influences on adoption of new 
prescription drugs by GPs. 
 
In Chapter 4, we address our first research question and explore the determinants of 
the timing of the first prescription of new drugs by GPs in Ireland. The Irish primary 
health care system provides a distinctive setting for this empirical exercise, given the 
commercial and prescribing autonomy which characterise Irish general practice. A 
focused literature review on prescribing behaviour by physicians is presented in this 
chapter. In our empirical analysis, we identify six drugs new to the Irish market, 
which see strong take-up by GPs and which operate on different physiological 
organs and systems, and identify commonalities in the adoption of these six drugs. 
Drawing on the theoretical framework described in Chapter 2, we use duration 
analysis to explore the influence of GP characteristics (rank effects), strategic 
behaviour (stock and order effects), informational acquisition (epidemic learning 
effects) and learning-by-using on prescribing innovation.  
 
Primary data collection, described in detail in Chapter 5, was undertaken to enable 
the empirical analyses of medical equipment and ICT adoption by general practices 
in Ireland, presented in Chapters 6 and 7 respectively. The purpose of this data 
collection is to reflect the nature of the general practices surveyed and their use and 
medical equipment and ICT, within the equilibrium, disequilibrium and learning-by-
using framework. All Irish general practices were surveyed. A sample size of 601 
was achieved, representing a 42 per cent response rate. This representative sample of 
Irish general practices and provides us with, previously unavailable, data to analyse 
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the adoption of medical equipment and ICT by Irish general practices from an 
economic perspective. 
 
In Chapter 6, we address our second research question and examine what influences 
the use of medical equipment by general practices in Ireland. A review of previous 
empirical studies on adoption and use of medical equipment in general practice is 
included in this chapter. In our empirical analysis, we focus on six items of medical 
equipment. In general, the majority of general practices utilise this equipment and we 
use diffusion curves to graphically illustrate their adoption over time. Here, we 
extend the application of our encompassing theoretical framework to multiple 
technology adoption, and apply multivariate Probit analysis to identify 
commonalities in the determinants of the probability of use of these six items of 
medical equipment. Specifically, we determine the influence of epidemic, rank, order 
and learning-by-using effects on the inter-related use of these six items of medical 
equipment. 
 
In Chapter 7, we address our third research question and identify the factors which 
influence intensity of ICT use in Irish general practices. A review of literature 
relating to ICT use is presented in this chapter, and our encompassing theoretical 
framework is extended to intra-practice diffusion. We distinguish between ICT use 
for administrative and patient care functions, and categorise practices as being 
„basic‟, „intermediate‟ or „enhanced‟ users of ICT for both these purposes. We use 
ordered Probit analysis to identify the influence of epidemic, rank and learning-by-
using effects on intensity of ICT use with respect to both administrative and patient 
care functions. 
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Chapter 8 outlines the contribution of this thesis to knowledge and theory, and 
discusses potential policy implications arising from this research. Research 
limitations are briefly discussed. A future research agenda is also suggested. 
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CHAPTER 2: THEORETCIAL MODELS OF ADOPTION 
 
2.1 Introduction 
The purpose of this chapter is to present the conceptual framework of this thesis. The 
main theoretical approaches used to explain adoption and intensity of adoption of 
innovations are presented. Our encompassing theoretical model of adoption, 
incorporates the equilibrium, disequilibrium and learning-by-using models of 
adoption, and informs the empirical analyses of this thesis. We also outline how the 
Irish general practice environment and the nature of the innovations examined may 
influence adoption decision-making.  
  
The contribution of new technology to economic welfare is only realised when the 
technology is widely used and diffused (Hall and Khan, 2003; Rogers, 2003; Hall, 
2004). Diffusion results from a series of individual decisions to begin using the new 
technology, i.e. to adopt the new technology (Hall and Khan, 2003). Adoption and 
diffusion are often discussed as two separate literatures, however, diffusion is the 
cumulative or aggregate result of a series of individual calculations that weigh the 
incremental benefits of adopting an innovation against the costs of change 
(McWilliams and Zilbermanfr, 1996). The rate or level of diffusion can be 
determined by summing up these individual decisions (Hall and Khan, 2003), and it 
is widely accepted that the rate of diffusion varies across technologies, industries, 
and countries (Rosenberg, 1972; Stoneman, 1987). 
 
Three complementary theoretical approaches have been used to explain the timing of 
innovation decisions. Equilibrium models, reflecting organisational characteristics 
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and strategic interactions, have been used primarily to examine the first adoption of 
new technologies by firms (Karshenas and Stoneman, 1993), while disequilibrium 
models, which take account of epidemic and learning effects, have been used 
primarily to examine innovation by individuals (Rogers, 2003), and learning-by-
using models reflect how cumulative learning from previous adoption decisions 
influence timing of adoption (McWilliams and Zilbermanfr, 1996). These theoretical 
models of adoption inform the empirical analyses of this thesis. To our knowledge, 
these models have not previously been applied to an empirical analysis of the 
adoption of innovations by health care professionals. 
 
In addition to presenting previous theoretical and empirical studies of adoption, we 
also outline the distinguishing features of the adoption decision-making examined in 
this thesis. We discuss how the Irish general practice environment is likely to 
influence adoption decision-making, as well as outlining how the nature of the 
innovation, such as prescription drugs, medical equipment and ICT, may also 
influence uptake and use. 
 
The rest of the chapter is organised as follows. The disequilibrium, equilibrium and 
learning-by-using approaches to the adoption and use of innovations are presented in 
Section 2.2, and the extension of these theoretical approaches to intensity of adoption 
is discussed in Section 2.3. Section 2.4 discusses how the general practice 
environment, as well as the nature of the three innovations, may influence adoption 
decision-making. Section 2.5 concludes this chapter. 
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2.2 Theoretical Models of Timing of Adoption 
This section discusses the disequilibrium, equilibrium and learning-by-using models 
of timing of adoption, specifically, the influence of epidemic, rank, stock, order and 
learning-by-using effects on the timing of adoption of new innovations. This section 
also outlines how these theories of adoption have developed, as well as discussing 
their complementary and competing aspects. Table 2.1 also provides a brief 
description of these influences on the timing of adoption of new technologies.  
 
Table 2.1: Influences on Timing of Adoption of Innovations 
Disequilibrium 
Model of 
Adoption 
Epidemic 
Learning Effects 
Potential adopters adopt a new innovation 
upon learning of its existence 
 
 
 
 
Equilibrium  
Model of 
Adoption 
Rank Effects Potential adopters  obtain different returns 
from the use of a new technology due to 
different inherent characteristics and 
therefore adopt at different times 
 
Stock Effects As the number of users of a new technology 
increases, the marginal benefits from 
adoption declines 
 
Order Effects Early adopters (those higher in the adoption 
order) obtain greater returns from their use of 
the new technology than later adopters 
Learning-by-
Using Model 
of Adoption 
Learning-by-Using 
Effects 
Potential adopters adopt a new technology 
earlier if they have cumulative learning 
experience from previous adoption decisions.  
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In the disequilibrium models of adoption, information is asymmetric and adoption is 
driven by information flows. The epidemic models regard diffusion as resulting from 
the spread of information, and assume that (i) a potential user will adopt a new 
technology upon learning of its existence and (ii) information on the existence of the 
technology is spread by direct contact between a potential user and user (Baptista, 
1999). Therefore, the simple epidemic models purport that potential users are more 
likely to adopt an innovation, the more widespread the use of that innovation by 
other members of their social system. A key aspect of the structure of the epidemic 
models is that there is an end level of use for the new technology, and the diffusion 
path is the disequilibrium approach to that end point (Stoneman, 1987).  
 
Disequilibrium studies of adoption, exemplified in Rogers‟ Diffusion of Innovations 
book, examine the adoption of a variety of innovations through the lens of epidemic 
and learning effects (Rogers, 2003). Rogers (2003) found that when the number of 
adopters of a new product or technology is plotted on a cumulative frequency basis 
over time, the resulting distribution is an S-shaped curve. Whether examining the 
adoption of agricultural innovations, new prescription drugs or public health 
initiatives, these S-shaped curves, referred to as „diffusion curves‟, follow a similar 
pattern. Adoption levels are initially slow, more rapid as adoption increases, then 
levelling off until only a small percentage of individuals have not adopted (Rogers, 
2003). 
 
In brief, epidemic theories of diffusion assume information asymmetries between 
different potential adopters resulting from factors such as location and interaction 
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with external agents. In what is considered the most influential diffusion study of all 
time, Ryan and Gross (1943) investigated the adoption of hybrid corn in Iowa 
(Rogers, 2003). This pioneering study found that early adopters of hybrid corn were 
those farmers with formal education and those who were frequent visitors to Des 
Moines, Iowa‟s largest city (Ryan and Gross, 1943). Another classic diffusion study 
also found evidence of epidemic learning effects with respect to the adoption of a 
new drug by physicians, with early adopters of a new antibiotic, tetracycline, 
attending more out-of-town medical meetings that late adopters (Coleman et al., 
1966).  
 
Since these earlier studies, a substantial diffusion and adoption literature has 
developed across a range of disciplines. Epidemic effects have been measured in 
many ways and applied to the analysis of the adoption of a wide range of 
technologies and innovations, although their influence on the timing of adoption is 
not always consistent (Karshenas and Stoneman, 1993; Baptista, 1999; Baptista, 
2000; Burton et al., 2003; Hall and Khan, 2003). However, the basic hypothesis of 
the simple epidemic model is that non-adopters are more likely to innovate, the more 
widespread adoption by other member of their social system.  
 
Unlike the implicit assumption of asymmetric information in disequilibrium models 
of adoption, equilibrium models assume that information in the economy is perfect. 
In equilibrium models, differences in the timing of adoption therefore occur not 
because of the spread of information but because of the gains from adoption relative 
to its costs. As these gains change over time, so too does the number of adopters. 
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Interestingly, Stoneman (1983) in equilibrium studies of adoption also reports 
evidence of S-shaped diffusion curves when the cumulative percentage of adopters is 
graphed over time.   
 
Three equilibrium effects on the timing of adoption are generally identified: rank, 
stock and order effects. Rank effects result from the assumption that potential 
adopters of a technology have different characteristics and therefore may obtain 
different returns from the use of a new technology. Here, potential adopters‟ 
heterogeneity is the key driver of the timing of adoption (Karshenas and Stoneman, 
1993). Empirical studies use firm characteristics, such as firm size and human 
capital, to measure rank effects. There is substantial evidence of rank effects 
influencing timing of adoption of new technologies, although these effects are not 
always consistent across economies or technologies (Baptista, 2000; Battisti et al., 
2007). In a study investigating the adoption of Computer Numerically Controlled 
(CNC) machines in the UK engineering industry,  Karshenas and Stoneman (1993) 
report that firm size positively influences timing of adoption. A subsequent study of 
the adoption of CNC machines and microprocessors in the UK also reports a positive 
size effect on timing of adoption (Battisti et al., 2007). Similarly, a study, examining 
ICT adoption by businesses in the UK and Switzerland, reports a positive size effect 
in relation to ICT adoption by Swiss firms, but no such effect in relation to adoption 
by UK firms. Rank effects are also measured in the adoption literature as human 
capital, firm age, and R&D, although the empirical evidence of their influence on 
adoption is not altogether consistent. Human capital positively influences the timing 
of ICT adoption in the UK and Switzerland, whereas R&D investment positively 
influences the timing of ICT adoption by Swiss firms only (Battisti et al., 2007). 
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However, there is no evidence of R&D investment influencing the adoption of CNC 
machines and microprocessors in the UK (Battisti et al., 2007). In general, there is 
strong evidence in the innovation literature of firm heterogeneity, or rank effects, 
influencing timing of adoption. The equilibrium model of adoption purports that, in 
addition to firm characteristics, strategic behaviour, conceptualised as stock and 
order effects, also influences timing of adoption. 
 
Stock effects are based on the idea that as the number of users of a new technology 
increases, the benefits from adoption decline. This steadily reduces the benefit-cost 
ratio until, at a certain point in time, the number of accumulated adopters makes 
adoption by the remaining non-adopters undesirable. Order effects suggest that an 
individual or organisation‟s position in the adoption order determines its returns 
from the use of the technology. Earlier adopters – those higher in the adoption order 
– will obtain greater returns than later adopters. Therefore, if a potential adopter 
expects the number of future adopters to be high, it will decide to adopt earlier 
(Karshenas and Stoneman, 1993). Both the stock and order effects capture strategic 
behaviour reflecting trade-offs between the costs and benefits of adoption by co-
related agents.  
 
Although the order and stock effects models imply that the profitability of adoption 
declines as the number of adopters increases, these effects are conceptually different. 
Firstly, the stock effect models focus on the equilibrium number of adopters and the 
associated lower profitability of adoption. Therefore, given an increase in the stock 
of adopters, the stock effect models predict a lowering of the probability of adoption. 
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In essence, the stock effect captures a negative effect on adoption. Contrastingly, the 
order effect models focus on the anticipation of subsequent adoptions. Therefore, if 
potential adopters anticipate high levels of uptake of a new technology, the order 
effect models predict a higher probability of adoption. So, the order effect has a 
positive effect on adoption.  
 
This conceptual distinction underlies the choice of variables used to capture the order 
and stock effects in empirical analyses. Therefore, in the limited empirical studies to 
date, stock and order effect variables are constructed based on the stock of pervious 
adopters and the timing of adoption relative to timing of adoption by other firms in 
the sample respectively. There is limited evidence of stock and/or order effects 
influencing timing of adoption (Karshenas and Stoneman, 1993; Baptista, 2000), 
although there is evidence of such effects in relation to the adoption of multiple 
technologies, where the technologies are complementary (Stoneman and Kwon, 
1994) or simultaneously adopted (Stoneman and Toivanen, 1997).  
 
Recent literature has also focused on learning-by-using effects when modelling 
adoption decisions, whereby a firm increases its‟ stock of knowledge based on its‟ 
previous experience with technologies.
10
 Previous studies report that learning from 
                                                 
10
 McWilliams and Zilbermanfr (1996) highlight three types of “learning” that play an important role 
in the adoption and demand for new technologies. “Learning by Doing”, as described by Rosenberg 
(1982), which is producers of a new technology learning over time how to make the technology more 
cheaply and/or to improve the quality of technology. “Learning by Doing” explains the supply of 
technology, and so is not pertinent to this study. The second type of learning is “Learning-by-using”, 
which Rosenberg (1982) describes as the effect of the users of a given technology increasing their 
productivity over time as they learn how to better use this new technology. McWilliams and 
Zilbermanfr (1996) highlight how economists use learning by doing and learning-by-using 
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the adoption of complementary technologies, complementarities between various 
functional groups of the same technology and the use of previous technology 
vintages positively impact on adoption decisions (Stoneman and Kwon, 1994; 
Colombo and Mosconi, 1995; McWilliams and Zilbermanfr, 1996; Stoneman and 
Toivanen, 1997; Arvantis and Hollenstein, 2001).  
 
A number of studies which report evidence of learning-by-using effects influencing 
timing of adoption are briefly discussed. Empirical studies report learning-by-using 
effects influencing adoption patterns within the Italian metalworking industry 
(Colombo and Mosconi, 1995) and the adoption of computer technology by farmers 
in California (McWilliams and Zilbermanfr, 1996). These studies highlight that 
technological interdependencies and cumulative learning-by-using effects are 
important determinants of firms‟ adoption decisions. Arvantis and Hollenstein 
(2001) also find strong evidence of learning-by-using effects in the adoption of 
technologies. They specifically investigated the existence of cumulative learning 
effects that may arise from the use of an earlier generation of manufacturing 
technologies which embody constituent elements of later applied, more advanced 
ones. Their findings are in line with those of Colombo and Mosconi (1995) that 
learning from the use of previous technology vintages within the same functional 
                                                                                                                                          
interchangeably, however, there is a clear supply and demand side distinction between the two 
(Rosenberg, 1982). Therefore, we will also refer to this particular learning process whereby a firm 
increases its‟ stock of knowledge based on its‟ previous experience with technologies as learning-by-
using. McWilliams and Zilbermanfr (1996) present the third type of learning as the „traditional‟ form 
of learning which involves potential adopters gathering information about the performance of the new 
technology. These epidemic „learning‟ effects, which have previously been discussed, capture a firm‟s 
ability to absorb knowledge from external sources and exploit it for its own innovative activities.  
 
29 
 
group positively impacts on the adoption of more advanced technologies. Therefore, 
previous empirical studies clearly indicate that learning-by-using effects positively 
influence the adoption of new technologies. It is nonetheless important to note that in 
contrast to much of the literature, Cabral and Leiblein (2003) find no evidence that 
experience with older technologies influences adoption decision-making. 
 
It is also worth noting that given the influence of learning-by-using effects on 
adoption decisions, there is clear validation in examining adoption within a multiple 
technology adoption framework. For instance, Stoneman and Kwon (1994)  were the 
first to explore the simultaneous diffusion of two new technologies. In line with 
Karshenas and Stoneman (1993), their study incorporated the main theoretical 
streams in the diffusion literature, namely the rank, stock, order and epidemic 
effects. Stoneman and Kwon (1994) put forward the hypothesis that the adoption of 
any one technology will be affected not only by variables relating to itself but also 
by variables relating to other technologies. Stoneman and Kwon‟s (1994) empirical 
results clearly indicate the existence of significant cross-technology effects in 
relation to the price and adoption timing of the technologies. As previously 
mentioned, subsequent studies also found evidence of cross-technology effects with 
respect to adoption decisions (Colombo and Mosconi, 1995; Stoneman and 
Toivanen, 1997), and highlight the importance of examining adoption and use of 
technologies within a multiple-technology framework as there may be cross-
technology effects influencing adoption decisions.  
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We conclude this section with a brief discussion on how the three theories of 
adoption, equilibrium, disequilibrium and learning-by-using, have developed as 
complementary approaches to adoption decision-making. The epidemic models of 
adoption were initially based on theories modelling the spread of diseases, and also 
feature very strongly in the marketing and sociological literature on diffusion 
(Baptista, 1999; Hall, 2004). Within this literature, the epidemic model of adoption 
has been used primarily to explain uptake of new technologies by individuals. 
Karshenas and Stoneman (1993) were forerunners in incorporating the 
disequilibrium model of adoption with the equilibrium model of adoption to 
investigate businesses adoption decisions.  
 
As discussed above, the main distinctions between the disequilibrium and 
equilibrium approaches to modelling timing of adoption is their implicit assumption 
about the availability of information and their behavioural content. In disequilibrium 
models information is asymmetric and adoption is driven by information flows; in 
equilibrium models information is perfect and adoption is driven by benefit-cost 
ratios. Despite these differences, Karsheanas and Stoneman (1993) viewed the 
equilibrium and disequilibrium models of diffusion as complementary rather than 
conflicting approaches and modelled both simultaneously.  
 
This approach of treating the equilibrium and disequilibrium approaches as 
complementary has continued in the innovation literature; with little discussion as to 
how the disequilibrium and equilibrium models of adoption interrelate with each 
other, particularly in relation to the conflicting assumptions of imperfect and perfect 
information. The equilibrium model of adoption assumes perfect information; 
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however, if this assumption is relaxed to less than perfect information it is likely that 
the model continues to work, and predictions that timing of adoption is influenced by 
firm characteristics and strategic behaviour still hold true. Relaxation of the 
assumption of perfect information removes the primary competing aspect of these 
two models. 
 
More recently, learning-by-using effects have been incorporated in economic studies 
of adoption. To date, learning-by-using effects have been used to explain adoption 
by businesses. Some authors have attempted to categorise learning-by-using effects 
within the equilibrium or disequilibrium models of adoption. It has been argued that 
the extent to which a firm has learned from the experience of previous adoption 
decisions can be considered a firm characteristic, i.e. the firm‟s stock of knowledge 
that distinguishes firms from each other. This line of reasoning would indicate that 
learning-by-using effects can be considered an extension of rank effects. However, 
one could also argue that learning-by-using effects could be deemed a feature of the 
disequilibrium model of adoption, and as a result of information asymmetries, 
information acquisition and learning can develop from within the business as well as 
from interactions with those outside the business. Categorising learning-by-using 
effects within the equilibrium or disequilibrium model of adoption is not necessarily 
important given that they are generally treated as complementary approaches in the 
innovation literature. 
 
Empirical studies exploring the influence of cumulative learning on timing of 
adoption decisions have generally treated learning-by-using effects as an appendage 
to the more established equilibrium and disequilibrium models of adoption, and have 
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not specifically identified the learning-by-using model of adoption as a mechanism 
for examining adoption decision-making on a par with the disequilibrium and 
equilibrium models of adoption. Also, the conceptualisation of learning-by-using 
effects has remained limited to focusing on learning from the adoption of 
complementary technologies and earlier technology vintages (Colombo and 
Mosconi, 1995; Arvantis and Hollenstein, 2001). 
 
The disequilibrium, equilibrium and learning-by-using theoretical models, employed 
to examine the timing of adoption and multiple technology adoption decisions, have 
also been extended to examine the intensity of use of an innovation following its 
adoption. Section 2.3 focuses on the application of the disequilibrium, equilibrium 
and learning-by-using models to intensity of use of adopted innovations. 
 
2.3 Theoretical Models of Intensity of Adoption  
Recent economic literature examining the adoption of innovations argue that an 
understanding of the intensity of use by adopting firms is of as much importance as 
understanding the decision to adopt an innovation in the first instance (Mansfield, 
1963; Battisti and Stoneman, 2003; Hollenstein, 2004; Battisti and Stoneman, 2005; 
Battisti et al., 2007). In the diffusion literature, the extent of use of an innovation is 
referred to as intra-firm diffusion, whereas the decision to adopt an innovation 
initially is referred to as inter-firm diffusion. There is limited data on within firm use 
of a new technology over time, resulting in few empirical studies of intra-firm 
diffusion (Battisti et al., 2007). However, a small number of studies have examined 
the intra-firm diffusion of technologies drawing on aspects of the equilibrium, 
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disequilibrium and learning-by-using models of adoption. Interestingly, these studies 
find that inter-firm and intra-firm adoption decisions are driven by different factors 
(Hollenstein, 2004; Battisti et al., 2007), indicating that being an early adopter does 
not necessarily translate into being an extensive user.  
 
Our knowledge of the intra-firm diffusion process is much less developed than our 
knowledge of the inter-firm diffusion process (Battisti and Stoneman, 2003). 
Mansfield‟s (1963) seminal work identifies „stylised facts‟ in relation to intra-firm 
diffusion: (i) intra-firm diffusion takes time and follows a similar shaped growth 
curve to inter-firm diffusion, i.e. initial levels of use are low, increasing rapidly to a 
point of inflexion, and then increases at a decreasing rate until an asymptote is 
reached, (ii) different firms exhibit different paths of intra-firm diffusion, and (iii) 
different technologies exhibit different paths of intra-firm diffusion. Battisti and 
Stoneman (2003) suggest that these facts are widely accepted but there is little 
agreement in the literature as to why these patterns emerge in this way. Mansfield 
(1963) hypothesises that initial use of a technology by a firm is limited because risks 
of use are high. However, this risk reduces with ownership and use, and as it does 
extent of use increases and intra-firm diffusion proceeds. Consequently, much of the 
limited literature on intra-firm diffusion has largely relied on epidemic effects 
models.  
 
However, subsequent studies have disputed that these epidemic effects explain intra-
firm diffusion. For example, Battisti and Stoneman (2003) in an examination of 
timing of adoption and intensity of adoption of CNC machines, report that low-use 
and high-use co-exist for common adoption dates. Therefore, time since adoption 
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cannot be the sole determinant of intra-firm diffusion as suggested by the epidemic 
model. Using backward projection techniques, Battisti and Stoneman (2003) show 
empirically that the inter-firm effect is more important in the early stages, and the 
intra-firm effect is more important in the later stages of the whole diffusion process. 
Battisti and Stoneman (2003) stress that inter-firm diffusion patterns alone are a poor 
indicator of overall diffusion and argue that much greater emphasis should be placed 
on intra-firm issues in future diffusion research.  
 
A number of studies (Battisti, 2000; Battisti and Stoneman, 2003) argue that 
theoretical propositions made in the inter-firm diffusion literature, namely the 
equilibrium model effects, should also be applied to studies of intra-firm diffusion. 
Thus, in determining the extent to which to use a new technology the firm will 
compare the profitability of further use against the cost of use. The profitability of 
further use may differ across firms, due to firm characteristics and capabilities, and 
may differ across technologies, due to various technology-related factors (Battisti 
and Stoneman, 2003; Battisti and Stoneman, 2005). Empirical investigations of the 
hypothesis that equilibrium effects influence intra-firm diffusion report conflicting 
results. For instance, Battisti and Stoneman (2005), in an examination of intensity of 
use of CNC machines, report that profitability considerations are important in 
relation to intra-firm diffusion, particularly in relation to firm size and the use of 
complementary technologies and managerial techniques. Interestingly, Battisti et al. 
(2007) find that firm size does not impact on intra-firm diffusion in either the UK or 
Switzerland, indicating that smaller firms, having adopted ICT, use it to the same 
extent as larger firms. There is a lack of empirical studies of the influence of 
learning-by-using effects on intensity of adoption, however, Battisti and Stoneman 
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(2005) report that use of complementary technologies positively influences intensity 
of use of CNC machines.   
 
There is conflicting evidence in relation to the influence of epidemic effects on intra-
firm diffusion, i.e. intensity of use. For example, Battisti and Stoneman (2005) report 
little evidence of epidemic effects; however, they acknowledge that their epidemic 
effects‟ variables may not be capturing the essence of the non-equilibrium model. 
They further hypothesize that learning may involve active search rather than passive 
information acquisition as purported by the epidemic model. In a previous study, 
Hollenstein (2004) reports that the capacity to absorb external knowledge is 
important in relation to intensity of ICT use, distinctly more important than its‟ 
impact on adoption in the first instance. Hollenstein (2004) purports the plausibility 
of this finding given the more complex problems to be solved when a large set of 
ICT elements are being used. 
 
To summarise, it is clear that the theoretical models of adoption developed to 
examine timing of adoption can also be applied to empirical examinations of 
intensity of adoption of innovations, i.e. intra-firm diffusion. Previous research 
indicates that being an adopter does not necessarily translate into being an extensive 
user (Hollenstein, 2004; Battisti et al., 2007), highlighting the need to examine the 
overall adoption process – adoption and intensity of adoption.  
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2.4 Adoption Decision-Making in Irish General Practices 
As previously discussed in Section 1.2, Irish general practices enjoy considerable 
strategic freedom with respect to health care provision and practice development. As 
self-employed private health care practitioners, Irish GPs are assumed to maximise 
utility functions that are increasing in profits and service delivery. In this thesis we 
examine GPs decision-making concerning the adoption of three distinctive types of 
innovation: new prescription drugs, medical equipment and ICT. In this section, we 
discuss how the nature of the three types of innovation may influence GPs‟ decision-
making.  
 
The prescribing adoption decision differs from other adoption decisions in a number 
of ways due to the distinctive nature of this innovation. Firstly, a GP prescribes a 
drug to a patient to treat a particular condition or ailment; therefore, in weighing up 
the costs and benefits of adoption of a new drug a GP is primarily concerned with the 
clinical efficacy of the drug which will have a direct impact on their patient‟s health. 
Secondly, given that Irish GPs are not constrained by prescribing budgets nor 
directly affected financially from prescribing decisions it is unlikely that drug prices 
influence their decision-making. Therefore, for the most part, prescribing decisions 
are likely to be altruistic in nature. Although, we must assume that, like any small 
business, GPs‟ decision-making is influenced by commercial considerations, and 
they will, at the very least, consider how their decisions may be perceived by 
potential patients. Furthermore, as previously mentioned, Irish GPs prescribing 
decisions are not constrained by NICE guidelines or based on practice or nationally-
agreed formularies, such as the British National Formulary (BNF). Therefore, 
although we expect GPs to be influenced by peer prescribing decisions, prescribing 
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decisions are made at the individual GP level. A further interesting aspect of the 
adoption of „new-to-market‟ branded drugs is the intense pre-release marketing 
which accompanies new drugs, and ensures GPs are well informed of their arrival on 
the market.  
 
Similar to a prescribing innovation, the adoption and use of medical equipment by 
general practices has direct implications for patients and the health care they receive. 
However, the nature of the adoption decision differs in that a general practice must 
decide to invest in a piece of equipment as opposed to an individual GP deciding to 
write a prescription. As previously discussed, Irish general practices incur the 
monetary cost of acquiring an item of medical equipment and this cost would usually 
be shared by the GPs in the practice. In addition, costs may include upkeep of 
equipment, as well as training costs to ensure efficient and correct use.  Therefore, 
this innovation, where the cost of acquisition and use is incurred by the business 
unit, is closer to the innovations generally examined within the economics literature 
and through the lens of the equilibrium models of adoption. Also, increasing the 
range of diagnostic and treatment capabilities of a practice must influence 
commercial aspects of the business. However, the health care provision aspect to the 
use of medical equipment cannot be ignored, with uptake of medical equipment 
equally likely to be influenced by the desire to improve service provision.   
 
The third innovation that features in our examination of adoption decision-making is 
ICT. Numerous studies have examined the adoption of ICT by firms. Indeed, the 
benefits to businesses of adopting ICT are well documented, as it is medical settings, 
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including general practice (Kvist and Kidd, 1998; Misan, 2003). In our intra-practice 
diffusion exercise, we explore the factors which influence the intensity of ICT use by 
general practices. Therefore, we are not concerning with the adoption of the 
innovation in this instance, but more so with increasing use of a range of ICT 
applications. There are similarities between this adoption decision and the previously 
discussed adoption decisions, particularly the use of medical equipment decision-
making. We assume that general practice‟s ICT use is influenced both by 
profitability and service provision considerations, and similar to medical equipment 
use can improve business efficiency as well as health care provision. Furthermore, 
intensity of adoption decision-making differs from adoption decision-making with 
respect to the costs and benefits of such decision-making. Within the context of this 
study, the cost of adopting ICT in the first instance would be considerable for an 
individual practice; although the cost of incorporating additional ICT applications is 
likely to vary relative to the types of ICT applications. In some instances costs are 
likely to be significantly lower as practices choose to use additional ICT applications 
available from their existing ICT package; although, on other occasions, more 
extensive ICT use may necessitate the purchase of new software. Similarly, some 
ICT applications such as a practice website development may incur additional costs. 
Similar to medical equipment use, more intensive ICT use might require additional 
training. However, in general, risks of adoption reduce with ownership and use of 
technologies and, consequently, general practices can reap the benefits of more 
extensive ICT use.   
 
The types of innovation examined in this thesis are discussed above to illustrate how 
the similar and contrasting features of these innovations are likely to influence their 
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adoption and use by Irish GPs. GPs are assumed to maximise utility functions that 
are increasing in profitability and service provision. Given the commercial and 
health care provision elements of the general practice environment and in line with 
the literature documented in the previous sections, we expect equilibrium, 
disequilibrium and learning-by-using effects to influence adoption decision-making 
in Irish general practices. As discussed above, the specific features of each 
innovation are likely to influence the trade-off between business and patient care 
motivations, and subsequently affect the relative impact of the three sets of 
influences on adoption behaviour. For completeness, we incorporate the equilibrium, 
disequilibrium and learning-by-using effects on adoption to our integrated 
examination of adoption decision-making in Irish general practices. Further 
justification for the application of this theoretical framework to the adoption and use 
of new prescription drugs, medical equipment and ICT in Irish general practices is 
discussed in Chapters 4, 6 and 7 respectively.   
 
2.5 Conclusion 
Three complementary theoretical approaches are used to explain the timing of 
adoption decisions. In general, disequilibrium models of adoption reflect 
informational and learning effects. In empirical analyses, epidemic effects are 
conceptualised to measure the likelihood of individuals interacting with others, and, 
therefore, learning about new technologies. Then, according to the disequilibrium 
model of adoption, potential adopters adopt new technologies upon learning of their 
existence. 
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In equilibrium models, differences in the timing of adoption occur, not because of 
the spread of information but, because of the incremental benefits of adoption 
relative to its costs. The equilibrium model of adoption identifies three effects on the 
timing of adoption: rank, stock and order effects. Ranks effects result from the 
assumption that potential adopters of a technology have different inherent 
characteristics, therefore, obtaining different returns from adoption. Here, potential 
adopters‟ heterogeneity is the key driver of timing of adoption. Stock and order 
effects capture strategic behaviour, whereby potential adopters are influenced by the 
adoption decisions of co-related agents. Specifically, as the stock of adopters 
increases, the marginal benefits from adoption declines (stock effect); and those 
higher in the adoption order obtain greater returns from adoption (order effect). 
 
The final influence on timing of adoption of new technologies identified is learning-
by-using effects. Learning-by-using effects are based on the assumption that 
potential adopters adopt a new technology earlier if they have cumulative learning 
experience from previous adoption decisions. Many authors view the disequilibrium, 
equilibrium and cumulative learning models of adoption as complementary and 
empirically model them simultaneously with respect to timing of adoption. These 
theoretical models have also extended to multiple technology adoption and intensity 
of adoption studies. 
 
The equilibrium, disequilibrium and learning-by-using models of adoption inform 
our empirical analyses. The autonomous nature of Irish general practice suggests the 
potential for both commercial and service provision motivations to influence 
adoption decision-making. The nature of the innovation being adopted is likely to 
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influence the extent to which commercial or service provision considerations impact 
on decision-making. In Chapters 4, 6 and 7, we discuss the applications of these 
theoretical models to innovative decision-making in general practices in Ireland and 
also present previous empirical research on the adoption and use of new prescription 
drugs, medical equipment and ICT by GPs. 
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CHAPTER 3: A DESCRIPTION OF THE GMS PRESCRIBING AND  
GP CHARACTERISTICS DATABASES 
3.1 Introduction 
This chapter describes the GMS Prescribing and GP Characteristics Databases. The 
GMS Prescribing Database has information on GPs prescribing history over 4½ 
years, and the GP Characteristics Database provides us with information about the 
GPs themselves. This data is used to address our first research question and identify 
the determinants of the timing of adoption of new prescription drugs by Irish GPs, as 
presented in Chapter 4.  
 
In Ireland, GPs play a core role in the provision of primary care to the general 
population (Department of Health and Children, 2001; Thomas and Layte, 2009). As 
previously discussed in Chapter 1, in general, Irish GPs are self-employed, private 
practitioners who choose where they set up their practices, who they employ, and 
how they equip their practices (Department of Health and Children, 2001; Wren, 
2003). They provide a range of services to their patients, including patient 
examination and diagnosis, prescription of medication, ordering of tests, 
performance of minor surgeries, and referral of patients to other health care 
providers (Competition Authority, 2010). 
 
Certainly, an integral part of the health care service provided by GPs to their patients 
is the prescribing of medication, and consequently consumer access to new 
prescription drugs is mainly through GPs (Prosser et al., 2009; Thistlehwaite et al., 
2010). In line with the commercial autonomy Irish GPs enjoy, they also have 
considerable autonomy with respect to their prescribing decisions. Once a particular 
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drug has been approved for use by the Irish Medicines Board, GPs can prescribe it to 
their patients.
11
 Nor are they constrained by prescribing guidelines, such as the 
National Institute for Clinical Excellence (NICE) guidelines in the UK. We have at 
our disposal a dataset which allows us to match prescribing data with data on GP  
charactersitics. The purpose of this chapter is to describe this matched dataset, 
comprising of the GMS Prescribing Database and the GP Characteristics Database. 
This data is used in the empirical analysis in Chapter 4, where we explore the factors 
which shape the timing of the first prescription of six new drugs by GPs in Ireland. 
 
This chapter is organised as follows. Section 3.2 describes the GMS Prescribing 
Database, and identifies patterns and trends in the prescribing patterns of a sample of 
approximately 625 Irish GPs. Section 3.3 describes the GP Characteristics Database. 
Finally, section 3.4 concludes this chapter with a synoposis of the matched dataset, 
outlining the advantages and limitations of this data.  
 
3.2 GMS Prescribing Database 
The GMS Prescribing Database contains data for all prescriptions filled for GMS 
patients in the Southern, South-Eastern and North-Eastern Health Boards for the 
period October 1999 to March 2004.
12
 When a GMS (public) patient gets a 
prescription from a GP, they fill it either in a pharmacy or, if their GP has a 
                                                 
11
 Drugs authorised by the IMB do not automatically receive a GMS code, although most drugs do. 
Drugs that receive a GMS code can be prescribed to public (GMS) patients. 
12
 Prior to January 2005, the Irish health care system comprised of eight regional health boards which 
were responsible for delivering health care to the population of those regions. The Health Act (2004) 
legislated for the establishment of the Health Service Executive (HSE), a single entity, responsible for 
delivering health care for the population of Ireland (See Appendix 1 for maps of regional health 
boards and HSE regions). 
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dispensing licence, at the GP practice. The medicine is dispensed free of charge to 
the patient and a duplicate of the prescription is sent by the dispenser to the GMS 
(Payments) Board for payment.
13
 A number of details are entered into the 
prescribing database, including GP identifiers, dispenser identifiers, drug details 
which follow the Anatomical Therapeutic Chemical (ATC) classification system
14
, 
and quantity prescribed. As this dataset relates to payment of dispensers, it provides 
a complete record of all prescriptions dispensed. The GMS Prescribing Database 
provides monthly data for the period October 1999 to March 2004. This section, 
firstly, describes the process of restructuring the GMS Prescribing Data to drug-level 
observations and, secondly, describes the prescribing patterns by GPs over the 54 
month time period. 
 
As received, the GMS Prescribing Database consisted of 54 monthly files 
comprising of two data files – the extract file and the drug file.15 The extract files 
contain information on each prescription filled for each patient, consisting of 
variables such as GP number, pharmacy number, patient number, prescribing GP 
number and drug code. The corresponding drug file contains information on each 
drug, such as drug code, ATC classification, defined daily dose, strength and price. 
The link variable, drug code, enabled us to merge the extract and drug files for each 
month. The prescription level observations in each monthly file ranged from 
approximately 600,000 to 1,000,000. 
 
                                                 
13
 In Budget 2010, a new charge of 50 cent per item was announced to be introduced in October 2010. 
This charge did not apply within the timeframe of this study. 
14
 The ATC classification system is described in detail later in this section. 
15
 The monthly files were provided by the HSE in the form of Digital Audio Tapes (DAT) (Oct 1999 
– Dec 2001) and CDs (Jan 2002 – Mar 2004). These DAT files were downloaded to CDs using a 
DAT tape drive in .out format. All monthly files were converted to Stata 11. 
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Next, the prescription level observations were converted to drug level observations. 
Each drug is classified according to the Anatomical Therapeutic Chemical (ATC) 
classification system, which divides drugs into different groups according to the 
organ or system on which they act and their chemical, pharmacological and 
therapeutic properties (World Health Organisation, 2008). Drugs are classified in 
groups at five different levels. The drugs are divided into fourteen anatomical main 
groups (1st level), with one pharmacological/therapeutic subgroup (2nd level). The 
3rd and 4th levels are chemical/pharmacological/therapeutic subgroups and the 5th 
level is the chemical substance. The following example illustrates the structure of the 
ATC code A10BA02 for the drug metformin. 
 
    Table 3.1: ATC classification of metformin 
ATC Code  Classification Levels 
A  Alimentary tract and metabolism 
(1st level, anatomical main group) 
A10  Drugs used in diabetes 
(2nd level, therapeutic subgroup) 
A10B  Blood glucose lowering drugs, excl. insulins 
(3rd level, pharmacological subgroup) 
A10BA  Biguanides 
(4th level, chemical subgroup) 
A10BA02  Metformin 
(5th level, chemical substance) 
     Source: World Health Organisation (2008) 
 
Therefore, in the ATC classification system all plain metformin preparations are 
given the code A10BA02. As illustrated in Table 3.1, the code A10BA02 provides 
five levels of information regarding this particular drug. This drug acts on the 
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alimentary tract and metabolism system (A) and is a drug used to treat diabetes 
(A10). It is a blood glucose lowering drug (A10B), with a chemical subgroup 
comprising biguanides (A10BA) and the chemical substance metformin (A10BA02). 
All ATC codes provide the same level of information and can be read in the same 
manner.
16
   
 
The restructured database provides drug-level observations for 1,137 drugs over 54 
months. The GMS Prescribing Database also contains GP identifiers for the GPs in 
the Southern, South-Eastern and North-Eastern Health Boards. The number of GPs 
over the period October 1999 to March 2004 ranged from 573 to 799.
17
 The 
restructured database provides us with data on whether or not each GP prescribed 
each drug in each of the 54 months. This allowed us to identify the date of first 
adoption of each drug by each GP and to construct diffusion curves for each drug 
reflecting the proportion of GPs prescribing each drug each month. 
 
The GMS Prescribing Database, even in its restructured format, is a large and 
cumbersome dataset. To provide an overview of dynamics within the dataset, it was 
decided to generate the percentage of GPs prescribing each drug in the first year 
(October 1999 – September 2000) and last year (April 2003 – March 2004) of the 
sample, categorise them into deciles and construct a 10 by 10 crosstabulation (Table 
3.2). This 10 by 10 crosstabulation is essentially a transition matrix, reflecting 
transitions in the level of prescribing by GPs of all 1,137 drugs in the first year of the 
                                                 
16
 The ATC codes are referred to as „drugs‟ from this point onwards. However, it is important to note 
that the ATC codes essentially provide the generic names for these drugs, and there may be a number 
of brands of each ATC code on the market. 
17
 The analysis was constrained to prescribing decisions by GPs for patients on their GMS patient list, 
i.e. prescriptions written by locums are not included in this restructured database. In general, GP 
characteristics data is not available for locums, so they were removed from the analysis. This allows 
the analysis to focus on GPs prescribing decisions in relation to public patients on their GMS lists. 
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sample and in the final year of the sample. Each count in the transition matrix refers 
to a drug, and while the drugs in each cell cannot be identified from the transition 
matrix, they can be identified from the dataset. The transition matrix allows for a 
greater understanding of general transitions in prescribing patterns by GPs at the 
beginning and end of the sample. In general, the level of prescribing of each drug 
follows one of three patterns: (i) a relatively constant proportion of GPs prescribing 
it, (ii) an increase in the proportion of GPs prescribing it, or (iii) a decrease in the 
proportion of GPs prescribing it. We identify and discuss a number of drugs which 
follow one of these three adoption patterns and draw diffusion curves to illustrate 
adoption patterns over the 54 months.
18
 
 
The transition matrix can be read as follows. Each count in the transition matrix 
refers to a drug. Therefore, 596 drugs were prescribed by the first decile of GPs in 
the first year of the sample (October 1999- September 2000) and by the first decile 
of GPs in the last year of the sample (April 2003 – March 2004). While the 596 
drugs in this cell cannot be identified from the transition matrix, they can be 
identified from the dataset. An example of one of these drugs consistently prescribed 
by less than 10% of GPs is D01AA01 or nystatin, an antibiotic.  
 
Similarly, all other cells on the leading diagonal represent drugs which are 
prescribed by a similar proportion of GPs in the first and last year of the sample. As 
is evident from Table 3.2, one drug is prescribed by more than 90 per cent (tenth 
decile) in the first and last year of the sample. From the database, this drug is 
identified as acetylsalicylic (B01AC06), or as it‟s more commonly called aspirin. 
                                                 
18
 It is important to note that these drugs are chosen to illustrate adoption patterns, and are not chosen 
for any other reason. 
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Further examples of drugs that are generally prescribed by the same proportion of 
GPs in the first and last year of the sample include phenobarbital (N03AA02), an 
antiepileptic, and chloramphenicol (S01AA01), an eye antibiotic.  
 
It must be stressed that the transition matrix identifies patterns in prescribing patterns 
in the first and last year of the sample. We have identified four drugs from the 
transition matrix which are prescribed by the same proportion of GPs in the first and 
last years of the sample. Next, we draw diffusion curves for these four drugs, which 
illustrate the cumulative percentage of GPs prescribing these drugs over the 54 
month sample. Diffusion curves, discussed in detail in the previous chapter, 
essentially illustrate the cumulative percentage of adopters over time. In general, 
diffusion curves follow a similar pattern –  adoption levels are initially slow, more 
rapid as adoption increases, then levelling off until only a small percentage of 
individuals have not adopted (Rogers, 2003). As discussed in Chapter 2, the 
epidemic models of adoption generally assume that a potential user will adopt a new 
technology upon learning of its existence. Rogers (2003) found that when the 
number of adopters of a new product or technology is plotted on a cumulative 
frequency basis over time, the resulting distribution is an S-shaped curve. Stoneman 
(1983), examining adoption within the equilibrium model, also states “if one can 
explain the date of adoption by individual firms, then by aggregation one should 
have the inter-firm or intrasectoral diffusion curve”. As per Rogers (2003) and 
Stoneman (1983), we illustrate adoption levels of the aforementioned drugs over the 
54 month time frame (Figure 3.1).  
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Table 3.2: Transition Matrix of Drug Adoption in First and Last Year of Sample 
 First Year of Sample 
(October 1999- September 2000) 
 
First 
Decile 
Second 
Decile 
Third 
Decile 
Fourth 
Decile 
Fifth 
Decile 
Sixth 
Decile 
Seventh 
Decile 
Eight 
Decile 
Ninth 
Decile 
Tenth 
Decile 
Total 
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0
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First 
Decile 596 28 10 2 1 2 1 0 1 0 641 
Second 
Decile 48 57 15 2 0 1 0 0 0 0 123 
Third 
Decile 19 22 19 9 2 0 0 0 0 0 71 
Fourth 
Decile 8 7 15 25 7 4 0 0 1 0 67 
Fifth 
Decile 3 8 2 11 16 7 4 0 0 0 51 
Sixth 
Decile 5 1 1 4 8 18 8 0 0 0 45 
Seventh 
Decile 6 0 2 3 6 6 20 5 0 0 48 
Eight 
Decile 3 0 2 0 1 6 7 22 12 0 53 
Ninth 
Decile 2 0 1 0 0 0 2 6 15 11 37 
Tenth 
Decile 0 0 0 0 0 0 0 0 0 1 1 
 
Total 690 123 67 56 41 44 42 33 29 12 1,137 
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Figure 3.1: Illustrative Curves for Consistently Prescribed Drugs: Oct 99-Mar 
04 
 
Figure Key: Graphs present the proportion of GPs prescribing Nystatin (A), Acetylsalicylic (B), 
Phenobarital (C), and Chloramphemicol (D) over time.  
  
Figure 3.1 clearly illustrates that the proportion of GPs prescribing these drugs is 
relatively constant across the 54 month time-frame. When viewing these diffusion 
curves, it is necessary to remember the sample is a 4½ year time-frame. Therefore, 
the diffusion curves presented in Figure 3.1 are in fact a snapshot or a portion of the 
S-shaped curve of these drugs over a longer timeframe. Given the flatness of these 
diffusion curves (Figure 3.1), it is possible to surmise that we are seeing the latter 
portion of their corresponding S-shaped curves where the level of adoption levels 
off. It is also likely that the remaining GPs in the sample are essentially non-
adopters.  
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789 of the 1,137 drugs are accounted for in leading diagonal in the transition matrix, 
indicating that approximately 70 per cent of the drugs in this sample are prescribed 
by the same proportion of GPs in the first and last year of the sample. We can 
assume that the diffusion curves for these 789 drugs would be, similar to the 
diffusion curves in Figure 3.1, relatively flat over the 4½ year period. However, we 
are particularly interested in identifying drugs that are prescribed by increasing 
proportions of GPs over time. Such drugs can also be identified from the transition 
matrix. 
 
Cells below the leading diagonal of the transition matrix indicate drugs which are 
being prescribed by a higher proportion of GPs in the last year of the sample than the 
first year of the sample. 214 of the 1,137 drugs fall into this category. The closer the 
cell is to the leading diagonal the smaller the movement between deciles, while the 
further the cell is from the leading diagonal the greater the movement between 
deciles. For example, in the first year of the sample two drugs were prescribed by the 
first decile of GPs and by the ninth decile of GPs in the last year of the sample. One 
of these drugs was identified from the dataset as being esomeprazole (A02BC05), a 
proton pump inhibitor. The diffusion curve for esomeprazole is presented in Figure 
3.2(A). As is evident from the graph, in the first year of the sample, no GPs in the 
sample were prescribing esomeprazole, although from early 2002 over 80% of GPs 
in the sample were prescribing it to their patients. The diffusion curve for celecoxib 
illustrates a similar pattern (Figure 3.2(B)).  
 
It is likely that the diffusion curves for esomeprazole and celecoxib are in fact 
complete S-shaped curves, illustrating patterns of no adoption, followed by 
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increasing adoption levels and then a levelling-off with respect to adoption levels. 
Given the length of time with respect to the levelling-off of adoption levels for both 
drugs, it is likely that the remaining GPs are essentially non-adopters. As previously 
mentioned, the change in the proportions prescribing each drug from the beginning 
to the end of the time-frame can be easily seen in the transition matrix by the 
distance of the cell in which a drug is accounted for from the leading diagonal. When 
the increase in the proportion of GPs prescribing a drug from the first to the last year 
of the sample is relatively large, then such a drug is accounted for in a cell far from 
the leading diagonal. This is the case for esomeprazole and celecoxib. 
 
Figure 3.2: Illustrative Curves for Drugs with Increasing Adoption Levels 
Figure Key: Graphs present the proportion of GPs prescribing Esmoprazole (A), Celecoxib (B), 
Alfuzosin (C), and Alendronic Acid (D) over time.  
 
Diffusion curves (Figure 3.2(C-D)) are also drawn for two additional drugs, 
alfuzosin (G04CA01) and alendronic acid (M05BA04), which are also prescribed by 
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more GPs later in the time-frame. It is clear from the diffusion curves for both drugs 
that they were being prescribed by some GPs in the sample prior to October 1999, so 
again it is likely that we are viewing a portion of an extended S-shaped curve over a 
longer time period. It is also worth noting that both drugs were identified from cells 
close to the leading diagonal in the transition matrix. Therefore, the increase in the 
proportion of GPs prescribing alfuzosin and alendronic acid is less relative to the 
increase in the proportion of GPs prescribing esomeprazole and celecoxib in the 
sample time-frame.  
 
To reiterate, approximately 70 and 19 per cent of the 1,137 drugs in the GMS 
Prescribing Database are prescribed by a similar and higher proportion of GPs in the 
last year of the sample compared to the first year of the sample respectively. The 
remaining drugs in the sample are prescribed by a lower proportion of GPs in the last 
year of the sample than in the first year of the sample. These drugs are accounted for 
in cells above the leading diagonal in the transition matrix. 134 of the 1,137 drugs, 
approximately 11 per cent of the sample, fall into this category.  
 
From the transition matrix, one drug is identified as being prescribed by over 80% 
(ninth decile) of the sample in the first year falling to under 40% (fourth decile) of 
the sample in the last year. From the dataset, this drug is identified as thioridazine 
(N05AC02), an antipsychotic. From the transition matrix, it is clear two drugs 
prescribed by the sixth decile of GPs in the first year of the sample decreased to 
being prescribed by the first decile in the last year of the sample. From the dataset, 
one of these drugs is identified as loratadine (R06AX13), an antihistamine. 
Diffusion curves for both thioridazine and loratadine, presented in Figure 3.3, 
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illustrate that both drugs saw a general decrease in adoption levels across the 54 
month time-period. The adoption pattern with respect to loratadine indicates a 
seasonal effect in the first half of the time-frame with less GPs prescribing this 
antihistamine in the winter months, however, adoption levels decrease steadily from 
mid-2001, with evidence of a small increase in adoption levels in Summer 2003.   
 
Figure 3.3: Illustrative Curves for Drugs with Decreasing Adoption Levels  
Figure Key: Graphs present the proportion of GPs prescribing Thiordazine (A) and Loratadine (B) 
over time. 
 
The purpose of this section is to describe the restructured GMS Prescribing 
Database. This data provides a rich source of data in relation to Irish GPs‟ 
prescribing patterns. The transition matrix allows us to identify some general 
patterns in relation to the adoption levels of these 1,137 drugs in the first and last 
year of the sample. Diffusion curves are used to further illustrate these patterns over 
the entire 4½ year time frame.  
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Approximately 70% of the 1,137 drugs are prescribed by the same proportion of GPs 
in the first and last year of the sample. The diffusion curves for these drugs are 
generally flat, indicating that we are seeing a snapshot of the latter part of Rogers‟ 
(2003) S-shaped diffusion curve, where the level of adoption has levelled off. Over 
50% of the 1,137 drugs are prescribed by less than 10 per cent of GPs in the first and 
in the last year of the sample. 
 
The level of adoption of 214 drugs increased over the 4½ year time-period. The level 
of adoption of 134 drugs decreased over the same time-period. This indicates that the 
GPs in the sample increased the portfolio of drugs they prescribe to public patients 
over the 4½ year time period.  
 
3.3 GP Characteristics Database 
In the GMS Prescribing Database each GP has a unique numerical identifier which is 
also included in the GP Characteristics Database. These identifiers are used to match 
each GP‟s prescribing innovations to their background characteristics in the GP 
Characteristics Database. Compiled in 2001, approximately the middle of the time 
period covered by the GMS Prescribing Database, the GP Characteristics Database 
provides GP & practice characteristics for 625 GPs in the Southern, South-Eastern 
and North-Eastern Health Boards. This sample of GPs comprises almost a third of all 
GPs in Ireland who hold a contract to treat provide public GMS patients (Health 
Service Executive, 2002), and provides this study with time-invariant GP and 
practice characteristics variables. 
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Table 3.3: Description of Variables in GP Characteristics Database 
Variable Name Variable Description Mean              St. Dev.           
Practice Nurse  
 
Practice with a nurse 0.58 0.49 
Practice Secretary  
 
Practice with a secretary 0.79 0.41 
Rural Practice  
 
Practice located in rural area (and in 
receipt of Rural Practice Allowance) 
0.12 0.32 
 
Dispensing Practice 
 
 
Practice has in-house dispensary  
 
0.12 
 
0.32 
IDTS60 
 
GPs receive 60 per cent of savings 
made from meeting prescribing targets 
0.37 0.48 
 
IDTS50 
 
 
GPs receive 50 per cent of savings 
made from meeting prescribing targets 
 
0.24 
 
0.42 
 
IDTS40 
 
 
GPs receive 40 per cent of savings 
made from meeting prescribing targets 
 
0.39 
 
0.49 
 
GP Age 
 
 
GP age in years 
 
49 yrs 
 
8.3 yrs 
Source: GP Characteristics Database 
  
Table 3.3 provides descriptive statistics for the GP and practice characteristics in this 
dataset.
19
 In 2001, 58 per cent and 79 per cent of GPs in the sample worked in a 
practice with a nurse and secretary respectively. 12 per cent of GPs in this sample 
were in receipt of a rural practice allowance, as they live and practice in an area with 
a population of less than 500 people. Given their remote location, these practices 
often dispense medication. 12 per cent of GPs worked in a dispensing practice. The 
average age of GPs in the sample is 49 years of age. 
 
The GP Characteristics Database also contains variables identifying whether GPs 
were beneficiaries from the Indicative Drug Treatment Scheme (IDTS). This 
initiative, intended to reduce overall prescribing costs, provided incentives for GPs 
                                                 
19
 These variables are discussed in the context of the theoretical models of adoption in Chapter 4.  
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able to reduce their prescribing costs and receive a percentage of the savings made to 
invest in their practice. Targets were calculated based on their previous year‟s 
prescribing costs, controlling for the age and sex of the patients.
20
 GPs were placed 
in one of three categories, which indicated the percentage of savings they were 
entitled to as a result of meeting drug costs targets. 37 per cent of GP‟s previous 
years‟ prescribing costs were less than 95 per cent of the national age related average 
costs and qualified for 60 per cent of any savings made due to meeting targets. 24 
per cent of GPs qualified for 50 per cent of any savings made due to meeting targets. 
A further 39 per cent of GPs qualified for 40 per cent of any savings made due to 
meeting targets. In each of these categories, the remaining savings were made 
available to the local health board.  
 
3.4 Conclusion 
The purpose of this chapter is to introduce the GMS Prescribing Database and the 
GP Characteristics Database. The GMS Prescribing Database provides a rich source 
of data in relation to Irish GPs prescribing patterns. A transition matrix (Table 3.2) is 
used to describe the prescribing patterns of the sample of 1,137 drugs from the 
beginning and the end of the sample period. Diffusion curves are used to graphically 
illustrate these patterns of a number of drugs. In general, three patterns emerge with 
respect to the adoption of each drug: a relatively constant proportion of GPs 
prescribing these drugs, an increase in the proportion of GPs prescribing these drugs, 
and a decrease in the proportion of GPs prescribing these drugs. Almost 70 per cent 
                                                 
20
 Participation in the Indicative Drug Treatment Scheme was voluntary and GPs retained the right 
and obligation to prescribe as they considered necessary. No sanctions were in place for those GPs 
who failed to reduce costs. 
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of the 1,137 drugs represented in the GMS database were prescribed by a similar 
proportion of GPs over the entire 54 months covered by the database. These are 
likely to be established drugs for which no alternative became available during the 
sample period. The level of adoption of 214 drugs (approximately 19 per cent) 
increased over the time period, with the level of adoption of 134 drugs 
(approximately 11 per cent) decreasing over the same period. 
 
The GMS Prescribing Database is matched to the GP Characteristics Database, by 
means of a unique GP identifier. The GP Characteristics Database provides us with 
data relating to GP and practice characteristics, such as GP age, nursing and 
administrative support, and practice location. In summation, the average age of GPs 
in our sample is 49 years. More than half of the GPs work with the support of a 
nurse, and three in four GPs have clerical support. One in eight GPs are entitled to a 
rural practice allowance and have a dispensary attached to their practice. The 
majority of GPs adjusted their prescribing to benefit from the IDTS. 
 
Our matched dataset brings together information of GPs prescribing history over a 
4½ year time period with information on the characteristics of GPs themselves. The 
GMS Prescribing Database was provided to the Department of Economics, 
University College Cork on a monthly basis from October 1999 to March 2004.
21
 
While we would prefer more timely data, this unique dataset allows us to identify the 
month that GPs first prescribe drugs new to the Irish market during a 4½ year time 
period. 
 
                                                 
21
 Along with the Departments of General Practice and Pharmacy at University College Cork, the 
Department of Economics has applied for the re-instatement of the provision of this data from April 
2004 to the present. To date, the request has not been granted. 
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The matched dataset covers three of the eight Irish health boards, the Southern, 
South-Eastern and North-Eastern Health Boards. These three health boards provided 
health services to 34 per cent health services to of the Irish population and to 35 per 
cent of all GMS patients (Department of Health and Children, 2002; Health Service 
Executive, 2002). Our GP Characteristics database, which is an administrative 
database, provides us with information on GP and practice characteristics for 625 
GPs, almost all GPs with a GMS contract in these three health boards.
22
 This sample 
provides us with prescribing information for approximately one third of all Irish GPs 
who hold GMS contracts and approximately one third of all public GMS patients 
(Department of Health and Children, 2002; Health Service Executive, 2002). 
 
Both the GMS Prescribing Database and the GP Characteristics Database provides 
us with a range of variables and opportunities to construct variables to enable the 
empirical analysis in Chapter 4. These variables are discussed briefly below.
23
 Given 
the monthly nature of the prescription data, we are able to determine the date a GP 
first prescribes a new drug, and also construct time -invariant stock effects and „first-
mover‟ order effects. From the GMS Prescribing Database, we also construct a 
portfolio breadth variable which captures learning-by-using effects. The GP 
Characteristics data provides us with a number of explanatory variables which allow 
us to sufficiently measure GP heterogeneity, i.e. rank effects. However, we are 
limited to measuring epidemic learning effects by whether or not a practice is in 
receipt of a rural practice allowance.
24
  
                                                 
22
 In 2001, 1,863 GPs held contracts with the Irish government to treat public patients. Of these 1,863 
GPs, 35 per cent (657) were located in the Southern, South-Eastern and North-Eastern Health Boards. 
23
 These variables are discussed in detail in the context of the conceptual framework in Chapter 4. 
24
 For example, the Medical Equipment and IT in General Practice survey includes questions relating 
to frequency of supplier visits, educational activities, whether the practice is a training practice or 
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Our matched dataset matches two rich sources of data, the GMS Prescribing 
Database which contains data relating to the payment of dispensers for prescriptions 
filled, and the GP Characteristics Database which provides data on approximately 
one-third of all GPs who hold a GMS contract. This matched dataset allows us to 
determine the influence of equilibrium, disequilibrium and learning-by-using effects 
on the timing of adoption of new prescription drugs by Irish GPs, as presented in 
Chapter 4. 
 
  
                                                                                                                                          
holds clinics. These questions provide us with a broader range of epidemic effects to test for in the 
empirical analyses of Chapters 6 and 7. 
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CHAPTER 4: TIMING OF ADOPTION OF NEW  
PRESCRIPTION DRUGS BY IRISH GPS 
4.1 Introduction 
The overall aim of this thesis is to explain the adoption and use of innovations in 
general practices in Ireland. As discussed in Chapter 1, Irish GPs enjoy considerable 
autonomy in terms of their prescribing and commercial decision-making. In fact, 
their scope for innovative behaviour includes decisions such as whether to prescribe 
drugs new to the market to their patients, whether to invest in particular items of 
medical equipment, and the extent to which they use ICT in the running of their 
practices. This chapter focuses on prescribing innovation, specifically addressing our 
first research question: what are the determinants of the timing of adoption of new 
prescription drugs by Irish GPs? 
 
Recent years have witnessed the rapid development of drug treatments in a number 
of therapeutic areas. In Ireland, as in most other European Union (EU) economies, 
access to new drugs and treatments is mainly through primary healthcare providers 
such as GPs or family doctors (Prosser et al., 2009; Thistlehwaite et al., 2010). An 
important element of the process by which new drugs achieve widespread use is 
therefore their adoption by GPs as part of the portfolio of drugs which they 
prescribe. In this chapter we explore the factors which shape the timing of the first 
prescription of new drugs by GPs in Ireland and hence their availability to potential 
patients. We focus specifically on the adoption of six new drugs which were 
introduced to the Irish market during the period October 1999 to March 2004 and 
which represent different therapeutic areas.  
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As previously discussed, Irish GPs have significant autonomy with respect to 
prescribing decisions. In Ireland, there are no explicit guidelines in relation to 
prescribing decisions, such as the National Institute for Clinical Excellence (NICE) 
in the UK.
25
 Once a particular drug has been approved for use by the Irish Medicines 
Board, GPs can prescribe it to their patients. The majority of Irish GPs treat private 
patients but also hold a contract with the government to treat public (GMS) patients. 
Approximately, one-third of the Irish population are entitled to these means-tested 
medical cards, however, it has been estimated that the GMS patients account for 
approximately 50 per cent of all GP consultations (Competition Authority, 2010), 
and that government spending through medical card patients makes up a substantial 
part of general practices‟ funding (Thomas et al., 2008; Competition Authority, 
2010). 
 
As discussed in Chapter 2, there is a substantial body of theoretical and empirical 
literature examining individual and business decision-making concerning the use of 
new technologies and innovations. In the innovation literature, informational or 
learning effects are generally interpreted as disequilibrium determinants of adoption, 
while commercial factors are interpreted as equilibrium elements of adoption 
reflecting the influence of individual practice heterogeneity (rank effects) and 
strategic behaviour (stock and order effects). The commercial and prescribing 
autonomy which characterise Irish general practice suggests that the prescribing 
decisions of Irish GPs may reflect both medical and commercial factors. Prescribing 
innovation may enable GPs to provide more effective treatments but may also help 
                                                 
25
 However, previous studies have reported that NICE guidance has little or no impact on GPs 
prescribing behaviour or uptake of new medicines (Wathen & Dean, 2004; Carlsen et al. 2009).  
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to attract and retain mobile and commercially valuable private and public patients. 
This suggests the potential value of considering both informational and commercial 
factors as determinants of GPs‟ prescribing innovation (Karshenas and Stoneman, 
1993).  
 
This study is the first to examine prescribing innovation through the lens of 
equilibrium, disequilibrium and learning-by-using models of adoption. We attempt 
to identify commonalities in the determinants of first prescription of six drugs by 
Irish GPs. Data is taken from a matched dataset which brings together information 
on GP‟s prescribing history with information on the characteristics of GPs 
themselves (see Chapter 3 for a detailed description of both sources of data). To our 
knowledge our study is the first to use duration analysis to examine prescribing 
innovation (Baptista, 2000). Duration analysis focuses on the factors which 
determine the probability that a GP will prescribe a new drug by a specific point in 
time, and provides a method of modelling the adoption S-shaped curve for newly 
introduced drugs (Rogers, 2003). The advantage of duration analysis is that it 
enables us to adopt a holistic approach to modelling the determinants of timing of 
prescribing innovation including a range of GP and practice characteristics, strategic 
behaviour, previous prescribing behaviour and informational factors.  
 
The rest of the chapter is organised as follows. Section 4.2 briefly revisits the main 
influences on adoption (discussed in detail in Chapter 2), along with a discussion of 
previous empirical prescribing studies and the potential for both informational and 
strategic influences on the timing of GPs prescribing innovations. Section 4.3 
describes our matched dataset, profiles the group of drugs which we consider and 
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outlines our econometric approach. Section 4.4 summarises the main econometric 
results, and the implications are considered in Section 4.5.
26
 
 
4.2 Theoretical & Empirical Influences on Adoption and 
Prescribing Behaviour 
Our unit of analysis here is the individual GP, and our focus is on the factors which 
shape their prescribing innovations. For the purposes of this paper and in line with 
previous literature, a GP makes a prescribing innovation when s/he prescribes a drug 
on at least one occasion to at least one patient (Jones et al., 2001; Rogers, 2003).
27
 
Individual prescribing innovations will reflect the perceived benefits of the new drug 
compared to the alternatives, and may reflect the availability of information on the 
efficacy of the new drug as well as any commercial implications. Taken together, the 
cumulative or aggregate result and timing of prescribing innovations by GPs will 
determine the level of diffusion of each new drug (Schumpeter, 1942; Rogers, 2003; 
Hall, 2004). It is important to note that here we are concerned with the diffusion of 
these drugs in relation to GPs decisions to prescribe them for the first time, not the 
number of times which they prescribe them to their patient(s) or the extent to which 
these drugs penetrate the market, i.e. their market share.  
 
Three complementary theoretical approaches have been used to explain the timing of 
innovation decisions. These theoretical approaches to examining timing of adoption 
of new innovations are discussed in detail in Chapter 2; however it is useful to 
                                                 
26
 Some of this material has already been published in the European Journal of Health Economics 
(Bourke and Roper, 2011). 
27
 We are concerned with the „prescribing innovation‟, i.e. a GPs decision to prescribe a new drug for 
the first time, rather than the „new drug‟ innovation. 
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briefly recall the propositions of these theoretical approaches.
28
 Disequilibrium 
models reflect the learning and informational influences on timing of adoption 
(Rogers, 2003), equilibrium models take account of how organisational 
characteristics and strategic interactions influence timing of adoption (Karshenas and 
Stoneman, 1993), and learning-by-using effects reflect cumulative learning 
experience from previous adoption decisions influencing timing of adoption 
(McWilliams and Zilbermanfr, 1996).  
 
Within the equilibrium framework, three influences on timing of adoption are 
identified; rank, stock and order effects. Rank effects result from the assumption that 
potential adopters of a technology have different characteristics and therefore may 
obtain different returns from the use of a new technology. Therefore, potential 
adopters‟ heterogeneity is the key driver of the timing of adoption (Karshenas and 
Stoneman, 1993). Stock effects assume that as the number of users of a new 
technology increases, the benefits from adoption decline. This steadily reduces the 
benefit-cost ratio until a point where the number of accumulated adopters makes 
adoption by the remaining non-adopters undesirable. Finally, order effects suggest 
that an individual or organisation‟s position in the adoption order determines its 
returns from the use of the technology. Adopters higher in the adoption order will 
obtain greater returns than later adopters. Therefore, if a potential adopter expects the 
number of future adopters to be high, it will decide to adopt earlier (Karshenas and 
Stoneman, 1993).  
 
                                                 
28
 See Table 2.1 for a summary of the influences on timing of adoption. 
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Within the disequilibrium framework, epidemic learning effects assume that 
potential adopters will adopt upon learning of the existence of a new technology. 
Potential adopters learn about a new technology from adopters within their social 
system. Finally, learning-by-using effects assume that potential adopters adopt a new 
technology earlier if they have benefitted from cumulative learning experiences from 
previous adoption decisions.  
 
In line with previous studies (Karshenas and Stoneman, 1993; Battisti et al., 2007), 
we consider the equilibrium, disequilibrium and learning-by-using models of 
adoption to be complementary approaches and simultaneously model them in our 
examination of the timing of adoption by Irish GPs of new prescription drugs. We 
acknowledge that previous studies implicitly use the disequilibrium approach in 
examinations of the adoption of new prescription drugs (Coleman et al., 1966; 
Williamson, 1975; Steffensen et al., 1999; Tamblyn et al., 2003; Kozyrskyj et al., 
2007). However information about new drugs is likely to be readily available to GPs 
through pre-release marketing. Indeed, four of the drugs we consider here were 
prescribed by Irish GPs in the same month they entered the Irish market and the 
diffusion curves we observe for each of the drugs exhibit relatively rapid early 
adoption again suggesting the general availability of information and the potential 
relevance of equilibrium models.  
 
To date much of the empirical literature examining the adoption of new prescription 
drugs has focused on physician‟s personal adoption decisions and the information 
asymmetries influencing these choices (Coleman et al., 1966). Kozyrskyj, Raymond, 
and Racher (2007), for example, conducted a study on newly marketed drugs in 
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Canada to determine if early prescribers had different socio-demographic or 
professional characteristics to later adopters. In two of the four drugs examined, 
Kozyrskyj et al. (2007) found that early prescribers were more likely than later 
adopters to be hospital affiliated. Previous studies also report that adoption times for 
new drugs are shorter for partnerships than single-handed practices (Williamson, 
1975; Steffensen et al., 1999). This may reflect the idea that the larger the number of 
patients in a practice, the more likely the GP is to see a patient who might be a 
candidate for a new drug (Tamblyn et al., 2003; Dybdahl et al., 2004). However, 
Williamson (1975) puts forward a different explanation suggesting that the longer a 
doctor spends in discussion with his or her doctor colleagues, the more likely s/he is 
to be an early adopter.  
 
Other studies have highlighted the potential importance of other practice 
characteristics on the timing of first prescription emphasising that most prescribing 
decisions are multi-factorial. For example, Tamblyn et al. (2003) examined the initial 
utilisation rate of new prescription drugs among physicians in Quebec, and found 
lower utilisation rates of new drugs among physicians with a rural or remote practice 
location. The same study also reports lower utilisation rates of new drugs among 
female physicians and those with a higher proportion of elderly patients in their 
practice who might, perhaps, be less receptive to „new‟ drugs. Similarly, Prosser et 
al. (2009), in a qualitative study of the factors influencing GPs‟ uptake of new drugs 
in the North-West of England, emphasise the importance of biomedical factors on 
drug choice, along with recommendations from hospital consultants and patient 
requests. 
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Previous prescribing studies have not explicitly modelled learning-by-using effects. 
However, some studies have examined if experience with other drugs impacts on a 
GPs‟ prescribing decisions. Florentinus (2006), in a qualitative study examining the 
adoption of five drugs by a sample of approximately 100 GPs in the Netherlands, 
reports that a GP‟s decision to prescribe a new drug is very much drug dependent, 
and did not identify GP characteristics specific to early drug adoption or an 
„innovator‟ category of GP. Kozyrskyj et al. (2007), in an examination of four newly 
marketed drugs, found that early prescribers of one new drug were not early 
prescribers of all four medications. They report that attributes of a drug, such as 
perceived efficacy and improvement over existing alternatives, impact early use. 
Steffensen et al. (1999) also report that their data did not indicate a universal 
innovator or laggard with respect to adoption of all five studied drugs. Their data 
indicates that the shape and slope of the adoption curve is both dependant on 
physician and drug characteristics. Similarly, Dybdahl et al. (2004) report that early 
adoption of one type of drug is not associated with early adoption of another; 
reporting no consistent association between GPs‟ level of drug prescribing and their 
adoption of new drugs of the same therapeutic group. Therefore, the empirical 
evidence suggests that GPs‟ previous prescribing decisions do not impact on their 
decision to prescribe a new drug for the first time. 
 
The commercial and prescribing autonomy of Irish GPs suggests the potential for 
both equilibrium – i.e. market – and disequilibrium – i.e. informational – influences 
on the timing of prescribing innovation. Previous studies of prescribing innovation 
by GPs – based almost solely in the disequilibriumm tradition – have also 
emphasised the potential importance of informational effects. Given the 
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heterogeneous nature of Irish general practices, it is likely that Irish GPs prescribing 
decisions may be influenced by commercial factors. In fact, there is previous 
evidence of Irish GPs adjusting their prescribing behaviour in response to economic 
incentives (Walley et al., 2001).
29
 In addition, health economics literature frequently 
profiles GPs as economic agents who respond to economic incentives and are aware 
of the competitive structure of their environment (Scott, 2000; Morris et al., 2007; 
Kann et al., 2010), indicating the potential for strategic behaviour influencing 
prescribing decisions.  
 
4.3 Data and Methods 
Section 4.3.1 describes the six new drugs analysed in this study and graphically 
illustrates the uptake of these new drugs over time. Our empirical analysis is based 
on two matched databases, the GMS Prescribing Database and the GP 
Characteristics Database. The GMS Prescribing Database contains data for 
prescriptions filled for GMS Patients in the Southern, South-Eastern and North-
Eastern health boards for the period October 1999 to March 2004. The GP 
Characteristics Database, which is matched to the GMS Prescribing Database using a 
unique identifier, provides GP and practice characteristics for 625 GPs in the three 
health boards. Both databases are discussed in detail in Chapter 3. In Section 4.3.1, 
the data is described in the context of the conceptual framework of this study, and 
the variables measuring rank, stock, order, learning-by-using and epidemic effects 
                                                 
29
 The Indicative Drug Treatment Scheme (IDTS) was developed to contain prescribing costs. GPs 
were set indicative prescribing budgets for their public patients, and received a proportion of the 
savings for practice development. In the first year alone of the IDTS, this scheme resulted in savings 
of IR£13.5 million (€17million) (Walley et al. 2001). The IDTS is discussed in detail in Section 3.3 
 70 
are discussed. Section 4.3.2 describes the econometric analysis employed to address 
our research question. 
 
4.3.1 Description of Prescribing Dataset 
The GMS Prescribing Database, in its restructured form, allows us to identify the 
date of first adoption of all drugs by each GP and to construct adoption curves for 
each drug reflecting the proportion of GPs prescribing each drug each month. In 
general, these adoption curves follow one of three patterns: a relatively constant 
proportion of GPs prescribing a drug, an increase in the proportion of GPs 
prescribing each drug, or a decrease in the proportion of GPs prescribing the drug. 
Here, our focus is on the factors which shape the timing of GPs‟ prescribing 
innovations, i.e. the date at which they first adopt a new prescription drug. We 
therefore focus on a group of six drugs which have increasing adoption curves and 
which operate on different physiological organs or systems. Using this diverse range 
of drugs should help to eliminate any potential inter-relationships between adoption 
patterns which might stem from individual GPs having a particular interest in a 
certain therapeutic area or medical condition. It is important to also note that the 
adoption of these drugs should not be influenced by a GP‟s patient-list as they are 
not drugs which are prescribed for very specific, infrequent-occurring conditions. 
Therefore, patient demand or need should not unduly influence adoption of these 
drugs, as we would expect that all GPs in this sample would face ample opportunity 
to prescribe these drugs.
30 The drugs we consider are:  
 
                                                 
30
 Nonetheless, it is important to acknowledge that GPs adoption of new prescription drugs may be 
influenced by patient-lists, particularly if a practice has a large proportion/number of patients with a 
particular condition the new drug is intended to treat. Given the drugs chosen for this analysis, we do 
not expect this to influence their uptake. 
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(1) escitalopram, an antidepressant used in the treatment of major depressive 
episodes, panic disorder with or without agoraphobia, social anxiety 
disorder, generalised anxiety disorder, and obsessive-compulsive 
disorder,  
 
(2) esmoprazole, a proton pump inhibitor used in the treatment of active 
duodenal ulcer, active benign gastric ulcer, symptomatic erosive or 
ulcerative gastro-oesophageal, reflux disease (GORD), gastro-
oesophageal reflux disease long-term management (GORD 
Maintenance), symptomatic treatment of moderate to very severe gastro-
oesophageal reflux disease (symptomatic GORD), and Zollinger-Ellison 
Syndrome,  
 
(3) rofecoxib, a nonsteroidal anti-inflammatory drugs (NSAID), used to 
reduce pain, inflammation, and stiffness caused by osteoarthritis, 
rheumatoid arthritis and certain forms of juvenile rheumatoid arthritis, to 
manage acute pain in adults, to treat migraines, and to treat menstrual 
pain,  
 
(4) desloratadine, an antihistamine, is used to relieve the symptoms of 
allergic rhinitis (inflammation of the nasal passages caused by an allergy, 
for example, hay fever or allergy to dust mites) or urticaria (a skin 
condition caused by an allergy, with symptoms including itching and 
hives),  
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(5) nicotine is used for the treatment of tobacco dependence by relieving 
nicotine craving and withdrawal symptoms, thereby facilitating smoking 
cessation in smokers,
31
 and  
 
(6) drospirenone & estrogen is a hormonal contraceptive which acts on the 
endocrine system (Irish Medicines Board, 2008).  
 
Under European and Irish legislation, all medicinal products must be authorised 
before being marketed. Medicinal products marketed in Ireland must be authorised 
by the IMB (Irish Medicines Board, 2008). Table 4.1 provides information on the 
date of authorisation of these six drugs to the Irish market. Once authorised by the 
IMB, Irish GPs can prescribe these drugs to both public and private patients.
 32
 
However, pharmacists can only dispense drugs assigned a GMS code to public 
patients free of charge (Health Service Executive, 2006). This information is also 
provided in Table 4.1, along with the date when the first prescription for each drug 
was written by a GP(s) in the sample. For instance, Escitalopram was first licensed 
in Ireland on the 21
st
 October 2002 and received a GMS code on 1
st
 November 2002 
(Table 4.1). 
                                                 
31
 Nicotine drugs, nasal sprays and chewing gum, are also available to purchase without prescription. 
32
 An agreement between the Irish Pharmaceutical Healthcare Association (IPHA) and the HSE 
outlines the supply, terms, conditions and pricing of medicines supplied to the health care service in 
Ireland. Under the terms of the 2006 Irish Pharmaceutical Healthcare Association (IPHA)/HSE 
agreement, the HSE reserves the right to assess new and existing technologies which may incur a high 
cost or have a significant budget impact. In response to requests from the HSE, the National Centre 
for Pharmacoeconomics (NCPE) appraises the cost effectiveness of technologies (medicines, 
diagnostics and devices) to the Irish health care system. However, it is important to note that prior to 
the current 2006 IPHA/HSE agreement, pharmacoeconomic data was used on an informal basis in 
Ireland (Tilson et al, 2010). Therefore, given the time period of this study (1999-2004) this current 
authorisation process would not impact on GP‟s prescribing decisions.  
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Table 4.1: Time Line of Authorisation of Drugs to Irish Market and GMS 
Scheme 
ATC Code Chemical 
Compound 
License Issued 
by IMB 
Assigned a 
GMS code 
First 
Prescription 
N06AB10 Escitalopram 21 Oct 2002 1 Nov 2002 Nov 2002 
M01AH02 Rofecoxib 12 Nov1999 1 Jan 2000 Oct 2000 
A02BC05 Esomeprazole 18 Aug 2000 1 Oct 2000 Oct 2000 
R06AX27 Desloratadine 15 Jan 2001 1 May 2001 May 2001 
N07BA01 Nicotine  25 Jul 1996 1 Apr 2001 Apr 2001 
G03AA12 Drospirenone & 
Estrogen 
27 Oct 2000 1 Mar 2001 Apr 2001 
Source: GMS Prescribing Database and Irish Medicines Board (2008). Date of assignment of GMS 
code was provided by the HSE South Primary Care Unit. 
 
 
Diffusion curves for each of these drugs are included in Figure 4.1a-e.
33
 
Escitalopram was first prescribed in November 2002, with approximately 10 per 
cent of the sample prescribing escitalopram to their patients. From the time of first 
adoption, levels of adoption increased rapidly and by March 2004 (the last month of 
the sample period) the level of adoption was approximately 70 per cent (Figure 
4.1a).  
 
  
                                                 
33
 It is important to note that these diffusion curves are not „cumulative‟ diffusion curves. Figure 4.1 
presents graphs indicating the proportion of GPs prescribing each drug over time. Therefore, if the 
proportion of GPs prescribing these drugs decreases at certain times we see a decline in the curve, 
which would not be evident in a cumulative diffusion curve. However, Figures 4.1a-e allow us to 
observe seasonal effects.  
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Figure 4.1a: Proportion of GPs prescribing Escitalopram – Oct 1999 to Mar 2004 
 
 
Figure 4.1b: Proportion of GPs prescribing Esomeprazole - Oct 1999 to Mar 2004
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Figure 4.1c: Proportion of GPs prescribing Rofecoxib - Oct 1999 to Mar 2004 
 
Figure 4.1d: Proportion of GPs prescribing Desloratadine - Oct 1999 to Mar 
2004
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Figure 4.1e: Proportion of GPs prescribing Nicotine - Oct 1999 to Mar 2004 
 
Figure 4.1f: Proportion of GPs prescribing Drospirenone & Estrogen – Oct 
1999 to Mar 2004 
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Similar diffusion curves are evident for esmoprazole (Figure 4.1b), rofecoxib (Figure 
4.1c) and drospirenone & estrogen (Figure 4.1d) where the proportion of GPs 
prescribing the drugs increased steadily throughout the sample period. As expected 
with an antihistamine, we see a marked seasonal pattern to the proportion of GPs 
prescribing desloratadine with up to 70 per cent of GPs prescribing it during the 
summer months, and lower prescribing levels during the winter months (Figure 
4.1e). The diffusion curve for nicotine also displays a seasonal pattern with more 
GPs prescribing this drug at the beginning of the calendar year.
34
  
 
The variables reflecting the timing of GPs‟ prescribing innovations for the six drugs 
we consider form the dependent variables for our econometric analysis. A notable 
feature of each of these drugs is the extremely short time period from authorisation 
under the GMS scheme and their prescription by Irish GPs to their patients. This 
very rapid rise in the initial adoption of each new drug is also evident in the drug 
adoption curves (Figures 1a-1f), and is reported in previous literature (Dybdahl et al., 
2004; Dybdahl et al., 2005; Florentinus, 2006). This differs from the slower initial 
adoption which characterises most new technologies (Karshenas and Stoneman, 
1993; Baptista, 1999; Battisti and Stoneman, 2005), and may be a result of intensive 
pre-release marketing by pharmaceutical companies.  
 
As discussed in Section 1.2, Irish GPs do not incur a monetary or budgetary cost 
with respect to prescribing decision-making. Within the time-period of this study, 
there was no element of cost-sharing on the part of public patients for prescription 
drugs received. Therefore, we assume that the price of each of the six drugs 
                                                 
34
 This may reflect a „new year resolution‟ effect as people seek support for giving up smoking.  
 78 
examined does not influence the uptake of these drugs, nor does it influence the 
uptake of these drugs relative to the uptake of alternative drug treatments available.  
 
Next, the explanatory variables, from the GMS Prescribing Database and the GP 
Characteristics Database, used in the econometric analysis are discussed. Both 
datasets are described in detail in Chapter 3. Descriptive statistics for the explanatory 
variables, categorised within the equilibrium, disequilibrium and learning-by-using 
framework, are presented in Table 4.2. A range of independent variables are 
constructed from the GMS Prescribing Database to reflect learning-by-using, stock 
and order effects on prescribing innovation. We anticipate, for example, that GPs 
which are already prescribing a wide range of drugs, i.e. have broad prescribing 
portfolios, may be better informed about drug options. This may influence their 
access to information on new drugs potentially reducing their time to adoption. To 
reflect this learning-by-using effect, we create a prescribing portfolio variable 
defined as the range of drugs prescribed by each GP as a percentage of the total 
number of drugs being prescribed by all GPs. This variable was constructed from the 
June 2001 GMS Prescribing Database to provide consistency with the 2001 GP 
Characteristics Database. In the GMS Prescribing Database for June 2001 a total of 
874 different drugs were prescribed by GPs, with each GP prescribing on average 25 
per cent of these drugs. The broadest prescribing portfolio of any GP was 45 per cent 
of all drugs prescribed (Table 4.2).
35
 There is little research as to the influence the 
breadth of a GPs prescribing portfolio has on the likelihood of he/she adopting a new 
drug. However, there is evidence that practices with large patient numbers are more 
                                                 
35
 In a robustness check, we also constructed this variable for the first and last month of the sample; 
both portfolio variables have similar means and standard deviations to the June 2001 portfolio 
variable. 
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extensive users of new drugs than practices with small patient numbers (Tamblyn et 
al., 2003). It is likely that GPs with large patient numbers require a larger portfolio of 
drugs (See Table 4.3 for a symbolic summary of our anticipated results). 
 
To capture potential order effects we create an order variable for each of the six 
drugs. Each order variable takes a value of one where a GP was among the first 
adopters in at least one of the other five drugs being examined. Specifically, the 
order variables take a value of one where a GP first prescribed one of the other five 
drugs considered here in the first six months after its first adoption. Between 25 and 
35 per cent of GPs may be considered „first adopters‟, and take a value of one in 
relation to these order variables. A stock effect variable was also constructed for 
each of the six drugs. This is defined as the cumulative percentage of GPs who had 
adopted the drug. This variable is time-variant and is intended to reflect the stock of 
previous adopters at each point in time (Table 4.2).  
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Table 4.2: Descriptive Statistics of Explanatory Variables  
 
 Mean             St. Dev.         
Rank Effects  
Practice Nurse  Practice with a nurse 0.58 0.49 
Practice Secretary  Practice with a secretary 0.79 0.41 
Dispensing Practice Practice has in-house dispensary 0.12 0.32 
GP Age GP age in years 49 yrs 8.3 yrs      
IDTS60 
 
GPs receive 60 per cent of savings made from 
meeting prescribing targets 
0.37 0.48 
IDTS50 
 
GPs receive 50 per cent of savings made from 
meeting prescribing targets 
0.24 0.42 
IDTS40 
 
GPs receive 40 per cent of savings made from 
meeting prescribing targets 
0.39 0.49 
 
Learning-By-Using and Epidemic Effects 
Prescribing Portfolio 
Breadth  
Per cent of drugs prescribed by GP out  
of portfolio of drugs prescribed by all GPs 
0.25 0.10 
Rural Practice  
 
Practice located in rural area  
(and in receipt of Rural Practice Allowance) 
0.12 0.32 
 
Order & Stock Effects 
Order effect esciatlopram GP is an early adopter (i.e. in first 6 months of 
adoption) in at least one of the other five drugs 
0.30 0.46 
Order effect esomeprazole GP is an early adopter (i.e. in first 6 months of 
adoption) in at least one of the other five drugs 
0.34 0.47 
Order effect rofecoxib GP is an early adopter (i.e. in first 6 months of 
adoption) in at least one of the other five drugs 
0.25 0.43 
Order effect desloratadine GP is an early adopter (i.e. in first 6 months of 
adoption) in at least one of the other five drugs 
0.31 0.46 
Order effect nicotine GP is an early adopter (i.e. in first 6 months of 
adoption) in at least one of the other five drugs 
0.33 0.47 
Order effect drospirenone 
& estrogen 
GP is an early adopter (i.e. in first 6 months of 
adoption) in at least one of the other five drugs 
0.35 0.48 
    
Stock effect esciatlopram Time variant percentage of GPs who have 
adopted escitalopram  
0.38 0.30 
Stock effect esomeprazole Time variant percentage of GPs who have 
adopted esomeprazole  
0.19 0.30 
Stock effect rofecoxib Time variant percentage of GPs who have 
adopted  rofecoxib  
0.59 0.31 
Stock effect desloratadine Time variant percentage of GPs who have 
adopted desloratadine  
0.50 0.34 
Stock effect nicotine Time variant percentage of GPs who have 
adopted nicotine  
0.58 0.29 
Stock effect drospirenone 
& estrogen 
Time variant percentage of GPs who have 
adopted drospirenone & estrogen 
0.59 0.30 
Source: GMS Prescribing Database and GP Characteristics Database 
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There is limited empirical testing of stock and order effects in adoption behaviour 
mainly due to data restrictions, and to date the evidence of such effects are 
inconclusive (Karshenas and Stoneman, 1993; Stoneman and Toivanen, 1997; 
Baptista, 2000; Burton et al., 2003; Hollenstein and Woerter, 2004). However, for a 
number of reasons we include these strategic behaviour effects in our prescribing 
innovation analysis. Firstly the free-market environment of general practice in 
Ireland and the prescribing autonomy enjoyed by Irish GPs provides opportunities 
for strategic behaviour. Secondly, there is previous evidence of GPs responding to 
economic incentives (Scott, 2000; Morris et al., 2007; Kann et al., 2010) and, in 
particular, Irish GPs responding to monetary incentives and adjusted their 
prescribing behaviour (Walley et al., 2001). Therefore, we expect Irish GPs to 
consider the commercial costs and benefits of their decision-making; however, as 
GPs do not incur a monetary cost from prescribing new drugs, a priori, we do not 
expect these effects to unduly influence prescribing decision-making. 
 
As discussed in Chapter 3, the GP Characteristics Database provides us with the 
explanatory variables which capture disequilibrium learning effects and equilibrium 
rank effects. The epidemic models of adoption purport that a potential user will 
adopt a new technology upon learning of its existence and information on the 
existence of the technology is spread by direct contact between a potential user and 
user. Ideally, we would like to examine the influence of prescribing patterns of other 
GPs within the practice on adoption decision-making. However, our prescribing 
dataset does not provide us with practice identifiers, and therefore, we are unable to 
determine which GPs work together in practices and which GPs work alone. We 
include a rural practice allowance to measure epidemic learning effects. As is 
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evident from Table 4.2, in 2001 12 per cent of GPs in this sample were in receipt of a 
rural practice allowance, as they live and practice in an area with a population of less 
than 500 people. This variable is included as an epidemic effect, as GPs in rural 
practices are perhaps less likely to have frequent contact with colleagues or drug 
company representatives. 
 
The GP Characteristics Database provides data reflecting individual and practice 
heterogeneity, i.e. rank effects. In 2001, 58 per cent and 79 per cent of GPs in the 
sample worked in a practice with a nurse and secretary respectively. We assume that 
each of these factors would have a positive impact on the benefit-cost ratio from 
prescribing innovation and will therefore have a negative effect on the time to 
adoption. GP age may also have an effect on time to adoption. 12 per cent of GPs 
worked in a dispensing practice. It is likely that this variable will have a positive 
effect on time to adoption, as there may stock level considerations in a small 
dispensary. The average age of GPs in this sample is 49 years. As in previous studies 
we anticipate this effect to be positive, i.e. older GPs will be slower to adopt new 
drugs. We also include the Indicative Drug Treatment Scheme (IDTS) variables. In 
the early 1990s, the Irish government developed the IDTS to try to contain 
prescribing costs, whereby GPs were set indicative budgets for prescribing for their 
public patients. GPs were entitled to keep a proportion (40-60 per cent) of savings 
for projects benefitting their patients and practices. Our three IDTS variables, 
IDTS60, IDTS50 and IDTS40, represent GPs who received 60, 50 and 40 per cent of 
savings made from meeting prescribing targets respectively.
36
 A priori, it is difficult 
to anticipate how this variable would influence prescribing innovation. GPs seeking 
                                                 
36
 See section 3.3 for a discussion of the IDTS scheme. 
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to reduce prescribing costs in order to benefit from the scheme might delay 
prescribing new – and possibly more costly – drugs. Alternatively, if new drugs were 
more cost effective than existing treatments the IDTS might actually encourage 
prescribing innovation.  
 
In brief, we expect rank effects to influence prescribing innovation. Specifically, we 
expect the human capital factors - nursing and secretarial support, which may also be 
proxies for practice size – to positively influence GPs‟ drug adoption decision-
making. These expectations are in line with much of the literature (Karshenas and 
Stoneman, 1993; Baptista, 2000). We expect increasing age to negatively influence 
prescribing innovation, in line with previous studies of adoption behaviour in a 
health care setting (Masters, 2008; Meade et al., 2009). It is more difficult to 
anticipate how variables such as dispensing practice and the IDTS may influence 
prescribing behaviour. We do not anticipate the strategic behaviour order and stock 
effects having a significant influence on prescribing behaviour, given the altruistic 
non-commercial nature of this decision-making as discussed in Section 2.4. 
However, we expect learning-by-using effects, measured by the variable „portfolio 
breadth‟, to positively influence prescribing innovation. On the other hand, we 
expect rural practitioners to be slower adopters of new drugs, as purported by the 
disequilibrium model of adoption.   
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Table 4.3: Symbolic Summary of Anticipated Effects on Time to Adoption of 
New Drugs 
 
Rank Effects 
 
Practice Nurse - 
Practice Secretary - 
GP Age + 
Dispensing Practice  + 
IDTS 50  - 
IDTS 60 - 
 
Order & Stock Effects 
 
Order Effects (-)  
Stock Effects (+) 
 
Learning-by-using Effects 
Prescribing Portfolio - 
 
Epidemic Learning Effects 
Rural Practice Allowance + 
Notes: „-‟ denotes a negative and significant effect on time to adoption, i.e. faster adoption; „+‟ 
denotes a positive and significant effect on time to adoption, i.e. slower adoption; (-) denotes a 
negative and insignificant effect on time to adoption; (+) denotes a positive and insignificant effect on 
time to adoption. 
 
 
 
This section describes the six drugs identified for inclusion in the analysis of the 
determinants of first prescription of drugs by GPs. It also describes the explanatory 
variables, in the context of the equilibrium, disequilibrium and learning-by-using 
models of adoption, used in the analysis, and our anticipated results based on 
previous literature and the economic general practice environment.   
 
4.3.2 Econometric Methodology 
To model the time to adoption or prescribing innovation for each of the six drugs we 
use duration analysis. This approach allows us to develop a multivariate model for 
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time to adoption as well as allowing for the conditional nature of adoption decisions 
due to potential stock effects (Burton et al., 2003). The aim of duration analysis is to 
identify those factors which have a significant effect on the length of a spell and the 
dependent variable therefore measures the time elapsed before an event occurs 
(Baptista, 2000). In our analysis, the dependent variables measure the time elapsed 
before a drug is prescribed by a GP after the drug is first adopted by any GP in the 
sample. In other words, we are defining the length of a spell for a GP in the sample 
as the realisation of a continuous random variable, T, that has the following 
cumulative distribution function or failure function: 
 
F(t) = P(T ≤ t).         (Eqn. 4.1) 
 
For example, the Accelerated Failure Time (AFT) model assumes a linear 
relationship between the log of (latent) survival time T and characteristics X: 
 
ln (T) = β*'X + z        (Eqn. 4.2) 
where β* is a vector of parameters and z is an error term.  
 
An AFT regression coefficient relates proportionate changes in time to adoption to a 
unit change in a given regressor, with all other characteristics held constant (Jenkins, 
2005). In our analysis, t is measured in months as the prescribing data relates to the 
monthly payment of dispensers. 
 
The probability distribution of duration can be specified by the Weibull, exponential, 
log-logistic and log-normal distribution (Eqn. 4.2). To identify the appropriate 
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distribution in any specific application specification tests can be used to determine 
which distribution best fits the failure time regressions. In line with previous studies 
(Kiefer, 1988; Baptista, 2000; Greene, 2003),specification testing of the failure time 
models in this study included an examination of pseudo-residuals, or generalised 
residuals, log-likelihood scores and Akaike's Information Criterion (AIC). These 
specification tests suggested that the log-logistic distribution was the best fit for five 
(esctialopram, esmoprazole, rofecoxib, desloratadine, nicotine) of the six failure 
time regressions and that the log-normal distribution was the best fit for the 
remaining failure time regression (drospirenone & estrogen).
37
  
  
Two of the main benefits of duration models include the consideration of time and 
the capacity to control for unobserved heterogeneity in the analysis. Unobserved 
heterogeneity, or „frailty‟ as it is called in the biomedical literature, eliminates the 
effects of unobserved characteristics that remain constant over time (Jenkins, 2003). 
In our study, unobserved heterogeneity may include characteristics, such as the 
number of GPs in a practice or the practice‟s patient profile, which we could 
reasonably assume to be constant over the sample period.
38
   
 
                                                 
37
 The Cox semi-parametric proportional hazard models tend to be more widely used than the 
parametric AFT models. However, the regression parameter estimates from AFT models are robust to 
omitted covariates and are also less affected by the choice of probability distribution. In addition, the 
results of AFT models are more easily interpreted than hazard ratios (Kay and Kinnersley, 2002; 
Lambert at al., 2004). 
38
 In practice, and despite some experimentation, we found that our duration models did not converge 
when we attempted to control for unobserved heterogeneity. This issue has been noted in the literature 
(Jenkins 2003) and we discuss the implications of this in the following section.  
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4.4 Econometric Results of Timing of First Prescription of Drugs 
Duration models are used to explain time to adoption of the six drugs as a function 
of the independent variables. When interpreting the results of a duration model, a 
negative marginal effect means a factor reduces duration, i.e. reduces the time to 
adoption (Baptista, 2000). Our preferred duration models, with marginal effects 
reported, are given in Table 4.4.
39
 Given that not all GPs have adopted each drug by 
the end of the sample period, the data is right-censored.
40
 The influence of rank, 
stock, order, learning-by-using and epidemic effects on time to adoption of the six 
new drugs are discussed below. 
 
In the models we represent potential rank effects using a series of variables reflecting 
the characteristics of GPs and their practices. As presented in Table 4.4, GP practices 
with a nurse have lower times to adoption than those without a nurse for two of the 
drugs examined. This finding is statistically significant at the 1 per cent level for the 
antidepressant and statistically significant at the 5 per cent level for the hormonal 
contraceptive drug. However, it is worth noting that the size of the practice nurse 
effect is relatively small, in that time to adoption decreases by one to two weeks 
(0.25 and 0.56 of a month) for practices with a nurse in relation to these two drugs. 
Similarly, a decrease in time to adoption is reported for practices with a secretary in 
one of the six drugs, the antihistamine. This finding is statistically significant at the 5 
per cent level. Again, this is a relatively small effect with time to adoption 
decreasing by approximately two weeks (-0.50 of a month) for practices with a 
                                                 
39
 Initially, six baseline models were estimated, presented in Table A2.1. Subsequently, in a 
„stepwise‟ fashion, variables with z-statistics of less than |0.5| were excluded from the relevant failure 
time models. Comparison of Tables A2.1 and 4.4 suggests that the exclusion of a number of 
insignificant variables has little effect on coefficient signs and values. 
40
 As a robustness check, we removed the non-adopters for each drug from the sample and ran the 
duration models individually. The same results as those reported were obtained. 
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secretary in relation to one of these drugs. These findings are in line with much of 
the literature which report organisation size and human capital impacting positively 
on the adoption of innovations (Karshenas and Stoneman, 1993; Baptista, 2000). 
Also, as expected, GP age is found to have a statistically significantly positive effect 
on time to adoption in four of the drugs considered here (the antidepressant, the 
antihistamine, the smoking cessation drug and the hormonal contraceptive). 
However, the size of this effect is again relatively small, with time to adoption 
increasing in the region of 0.1 to 0.4 of a month for each increasing year. Following 
a systematic review of the literature, Masters (2008) reports similar findings in 
relation to doctors and internet adoption, with adoption being greater among younger 
doctors. There is also evidence of greater adoption of electronic patient records by 
younger GPs in Ireland (Meade et al., 2009).
41
  
 
Results in relation to the dispensing practice variable are insignificant. Finally, the 
effect of IDTS, which reflects the effect on time to adoption of receipts from drug 
cost savings, impacts on one drug, the antihistamine. Time to adoption decreases by 
a little less than two weeks for the antihistamine drug for practices eligible for 50 per 
cent of savings from meeting prescribing targets and also for those practices that 
receive 60 per cent of savings relative to those practices eligible for 40 per cent of 
savings. It is worth acknowledging that the IDTS variables may also be capturing 
informational or experiential effects. The IDTS variables capture GPs that are 
willing to change their prescribing practices to meet budgetary targets, and are 
learning and gaining experience from these prescribing decisions.   
 
                                                 
41
 However, not all small business adoption studies report significant findings in relation to age. For 
example, Burton et al (2003) report no statistically significant relationship between age of a farmer 
and the adoption of organic horticultural technology. 
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Epidemic learning effects are captured in the models specifically by the rural 
practice variable. An increase in time to adoption is reported for practices in receipt 
of a rural practice allowance for two of the drugs examined. This finding is 
statistically significant at the 5 per cent level for the antidepressant and hormonal 
contraceptive drugs, with time to adoption increasing by 0.2 and 0.9 of a month for 
rural practices. Tamblyn et al. (2003) found similar results with lower utilisation 
rates of new drugs among physicians with a rural or remote practice location. 
Coleman et al. (1966) report in the classic drug diffusion study where physicians‟ 
decisions to prescribe a new antibiotic tetracycline were investigated that early 
adopters attend more out-of-town medical meetings that late adopters. While similar 
data is not available for this study, it is fair to suggest that GPs with practices in 
receipt of a rural practice allowance are less likely to be able to attend meetings and 
conferences than urban based GPs. Similarly, it is likely that such practices are 
visited less frequently by drug company representatives, which might be an 
important source of information for GPs in relation to prescribing decisions (Jones et 
al., 2001).  
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Table 4.4: Duration models of time to first adoption – Preferred Models 
 
 
Esciatlopram
1
 
 
mfx/se 
 
Esmoprazole
2
 
 
mfx/se 
 
Rofecoxib
3
 
 
mfx/se 
 
Desloratadine
4
 
 
mfx/se 
 
Nicotine
5
 
 
mfx/se 
 
Drospirenone 
& Estrogen
6
 
mfx/se 
 
     Rank Effects 
Practice 
Nurse 
-0.253***  -0.209 -0.08  -0.559** 
(0.062)  (0.170) (0.164)  (0.236) 
Practice 
Secretary 
-0.106 0.058  -0.504** -0.237* -0.581* 
(0.078) (0.095)  (0.216) (0.131) (0.304) 
GP Age 0.012*** 0.003  0.020** 0.015** 0.044*** 
(0.004) (0.004)  (0.010) (0.007) (0.014) 
Dispensing 
Practice 
 0.163 -0.42  -0.22 0.718* 
 (0.108) (0.318)  (0.188) (0.373) 
IDTS50 -0.044 0.013  -0.459** 0.082 -0.328 
(0.071) (0.089)  (0.196) (0.124) (0.276) 
IDTS60 -0.06 -0.135  -0.458***  -0.269 
(0.063) (0.083)  (0.176)  (0.243) 
    Epidemic Effects 
Rural 
Practice  
0.181**  0.295 0.26 0.159 0.909** 
(0.083)  (0.311) (0.225) (0.183) (0.380) 
    Learning-By-Using Effects 
Portfolio 
Breadth 
-3.176*** -5.817*** -8.322*** -10.518*** -10.117*** -5.882*** 
(1.118) (1.861) (1.398) (3.181) (2.188) (1.292) 
Portfolio 
Breadth
2
 
2.99 5.343  9.267 9.658**  
(2.360) (3.644)  (6.597) (4.533)  
Order 
Effects 
-1.698*** -0.277* -6.016*** -8.635*** 0.694*** -1.044*** 
(0.128) (0.153) (0.374) (0.318) (0.130) (0.297) 
Stock 
Effects 
12.375*** 10.531*** 15.954***  6.155*** 20.632*** 
(0.208) (0.402) (0.949)  (0.775) (0.935) 
N 23366 8607 8176 13628 10871 15082 
Chi- 
squared 
665.933 609.9 988.226 430.136 793.732 291.571 
Log-
likelihood 
828.98395 294.391 395.43572 274.67431 714.38295 7.7404151 
AIC -1627.97 -560.782 -768.871 -521.349 -1400.77 14.519 
BIC -1507.08 -461.937 -691.773 -416.07 -1298.65 128.838 
Notes: Models all include seasonal dummies (not reported). Models predict time after first adoption 
by any GP, hence N differs depending on time of first adoption. Specifically N denotes the number of 
GPs in each month who have not prescribed the drug. *** denotes significance at the 1 per cent level; 
** at the 5 per cent level and * at the 10 per cent level.  Variable definitions are given in Table 1.  
Drug Descriptions: 1 – Antidepressant; 2 - Proton Pump Inhibitor; 3 - Anti-inflammatory; 4 - 
Antihistamine; 5 - Smoking Cessation Medicines; 6 -Hormonal Contraceptive. 
Source: GMS Prescribing Database and GP Characteristics Database.  
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The portfolio breadth variable, which was constructed to capture learning-by-using 
effects, reveals a consistent effect.  Across all six drugs and statistically significant at 
the 1 per cent level, time to adoption decreases for GPs who prescribe drugs from 
larger portfolios. As demonstrated by the marginal effects for this variable, time to 
adoption decreases substantially for all six drugs for GPs who have larger 
prescribing portfolios. A percentage increase in a GPs portfolio decreases time to 
adoption of these drugs from three to ten and a half months. As discussed in the 
previous section, this relationship between portfolio size and time to adoption is non-
linear in relation to the nicotine drugs, suggesting a u-shaped relationship between 
portfolio breadth and time to adoption. Previous studies have highlighted that being 
an early adopter of one drug does not impact on subsequent adoption decisions 
(Steffensen et al., 1999; Dybdahl et al., 2004; Kozyrskyj et al., 2007), however, our 
study highlights that the relative size of a GP‟s prescribing portfolio significantly 
impacts on the decision to prescribe a new drug. It is also possible that our portfolio 
breadth variable could also be considered a proxy for practice size, as the more 
patients a GP sees the more likely they require a larger portfolio of drugs from which 
to prescribe. Previous studies have reported higher utilisation rates of new drugs for 
larger practices, as measured by practice volume (Tamblyn et al., 2003).  
 
In our duration models, potential order effects variables for each drug are 
represented by a dummy variable taking a value of one where a GP prescribed at 
least one of the remaining five drugs in the first six months after their first adoption. 
There are strongly statistically significant negative order effects for four of the six 
drugs. As is evident from Table 4.4, time to adoption decreases in these drugs for 
GPs who are deemed „first-movers‟ in the other drugs being examined. In relation to 
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the antidepressant and hormonal contraceptive drugs, time to adoption decreases by 
approximately four to six weeks for „first-mover‟ GPs. The order effect is quite large 
in relation to the anti-inflammatory and antihistamine drugs with time to adoption 
decreasing by six and eight months for „first-movers‟ respectively. In standard terms, 
this suggests that some GPs are early adopters of new drugs in order to maximise the 
returns from that new adoption given anticipated future levels of adoption 
(Karshenas and Stoneman, 1993). It is important to note however that time to 
adoption of nicotine increases for „first mover‟ GPs. Previous literature has reported 
order effects in relation to the adoption of multiple technologies, where the 
technologies are complementary (Stoneman and Kwon, 1994) or simultaneously 
adopted (Stoneman and Toivanen, 1997). While the six drugs in this study are not 
complementary therapies, they were adopted over a similar time-period. A plausible 
explanation here is that, some GPs who for whatever reason were early adopters of 
one drug have learnt the benefits of early adopting, and therefore tend to be early 
adopters of other drugs. 
 
Finally, in our models potential stock effects are represented by the proportion of 
GPs who had adopted a drug at any given point in time (Karshenas and Stoneman, 
1993). We find a positive effect (i.e. time to adoption increases as the stock of 
previous adopters increases) for five of the six drugs examined. As is evident from 
Table 4.4, for each percentage increase in the stock of previous adopters, time to 
adoption increases from six to twenty months for these five drugs. It is unlikely GPs 
have sufficient information or ability to correctly anticipate future adoption patterns. 
However, the stock of previous adopters in all 6 drugs over the time-period in 
question is high relative to the non-adopters. For instance, within the first year of the 
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adoption of all 6 drugs, over half of GPs in the sample have adopted them; in fact, 
sometimes this figure is greater than 70 per cent. Therefore, given the rapid adoption 
rates of these drugs, it is perhaps not surprising that as the stock of previous adopters 
increases time to adoption increases for the remaining GPs (some of whom may 
remain non-adopters). Stoneman and Kwon (1994) in a study of the adoption of 
complementary technologies also report evidence of stock effects. 
 
In this chapter, we examine the factors which lie behind the rapid adoption by Irish 
GPs of six prescription drugs following their launch in the Irish market. Our study 
highlights a range of commonalities across all of the drugs considered and suggests 
the importance of GP and practice characteristics, strategic behaviour, informational 
and cumulative learning factors in shaping prescribing decisions. Our evidence on 
rank effects, intended to capture the differential benefit-cost ratio of adoption by GPs 
with different characteristics, largely mirrors that of other studies. Practices with 
either a nurse or clerical support are more likely to be early adopters of new drugs as 
are younger GPs. We also find evidence that the IDTS, designed primarily to reduce 
prescribing costs, may also be having additional benefits by stimulating early 
adoption. However, it is important to note that in general the size of these rank 
effects is relatively small in terms of reducing or increasing time to adoption. 
 
More surprising, perhaps, is that we find strongly significant stock and order effects. 
GPs who have a track record of early adoption tend also to be early adopters of any 
new drug (order effect)
42
 and, the larger the proportion of GPs which have already 
                                                 
42
 Being an early prescriber of one drug in our data does predict early adoption of some drugs. 
However it is not a strong predictor of being an early adopter of all drugs examined. For instance, no 
GP in the sample adopted all six drugs within the first six months of them being adopted. This 
contradicts the image of early adopters as being related to a general innovative predisposition. 
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adopted a new drug the slower is subsequent adoption (stock effect). The standard 
interpretation of the stock and order effects in studies of new technology adoption by 
firms relates to the impact of the timing of adoption on the subsequent returns 
(Karshenas and Stoneman, 1993). Here, given the commercial autonomy of Irish 
GPs similar effects may be operating. Other potential, and observationally 
equivalent, explanations for these effects may relate more directly to information 
flows, a suggestion reinforced by the epidemic and learning-by-using effects we also 
find. Prescribing innovation tends to be slower in rural practices suggesting that 
isolated GPs with less opportunity for acquiring information about new drugs are 
slower to innovate. We find evidence of learning-by-using effects influencing the 
timing of first prescription of all six drugs examined, with slower adoption among 
GPs with narrower prescribing portfolios.  
 
It is worth noting that the availability of similar drugs in the same therapeutic class 
may affect the uptake of each of the drugs examined. While Irish GPs‟ prescribing 
decisions are not constrained by NICE guidelines or based on the British Medical 
Formulary (BMF), it would be important to consider how availability of and 
information concerning alternative treatments may influence adoption decision-
making. In Chapter 8, we discuss future research possibilities, one of which is an 
analysis of the determinants of adoption of drugs from the same therapeutic class. 
The availability of similar drugs could be incorporated in the study by including the 
„stock‟ of adopters of alternative drugs in the analysis. 
 
                                                                                                                                          
Therefore, it appears that a GPs decision to prescribe is heavily dependent on the new drugs in 
question (Dybdahl et al. 2005, Steffensen et al, 1999).  
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The duration models used enable the consideration of a wide range of factors on the 
timing of prescribing innovations. In fact, the innovation literature highlights the 
lack of panel data in relation to adoption of new innovations (Battisti et al., 2007). 
Three important limitations of this empirical study are worth highlighting, however. 
First, a common idea in the literature is that new drugs diffuse into general practice 
through a two-step model with hospital consultants as the innovators and GPs as the 
followers. In other words, it is the consultant who initially prescribes the new drug 
and GPs repeat prescribe these drugs when the patient returns to the primary care 
setting. Florentinus‟ (2006) study of the adoption of new drugs in a Danish primary 
care setting, however, contradicts this two-step model. While acknowledging the 
influence of medical specialists in GPs‟ prescribing decisions, Florentinus (2006) 
finds that GPs themselves are responsible for a considerable amount of all early 
prescriptions for new drugs. Here, data restrictions mean that we are not able to 
control for the potential influence of hospital consultants on GPs‟ prescribing 
decisions. However, of the six drugs examined, four (the antihistamine, the smoking 
cessation medication, the hormonal contraceptive and the antidepressant) are 
unlikely to be repeat prescriptions following an initial prescription by a hospital 
consultant. It is perhaps more likely that prescribing decisions for the proton pump 
inhibitor and the anti-inflammatory considered here may be more strongly influenced 
by hospital consultants‟ initial prescribing decisions. Secondly, due to data 
restrictions we do not control for the impact of advertising in relation to GPs 
decisions to adopt these six drugs. However, this is something to be considered in 
future research. Advertising noise or impact could be measured through a citation 
search in medical journals or ranking the market power of the pharmaceutical 
companies which initially released these drugs.  
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As discussed in the methodology section, an advantage of duration models is the 
ability to control for unobserved heterogeneity. However, our duration models did 
not fit when we attempted to control for unobserved heterogeneity.
43
 Jenkins (2003) 
acknowledges that the frailty models can be relatively „fragile‟ in the statistical 
sense, as they can be relatively hard to fit particularly if the frailty variance is close 
to zero. Jenkins (2003) highlights three sources of potential bias in „non-frailty‟ 
duration models. Firstly there is potential to over-estimate the degree of negative 
duration dependence, and under-estimate the degree of positive duration dependence. 
Secondly, the proportionate effect of a given regressor on the hazard rate may no 
longer be constant and independent of survival time. Thirdly, the estimate of a 
positive (negative) coefficient derived from the non-frailty model will underestimate 
(over-estimate) the „true‟ estimate. Jenkins (2003) also reports that the empirical 
literature generally confirms these theoretical propositions. However, he concludes 
that if a fully flexible specification of the baseline hazard function is used, then the 
magnitude of the biases in the „non-frailty‟ model is diminished. While unobserved 
heterogeneity is likely to exist in these duration models, our explanatory variables 
differentiate between individual GPs well.  
 
4.5 Conclusion 
The purpose of this chapter is to explain the determinants of timing of first 
prescription of new drugs by GPs. The Irish primary health care system provides a 
distinctive setting for such an examination. The commercial and prescribing 
autonomy which characterise Irish general practice suggests that prescribing 
                                                 
43
 The Stata command „streg‟ is used in our analysis. We included the „frailty‟ option to control for 
unobserved heterogeneity.  
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decisions may reflect both commercial and medical factors. Six drugs new to the 
Irish market were identified for inclusion in the analysis, all of which were 
prescribed by Irish GPs to GMS patients in an extremely short time period from 
authorisation under the GMS scheme (see Table 4.1 and Figure 4.1a-e). Using data 
pertaining to 625 Irish GPs, duration analysis is performed to determine the 
equilibrium, disequilibrium and learning-by-using determinants of prescribing 
innovation (See Table 4.5 for a symbolic summary of results). 
 
Our study finds some evidence of rank effects in relation to adoption of new 
prescription drugs by GPs. Practices with nursing and clerical support tend to be 
early adopters of new drugs, and younger GPs tend to be early adopters of new 
drugs. We find strongly significant and consistently signed, learning-by-using, stock 
and order effects across these drugs; GPs with broader prescribing portfolios tend to 
be early adopters of new drugs, GPs that have a track record of early adoption tend 
to be early adopters of other new drugs, and the larger the proportion of GPs which 
have already adopted a new drug the slower is subsequent adoption. Epidemic 
effects are also evident with slower adoption by rural practices.  
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Table 4.5: Symbolic Summary of Anticipated Results and Results 
 Anticipated 
Effects 
A B C D E F 
 
Rank Effects 
Practice Nurse - -     - 
Practice Secretary -    - - - 
GP Age + +   + + + 
Dispensing Practice  +      + 
IDTS 50  -    -   
IDTS 60 -    -   
 
Order & Stock Effects 
Order Effects (-) - - - - - - 
Stock Effects (+) + + + + + + 
 
Learning-by-using Effects  
Prescribing Portfolio - - - - - - - 
 
Epidemic Learning Effects 
Rural Practice Allowance + +     + 
Notes: A: Esciatolopram; B – Esmoprazole; C – Rofecoxib; D – Desloratadine; E – Nicotine; F – 
Drospirenone & Estrogen; „-‟ denotes a negative and significant effect on time to adoption (at the 10 
per cent level or above), i.e. faster adoption; „+‟ denotes a positive and significant effect on time to 
adoption, slower adoption. 
 
 
This empirical study validates the application of our theoretical model to Irish GPs 
decision-making concerning adoption of new drugs. As discussed in Chapter 1, this 
theoretical framework is extended to a multiple technology adoption and intensity of 
adoption approach to the use of medical equipment and ICT in general practices. 
These empirical exercises are presented in Chapters 6 and 7. In Chapter 8, we 
discuss and compare our findings from all three empirical examinations to form a 
holistic view of Irish GPs innovative behaviour.  
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CHAPTER 5: MEDICAL EQUIPMENT AND IT IN GENERAL 
PRACTICE – SURVEY DESIGN AND ADMINISTRTAION AND 
DESCRIPTION OF DATA 
 
5.1 Introduction 
The purpose of this chapter is to describe the design and administration of our 
primary data collection, as well as providing a detailed description of the data. The 
Medical Equipment and IT in General Practice survey data, cross-sectional in 
natures, provides us with a timely profile of 601 Irish general practices, along with 
information on decision-making concerning use of medical equipment and ICT. This 
data allows us to address our research questions concerning the influences on the use 
of medical equipment and intensity of use of ICT in Irish general practices, as 
presented in Chapters 6 and 7.  
 
In Ireland, GPs play a core role in the provision of primary care to the general 
population (Department of Health and Children, 2001; Thomas and Layte, 2009). As 
discussed in previous chapters, an integral part of the health care service provided by 
GPs is the prescribing of medication to their patients. However, Irish GPs provide a 
range of services to their patients, including: patient examination and diagnosis, 
ordering of tests, performance of minor surgeries, and referral of patients to other 
health care providers (Competition Authority, 2010). Therefore, the extent and range 
of services provided by GPs is influenced by the use and extent of use of medical 
and ICT equipment in each practice. As outlined previously, Irish GPs have 
considerable freedom in how they equip their practices (Department of Health and 
Children, 2001; Wren, 2003), and there is evidence of considerable variation 
 100 
concerning the range of medical equipment (Boerma and Dubois, 2006; O'Dowd et 
al., 2006) and the extent of ICT use (Irish College of General Practitioners, 2003; 
Lordan and Normand, 2005; Boerma and Dubois, 2006; O'Dowd et al., 2006; 
Dobrev et al., 2008; Meade et al., 2009) in Irish general practices. In the previous 
empirical analysis, we focus on prescribing innovations and examine the 
determinants of the adoption of new prescription drugs by GPs (Chapter 4). In the 
following chapters, we further our understanding of GPs‟ innovative behaviour with 
an examination of use of medical equipment (Chapter 6) and intensity of use of ICT 
(Chapter 7) in Irish general practices.  
 
With respect to the analysis of medical equipment and ICT use, the unit of analysis is 
the general practice rather than the GP, as decision-making concerning medical 
equipment and ICT is at the practice level rather than the individual GP level.
44
 
Existing data sources were consulted, but proved unsuitable for addressing our 
research questions.
45
 Therefore, it was necessary to collect primary data that would 
reflect the nature of the general practices surveyed, as well as their characteristics 
within the equilibrium, disequilibrium and learning-by-using framework, and their 
use and extent of use of medical and ICT equipment. A further objective of the data 
collection procedure was to ensure that the sample obtained from the survey process 
is representative of all general practices in Ireland.  
 
This chapter is organised as follows. Section 5.2 describes the exploratory work 
conducted prior to designing the questionnaire. Section 5.3 primarily describes the 
                                                 
44
 In meetings with a number of GPs, this viewpoint was also confirmed. It is worth mentioning that 
in Chapter 4, the unit of analysis is the GP; as the decision to prescribe a new drug to a patient is 
made at the individual GP level rather than at a practice level. 
45
 These data sources are discussed in detail in Section 5.2 
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process of designing our questionnaire and Section 5.4 describes the administration 
of the pilot study and final survey. Section 5.5 describes the survey data, and Section 
5.6 concludes the chapter with a discussion concerning the representativeness of the 
survey data and a description of a „typical‟ Irish general practice. 
 
5.2 Exploratory Work 
Prior to designing the data collection instrument, it was necessary to ascertain if 
existing data sources were sufficient to address our research questions in relation to 
use of medical equipment and ICT, and also gain a deeper understanding of the Irish 
general practice environment. This aspect of the research design involved a detailed 
examination of existing data sources, as well as a number of exploratory interviews 
with GPs and HSE officials concerning the structure of general practice and the 
range of medical equipment and ICT applications used by GPs. A description of 
existing data sources and exploratory interviews conducting with GPs and HSE 
officials are given below.  
 
In the last decade, the Irish College of General Practitioners (ICGP) has carried out 
two major surveys of GPs in Ireland. In 2005, the ICGP collected survey data on 
demographic and educational characteristics of GPs, the structure and organisation 
of their practices, practice equipment, service provision, and on a broad range of 
issues such as stress, morale and retirement plans (O'Dowd et al., 2006).
46
 Similar 
studies had previously been carried out in 1982 and 1992, enabling trends in general 
                                                 
46
A 22 per cent random sample of GPs was drawn from 2,477 GPs listed on the General Medical 
Service (GMS) and Mother and Infants (MIS) Schemes. Of the 545 GPs surveyed, 476 responded 
representing a response rate of 87 per cent. This sample size represents approximately 19 per cent of 
Irish GPs (0.22 random sample x 0. 87 response rate of 2,477 GPs). 
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practices to be reported (O'Dowd et al., 2006). The report, entitled Structure of 
General Practice in Ireland, provides a comprehensive depiction of general practice 
in Ireland, and is widely cited in official reports and policy documents (Thomas and 
Layte, 2009; Competition Authority, 2010). In 2003, ICGP members were surveyed 
on the extent of computerisation in their practices (Irish College of General 
Practitioners, 2003; Meade et al., 2009).
47
 
 
Aspects of both these data sources fit some of the data requirements of this study.
48
 
However, it was felt that neither adequately covers all the data requirements 
necessary to conduct the empirical analyses of Chapters 6 and 7.
49
 This is mainly due 
to different research objectives informing the data collection undertaken by the 
ICGP. Furthermore, with respect to both these studies, the unit of analysis is the GP, 
whereas our focus is on the practice. Collecting our own survey data, while an 
onerous task, benefits us with timely data concerning the structure of general 
practices in Ireland, and their interactions with external agents, and use of medical 
equipment and ICT. It is also widely acknowledged that there is a lack of data on all 
aspects of general practice in Ireland (Thomas and Layte, 2009; Competition 
Authority, 2010). Timely data is of particular importance given many of the changes 
in the GP profession in recent years, such as the increased numbers entering the 
profession, the increased feminisation of the profession, and changes in the structure 
of GP training, and the formalisation of general practice as a distinct speciality 
                                                 
47
2,362 ICGP members were surveyed. 1,452 completed questionnaires were returned representing a 
response rate of 66 per cent of all GPs registered with the ICGP. In 2005, a complementary qualitative 
study was commissioned examining the attitudes of GPs to computerisation in Ireland and Northern 
Ireland (Lordan and Normand, 2005). 
48
 It is also worth noting that an application to the ICGP for access to this data may not have been 
successful. 
49
 The disparities between these datasources and the requirements of our study are expanded on in 
more detail in Section 5.3. 
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within the wider medical profession.
50
 It is widely accepted that GP services in the 
Irish health care system have developed in a fragmented and unsystematic fashion 
(Caulfield, 2001; Wren, 2003; Thomas and Layte, 2009). In this regard, both ICGP 
studies and their subsequent publications proved extremely helpful in terms of 
understanding the development of the general practice environment in Ireland, with 
respect to practice structure, interaction with external agents, staffing, and practice 
equipment (Irish College of General Practitioners, 2003; Lordan and Normand, 
2005; O'Dowd et al., 2006; Meade et al., 2009). 
 
Both surveys helped in the identification of medical equipment and ICT applications 
for possible inclusion in our questionnaire. The identification of medical equipment 
and ICT applications is particularly important, as the questions relating to medical 
equipment and ICT use provide information for the dependent variables in the 
analyses in Chapters 6 and 7. The Structure of General Practice in Ireland 
questionnaire asks respondents which medical equipment they use in their surgery 
and which equipment they have direct access to, i.e. without referral to the outpatient 
department (O'Dowd et al., 2006). O‟Dowd et al. (2006) report that many of the 
items of medical equipment included in their survey are used by a large proportion of 
practices, possibly as all GPs with a GMS contract must equip their practice with 
such equipment. Therefore it was decided such equipment did not merit inclusion in 
this study. For the purposes of our study, it was necessary to focus on a small list of 
medical equipment, given the depth of information required, i.e. the year of adoption 
of medical equipment, and how the equipment was funded. We were conscious that 
item non-response in relation to these questions would have significant consequences 
                                                 
50
 It is estimated that the number of GPs per thousand of population grew from 0.60 in 2005 to 0.63 in 
2008. 70 per cent of GP graduates between 1997 and 2003 were female. Since the mid-1990s, GPs are 
required to undertake a formal three year training programme (Competition Authority, 2010). 
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for our study. At this point, five items of medical equipment were identified for 
possible inclusion in our questionnaire.
51
 As expected, a large percentage of 
practices use ICT. However given the range of ICT applications suitable for general 
practice use, there are large variations in extent of use (Irish College of General 
Practitioners, 2003; O'Dowd et al., 2006; Meade et al., 2009). Therefore, a 
substantial number of ICT applications were identified for possible inclusion in our 
questionnaire.  
 
Next, it was decided that some inductive interviews with practicing GPs would be 
beneficial in terms of gaining an understanding of recent developments in general 
practice and obtaining some practitioner opinions on the medical equipment and ICT 
being considered for inclusion in our questionnaire. Meetings with the HSE South 
Primary Care Unit (PCU), a number of practising GPs, Dr. Paddy Ryan, Head of the 
GP Training Unit, UCC and Prof. Colin Bradley, Head of Department of General 
Practice, UCC were arranged and are discussed below. These interviews were 
conducted during August and September 2009.  
 
An initial one-hour meeting with HSE South PCU officials was arranged in August 
2009 to discuss the research being undertaken, to determine if any secondary data 
sources had been overlooked in the exploratory data search, and to discuss the 
collection of primary data for this research. A further meeting (2 hours) was arranged 
with the five GPs of the HSE South PCU. The primary purpose of this meeting was 
to discuss with GPs the medical equipment used and the extent of ICT use in general 
practices. These meetings confirmed that both ICGP surveys previously discussed 
                                                 
51
 The medical equipment identified comprises of ECG machines, 24 hour blood pressure monitors, 
spirometers, cryotherapy equipment, and minor surgery equipment. These items of medical equipment 
are discussed in more detail later in this section. 
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would be considered the most comprehensive surveys of Irish general practice to 
date. The GPs also advised that there is considerable „survey fatigue‟ among GPs. 
Trainee GPs, undergraduate medical students and various undergraduate health care 
students frequently survey GPs. In line with this anecdotal evidence, UK researchers 
report evidence of falling response rates from GPs due to an increased use of 
questionnaires by researchers (McAvoy and Kaner, 1996; Barclay et al., 2002). The 
PCU GPs also recommended discussing the research with Dr. Paddy Ryan, Head of 
GP Training in UCC and Prof. Colin Bradley, Head of Department of General 
Practice, UCC.  
 
Further interviews were conducted with two GPs in the Cork area in August 2009. 
Again, the purpose of these interviews was to deepen our understanding as to how 
general practices operate in Ireland. An interview schedule was designed and used in 
the interviews (see Appendix 3). As is evident from the interview schedule, open-
ended questions were used to allow interviewees the opportunity to provide detailed 
answers. Interviewees were asked: how their practice is managed, who the decision-
makers are, what factors inform decisions, what medical equipment they use and for 
what purposes ICT is used. Interviewees were also asked if there were other 
innovations or technologies, other than medical equipment, ICT and prescription 
drugs, that general practices use that this study may be overlooking. These 
interviews were approximately one hour in duration and, with the permission of the 
respondents, were recorded.  Advice was also sought as to whether the survey should 
be distributed by post or email. Both GPs interviewed advised that a postal survey 
would generate a higher response rate. In subsequent meetings with Dr. Ryan and 
Prof. Bradley, postal questionnaires were also advised, based on their experiences 
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with supervising students undertaking primary data collection. Previous studies also 
report favourable response rates to postal questionnaires (Jones and Pitt, 1999; Leece 
et al., 2004). From a practical perspective, it would be extremely difficult to acquire 
email addresses for the Irish GP population.
52
  
 
In September 2009, Dr. Paddy Ryan, and Prof. Colin Bradley were also interviewed. 
Dr. Ryan and Prof. Bradley are practising GPs, whilst also holding academic 
positions. Both interviews were between one and a half to two hours in duration, and 
both interviewees consented to their interview being recorded. These interviews 
proved particularly fruitful with respect to identifying and choosing the medical 
equipment and ICT applications for inclusion in our questionnaire.  
 
In relation to medical equipment, five items of medical equipment were identified 
from previous survey instruments and literature, for inclusion in the questionnaire. 
Dr. Ryan and Prof. Bradley thought that that there would be variation in the adoption 
and use of the equipment identified. Dr. Ryan and Prof. Bradley helped identify two 
further items of medical equipment, namely dexas scanning equipment and ultra 
sound and Doppler foetal monitors, which in their opinion warranted inclusion in the 
questionnaire. The seven items of medical equipment identified for inclusion in our 
questionnaire are listed and described below. 
 An ECG or Electrocardiogram machine records the electrical activity of the 
heart. Electrodes are placed on the skin of the chest and connected in a 
                                                 
52
 In fact, one in five respondents to our survey does not use email (see Section 5.4). 
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specific order to the ECG machine which enables the measurement of 
electrical activity around the heart.  
 
 A 24 hour Blood Pressure Monitor is a portable battery-operated device, 
which continuously records a patients blood pressure throughout the day and 
night over and expired by the lungs, thus assessing pulmonary function.  
 
 A Spriometer is a device for measuring flows and volumes inspired and 
expired by the lungs, thus assessing pulmonary function.  
 
 Cryotherapy is the application of extreme cold, usually in the form of liquid 
nitrogen, to destroy abnormal or diseased tissue, such as warts, moles and 
skin tags. The liquid nitrogen may be sprayed on the diseased tissue, 
circulated through a tube called a cryoprobe, or simply dabbed on with a 
cotton or foam swab.  
 
 A Minor Surgery Equipment kit contains the instruments necessary for minor 
surgical procedures. Such a kit would normally include scalpel, scissors, 
forceps, suture material and gauze pads.  
 
 Dexas scanning equipment is used to measure bone mineral density, and is 
typically used to diagnose and follow osteoporosis.  
 
 Ultrasound and Doppler foetal monitors are used to monitor a foetus‟ 
heartbeat and detect foetal abnormalities in prenatal care. 
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The ICT applications used in general practices were also discussed with Dr. Ryan 
and Prof. Bradley. From these discussions, it became clear that ICT is used in 
general practices for two functions: administrative and patient care. This distinction 
was not apparent from the previous surveys or studies reviewed. It was decided that 
our analysis of ICT use would benefit from distinguishing between these two distinct 
ICT functions. The administrative functions identified for inclusion in the 
questionnaire were: accounts, word processing, billing, patient registration, referral 
letters, appointments, practice staff‟s calendar, email, and practice website. The 
patient care functions identified were: recall of items (vaccinations, immunisations, 
smears), repeat prescriptions, downloading hospital laboratory reports, coding of 
diseases, internet research, scanning hospital and consultant correspondence, and 
audit/quality assurance. Dr. Ryan also advised including a question looking 
specifically at the extent to which consultation records are computerised in practices, 
i.e. completely computerised consultation records, completely paper-based 
consultation records or a combination of both.  
 
Following this exploratory work, the data collection instrument, a self-administered 
postal questionnaire, was designed; and is discussed in the following section. 
 
5.3 Designing the Questionnaire 
This section provides a detailed description of the Medical Equipment and IT in 
General Practice questionnaire, with some excerpts from the questionnaire included 
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for illustration. The questionnaire, as well as the cover letter, is included in full in 
Appendix 4.
53
  
 
Much consideration was given to the design of the self-administered postal 
questionnaire. The questionnaire contained 20 closed-ended questions which 
encompassed all the data requirements of the study. In general, closed-ended 
questions result in higher response rates than open-ended questions (Fowler, 1995; 
Bryman and Bell, 2007). The questionnaire was printed, double-sided, on one sheet 
of paper, for the purpose of ensuring a high response rate. Bryman and Bell (2007) 
state that shorter questionnaires tend to achieve higher response rates than longer 
ones. The questionnaire was green in colour. There is evidence that self-administered 
postal questionnaires printed on green paper achieve higher response rates that those 
printed on white paper (Gullahorn and Gullahorn, 1963; Fox et al., 1988; Philips et 
al., 1991). In fact, the Central Statistics Office distributes many of their self-
administered questionnaires on green paper, such as the Census of Population of 
Ireland. The questions relating to the adoption and use of medical equipment and 
ICT are discussed, followed by the questions relating to practice and GP 
characteristics, and prescribing decisions. Prof. Bradley also advised on a number of 
drafts of the questionnaire.  
 
As discussed in the previous section, seven types of medical equipment were 
identified for inclusion in the Medical Equipment and IT in General Practice 
questionnaire. Question 9 asks whether or not the practice has seven types of medical 
                                                 
53
 A number of minor amendments were made to the questionnaire following the pilot study. These 
amendments are discussed in Section 3.2.4. 
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equipment, and if so, in what year did the practice obtain the equipment. This 
question is provided in Figure 5.1.
 54
   
 
Figure 5.1: Adoption of Medical Equipment Question 
 
Q9. Does your practice have the following medical equipment? If so, approximately when did 
you first obtain this equipment? 
 
 Practice 
Equipment 
Equipment 
obtained in Year 
ECG Machine 
 
  
24-Hr Blood 
Pressure Monitor 
  
Spirometer 
 
  
Cryotherapy 
 
  
Minor Surgery 
Equipment 
  
Dexas Scanning 
 
  
Ultra sound/doppler 
/ foetal monitor 
  
 
 
 
Responses to Question 9 provide us with a binary measure as to whether the practice 
uses this equipment or not, which forms the basis of the econometric analysis in 
Chapter 6, and the year the practice adopted each item of equipment allowing us to 
draw diffusion curves depicting the level of adoption of these items of equipment 
over time (see Chapter 6). Additional questions also determined how each item of 
equipment was funded (Question 10), and how important several factors are in 
informing the decision to purchase medical equipment (Question 11). 
                                                 
54
 In other health care systems, such as the NHS, „hub and spoke‟ service delivery models are being 
implemented in many areas. In general, a „hub‟ would be a larger better-equipped centre of 
excellence, with a number of „spokes‟, i.e. smaller centres, in the same geographical area. Such a 
model in a primary care setting enables the provision of a wider range of services across a 
geographical area without the need for individual practices to make considerable investments in 
medical equipment. However, at present, no such „hub and spoke‟ model of primary care delivery 
operates in Ireland. However, in health care systems with „hub and spoke‟ service delivery models 
uptake and use of medical equipment is likely to be influenced by whether a practice is categorised as 
a „hub‟ or „spoke‟. 
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 As discussed in Section 5.2, Dr. Ryan and Prof. Bradley advised to examine 
intensity of ICT use from the perspective of administrative and patient care 
functions. Questions 12 and 13, presented in Figure 5.2, ask for which administrative 
and patient care functions practices use ICT. These questions provided us with 
binary measures of use for all ICT applications for administrative and patient care 
functions, and also enabled the construction of intensity of use measures which 
provide the dependent variables for the econometric analysis in Chapter 7. It was 
deemed too onerous a task to ask respondents when they introduced each type of 
application, and also given the variation in the economic importance of each ICT 
application the benefits of including such a question are debatable. 
 
Figure 5.2: Administrative and Patient Care ICT Questions 
Q12. For which of the following administrative functions does your practice use Information 
Technology? Please tick all that apply 
 
Accounts  
Word Processing  
Billing  
Patient registration  
Referral letters  
Appointments  
Practice Staff’s Calendar  
Email  
Practice Website  
 
 
Q13. For which of the following patient care functions does the practice use Information 
Technology? Please tick all that apply 
 
Recall of items: vaccinations; immunisations; smears  
Repeat prescriptions  
Download hospital laboratory reports  
Consultation Records  
Coding of Diseases  
Internet research  
Scan hospital/consultant correspondence  
Audit/Quality Assurance  
  
 
 
 112 
As advised by Dr. Ryan, we included a question which asks whether the practice 
keeps computerised or paper consultation records or a combination of both (Question 
14).We also included a question to determine how important a number of factors are 
in informing practices‟ use of IT (Question 15).  
 
The medical equipment and ICT use questions were included to provide us with the 
dependent variable measures for the econometric analysis in Chapters 6 and 7. These 
variables also enabled us to construct a number of explanatory variables, such as 
learning-by-using effects variables for both medical equipment and ICT use. 
Determining the year each item of medical equipment was obtained by each practice 
enabled the construction of an order effects variable. There variables are discussed in 
detail in Chapters 6 and 7. However, we also included a range of questions in the 
questionnaire to capture practice characteristics (rank effects), such as practice size, 
support staff, number of patients, and interaction and learning effects (epidemic 
effects), such as practice location, visits from suppliers, involvement with research 
projects and continuing education.  
 
Questions relating to the number of GPs (male and female), the age of the GPs, and 
the number of principals (male and female) in the practice, nursing and 
administrative support (Questions 1-4), and the year the practice was established 
(Question 6) were included.
55
 A question relating to the main location (city, large 
town, small town, village or rural) of the practice is also included. While there is an 
element of subjectivity about this question, it is reasonable to assume that 
                                                 
55
 Question 6 was included following the pilot study which is discussed in Section 5.4 
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respondents are able to identify which of the four categories correctly identifies the 
main location of their practice.
56
  
 
Additional practice characteristics, such as whether it receives a rural practice 
allowance, acts as a training and/or dispensing practice, participates in a „Primary 
Care Team‟ and, if so, whether it is co-located with the team, are included (Question 
7). GP practices are entitled to a rural practice allowance if the practice is in an area 
with a population of less than 500 people. The allowance is also paid in some cases 
where the HSE is trying to attract a doctor to a remote area. Practices who qualify for 
the rural practice allowance are automatically entitled to receive full practice support 
subsidies for the employment of a nurse and a secretary, i.e. the full secretarial and 
nurse allowance (provided they are full-time) irrespective of patient panel list size. 
Approximately, one in eight GPs are in receipt of a rural practice allowance 
(O'Dowd et al., 2006). Given their remote location, these practices often dispense 
medication. A proportion of GP practices are registered GP training practices, and at 
different times of the year will employ a post-graduate GP trainee in the practice. 
 
The Primary Care Strategy proposes that primary care be delivered through „primary 
care teams‟ which include GPs, nurses, midwives, health care assistants, home helps, 
physiotherapists, occupational therapists, social workers, receptionists, clerical 
officers, and administrators. These inter-disciplinary teams will come together, 
preferably in a single location (co-location), to serve a population of 3,000 to 7,000 
people (Department of Health and Children, 2001). The strategy envisages that 600 
to 1,000 primary care teams will be required nationally based on a population of 3.8 
                                                 
56
 A cross-check of answers to this question and the mailing address was carried out on a sample of 
returned questionnaires to validate the responses to this question. 
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million. However, development has been very slow and it estimated that only one-
tenth to one-sixth of that number had come into existence by April 2008 (Thomas 
and Layte, 2009). 
 
The number of GMS (public) and private patients on the practice‟s list is also 
measured (Question 16). All GMS patients in Ireland must register with a GP. 
However private patients do not have to register with a GP, therefore making it 
difficult for GPs to know their practice‟s exact number of private patients. This 
question provides a measure of practice size. The number of GPs in the practice is 
determined from answers received in questions 1 and 2, and provides an additional 
measure of practice size.  
 
Interaction with other health care professionals, in terms of clinics held at the 
practice, is measured (Question 8), as is the frequency with which respondents attend 
professional development meetings (Question 18), and respondents‟ professional and 
academic involvement over the previous three years (Question 17). Prof. Bradley 
advised the inclusion of these questions to facilitate distinguishing between 
respondents with an interest in continued learning and professional development and 
those without. Frequency of visits from suppliers of medical and IT equipment and 
pharmaceutical company representatives are also included (Question 19).  
 
As discussed, this survey instrument was designed to provide data for the empirical 
exercises examining the adoption of medical equipment and IT in general practices. 
However, it was also decided to take the opportunity to ask some questions relating 
to prescribing decisions which would complement the empirical exercise examining 
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the timing of adoption of prescription drugs (Chapter 4). The GMS Prescribing 
Database provides good quality data on prescribing decisions, however, it does not 
include variables which measure interaction with drug company representatives or 
variables that measure what factors influence prescribing decisions. Therefore, along 
with a question on the frequency of visits to the practice by pharmaceutical company 
representatives (Question 19), the final question of the questionnaire asks how 
important a number of factors are in informing the decision to prescribe a new drug 
for the first time.  
 
While designing this survey, we considered including a question on the consultation 
fee charged for private patients. At present, general practices are not obliged to 
display the price of a consultation, although an updated Guide to Professional 
Conduct and Ethics for Registered Medical Practitioners specifies that GPs can 
display prices. The Competition Authority estimated that the average cost of a GP 
visit for a private patient is approximately €50-55 in urban areas, with slightly lower 
charges in rural areas (Competition Authority, 2010). The National Consumer 
Agency also reported a wide range of prices for GP visits, averaging at €51, with a 
minimum of €35 and a maximum of €70 (Thomas and Layte, 2009). A recent 
Competition Authority report highlighting the lack of transparency and data 
concerning private patient consultations fees provided justification for the collection 
of timely data on private patient consultation fees (Competition Authority, 2010). 
However, on reflection, it was decided to omit this question given the sensitivity of 
the topic. 
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In brief, the Medical Equipment and IT in General Practice questionnaire differs 
from previous questionnaires surveying general practice in Ireland in a number of 
ways. Firstly, it is the first questionnaire in relation to Irish general practices where 
the unit of analysis is the practice rather than individual GPs. Such an approach is 
warranted as investments in medical equipment and ICT are more likely to be at a 
practice level than at a GP level, and recent changes in general practice indicate a 
move away from solo-practitioner to multi-partner practices (O'Dowd et al., 2006; 
Bourke and Bradley, 2010; Competition Authority, 2010). More specifically, we 
focus on seven items of medical equipment, allowing us to ask more in-depth 
questions relating to when the equipment was obtained. Also, we distinguish 
between ICT use for patient care and administrative purposes. A possible omission 
by previous studies.
57
 Also, our questionnaire provides us with extensive information 
concerning interaction with external sources, and their influence on decision-making, 
with respect to medical equipment and ICT use. 
 
As previously discussed, it was advised that administering the Medical Equipment 
and IT in General Practice questionnaire by post would positively influence the 
overall response rate. The survey instrument pack contained a cover letter, the 
questionnaire and a stamped-addressed envelope. The cover letter, addressed to a GP 
in the practice, explained the purpose of the study, encouraged the practice‟s 
participation in the study, and explained that ideally a principle in the practice should 
complete the questionnaire. A practice principal usually owns (or part-owns) the 
practice and holds the GMS contract in the practice (Competition Authority, 2010). 
Therefore, a principal would be well informed as to the use and purchase of medical 
                                                 
57
 Our results in Chapter 7 clearly justify distinguishing between administrative and patient care ICT 
applications. 
 117 
and ICT equipment, and all aspects of practice structure and organisation. The cover 
letter assured the participant that data provided would be treated confidentially and 
would be published only in aggregate form. The letter was signed by Prof. Colin 
Bradley, Department of General Practice, UCC and Ms. Jane Bourke, Department of 
Economics, UCC (see Appendix 4). The cover letter and questionnaire was 
submitted to the Social Research Ethical Committee, UCC for ethical approval, 
which was granted in February 2010. 
 
5.4 Survey Administration 
The following section describes the process of administering the survey, with respect 
to the sample frame employed (5.4.1), the pilot study (5.4.2) and the survey 
distribution (5.4.3). 
 
5.4.1 The Sample Frame 
Designing a sample frame of all general practices in Ireland is complicated by the 
fact that there is no official register of Irish GPs (O'Dowd et al., 2006). Under the 
Medical Practitioners Act (1978), it was not possible to distinguish GPs from other 
types of Medical Practitioner on the General Register (Government of Ireland, 
1978). A new Medical Practitioners Act (2007) requires GPs, as of March 2009, to 
register as a GP specialist (Competition Authority, 2010). Therefore, up to recently, 
it was difficult to determine exactly how many GPs are practicing in Ireland. In fact, 
many reports projecting future supply of GPs were required to work from estimates 
based on the previous ICGP surveys discussed and HSE estimates (Thomas and 
Layte, 2009; Competition Authority, 2010). 
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It is also worth noting that the ICGP surveys devised sample frames from ICGP 
membership and GPs registered on the Maternity and Infant Care Scheme (MIS), 
neither listings would include all GPs in Ireland (Irish College of General 
Practitioners, 2003; O'Dowd et al., 2006). Consideration was given to approaching 
the ICGP for a list of GPs registered with them. However, this was decided against 
as it could be quite a lengthy process. Therefore, we decided to use the Golden Pages 
website as the sample frame for this study, as we would expect that most general 
practices would have a presence on the website.
58
 
 
As stated previously, there is no official comprehensive register of practising GPs in 
Ireland. However it is estimated that there are approximately 2,500 GPs in Ireland 
(Leahy and Wiley, 1998; O'Dowd et al., 2006; Thomas and Layte, 2009) and 
approximately 1650 general practices in Ireland (Wren, 2003). At the outset, 2,363 
GP names and addresses were downloaded from the Golden Pages website. As our 
focus is on the general practice rather than the GP, it was necessary to identify one 
GP per practice to be included in the sample frame. Therefore, where there was more 
than one GP listed at the same address, all GPs were removed except one. Also if 
there were two addresses for the one GP (two practice addresses or a home and 
practice address), one of the addresses was removed from the sample frame. At this 
stage, there were 1501 general practice addresses in the sample frame. A survey 
instrument pack, comprising a cover-letter, questionnaire and FreePost envelope, 
was sent to all 1501 general practices.
59
 84 questionnaires were returned due to 
incomplete addresses or retired or deceased GPs. Therefore, the final sampling frame 
                                                 
58
 The Golden Pages, the equivalent of the Yellow Pages in the UK, is the Irish telephone directory 
for businesses.  
59
 This includes the 50 pilot study questionnaires. 
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consisted of 1417 general practices. Table 5.1 illustrates these different stages in 
constructing the sample frame.  
 
Table 5.1: Stages of Sample Frame Construction 
 Number of Units 
Target population elements identified for sample frame 
 
2,363 
Duplicates of target population elements in sample frame  
 
862 
Target Population Sample Frame 
 
1501 
Ineligible units – questionnaires returned unanswered 
 
84 
Final Sample Frame 
 
1417 
 
5.4.2 Administering the Pilot Study 
On February 16
th
 2010, the survey instrument pack was sent to 50 GP practices in 
the Cork region selected for inclusion in the pilot study. It was decided to pilot GPs 
in proximity to UCC, as it was more likely that they would contact either Prof. 
Bradley or Ms. Bourke if they had any issues or concerns with the questionnaire. The 
survey instrument pack contained the cover letter, the Medical Equipment and IT in 
General Practice questionnaire and a stamped-addressed envelope.  
 
A response rate of 56% (28 returned questionnaires) was achieved with the pilot 
study. In general, all questions were completed. Some minor changes were made to 
the questionnaire following discussion of the pilot study responses. All changes 
discussed in this section were implemented in the final questionnaire (Appendix 4).  
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In the pilot study, the frequency of visits from drug company representatives 
question comprised of four responses categories. All respondents answered that drug 
company representatives visited the practice 6 or more times a year (see Figure 5.3). 
In light of this, an additional category was included (9 or more) in the final 
questionnaire (see Appendix 4). 
 
Figure 5.3: Pilot Study Questions 
 
Q17. On average, approximately how many times a year do the following visit your practice? 
 
 None 1 or 
2   
3 to 
5   
6 or 
more 
Suppliers of Medical Equipment     
Suppliers of IT equipment     
Drug Company Representatives     
 
 
Q18. Finally, how important are the following in informing your decision to prescribe a new 
drug for the first time? 
 
 Not  
Important 
        Very 
Important 
Other GPs/Primary Care 
Professionals 
1 2 3 4 5 
Internet 1 2 3 4 5 
Hospital Consultants 1 2 3 4 5 
Pharmaceutical Co. Reps. 1 2 3 4 5 
Conferences/CME meetings 1 2 3 4 5 
Other, please specify 
 
     
      
 
 
 
The final question of the questionnaire regarding the importance of a number of 
factors in informing prescribing decisions was amended following the pilot study. A 
number of respondents to the pilot study had included „journals‟ as important in 
informing their prescribing decision in the „Other, please specify‟ category (see 
Figure 5.3). Therefore, „journals‟ was included in the response categories in the final 
questionnaire. 
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The pilot study omitted to ask a question regarding the year the practice was 
established. This was included in the final questionnaire. The 26 respondents to the 
pilot study were contacted regarding this missing information, with 20 respondents 
providing us with the year their practice was established. 
 
5.4.3 Administering the Survey 
In March 2010, the survey instrument pack, which included the amended 
questionnaire, was mailed to all general practices identified in the sample frame. As 
discussed in section 5.4.1, the final sample frame consisted of 1417 general 
practices. In total, 601 completed questionnaires were returned.
60
 An overall 
response rate of 42 per cent was achieved. Prior to administration of the survey, we 
were advised that GPs can receive a number of questionnaires every week. Therefore 
we expected that a substantial amount of time would be required to devote to follow-
up mailings and phone-calls to achieve an adequate sample. Our sample size of 601 
proved an adequate number of observations for the required analyses in Chapters 6 
and 7. Also, given the reasonable representativeness of the sample by HSE region it 
was decided that no follow up surveys were required.
61
 
 
  
                                                 
60
 This figure includes the 28 completed pilot study questionnaires. 
61
 Previous innovation surveys attain much lower response rates. For instance, the Open Innovation 
survey conducted by the UK Innovation Research Centre achieved a response rate of approximately 
10 per cent(Cosh et al., 2011).” 
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Table 5.2: Response Rates by HSE Region and County 
 Distributed 
Questionnaires 
Returned 
Questionnaires 
Response 
Rate 
Dublin Mid-Leinster 
Kildare 48 21 44% 
Dublin South 210 69 33% 
Wicklow 35 17 49% 
Longford 11 6 55% 
Westmeath 30 13 43% 
Laois 14 6 43% 
Offaly 37 9 24% 
 385 141 37% 
    
Dublin North-East 
Dublin North 139 44 32% 
Meath 33 11 33% 
Louth 26 19 73% 
Cavan 24 11 46% 
Monaghan 13 6 46% 
 235 91 39% 
    
South 
Cork 226 122 54% 
Kerry 44 26 59% 
Tipperary South 29 14 48% 
Wexford 37 18 49% 
Waterford 38 15 39% 
Kilkenny 20 8 40% 
Carlow 18 8 44% 
 412 211 51% 
    
West 
Galway 106 46 43% 
Mayo 56 21 38% 
Roscommon 19 8 42% 
Limerick 74 33 45% 
Clare 33 17 52% 
Tipperary North 20 6 30% 
Donegal 44 15 34% 
Sligo 20 8 40% 
Leitrim 13 3 23% 
 385 157 41% 
    
Total 1417 601* 42% 
*One questionnaire was returned without a county identifier. The respondent removed the unique 
identifier. 
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Table 5.2 presents the response rates by HSE region and county. In the HSE Dublin 
Mid-Leinster and HSE Dublin North-East regions response rates of 37 and 39 per 
cent respectively were achieved. A higher response rate of 51 per cent was achieved 
in the HSE South region where UCC is located. A response rate of 41 per cent was 
achieved in the HSE West region. These response rates by HSE region are presented 
in Figure 5.4.
62
 
 
Figure 5.4: HSE Executive Region Response Rates 
 
 
                                                 
62
 A Chi- Square Goodness of Fit test was conducted to determine if the responses by HSE region 
were representative geographically. There is slight over-response from the HSE South region; 
potentially as a result of the survey‟s association with UCC and its location in the south of Ireland. 
The extent of over-response is small. However, if 11 fewer responses had been received from the HSE 
South, the sample would have been representative.  
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This section outlined the administration of the Medical Equipment and IT in General 
Practice questionnaire. The following section describes the data collected from the 
601 general practices who returned completed questionnaires. 
 
5.5 Description of Survey Data 
The objective of this section is to provide the reader with an in-depth description of 
Irish general practices in 2010.
63
 Firstly, we discuss the adoption and use of medical 
equipment (5.5.1) and ICT (5.5.2) in general practices, followed by a discussion of 
the structure of general practices and their interaction with external agents (5.5.3).
64
 
65
Where possible, we endeavour to compare this study‟s findings with previous 
research.
66
  
 
5.5.1 Medical Equipment Adoption Variables 
A European study reported that Irish GPs provide a comprehensive mix of services, 
in fact, to a greater extent than many of their European counterparts. Consequently, 
Irish general practices are well equipped with respect to their portfolio of medical 
equipment (Boerma and Dubois, 2006). Therefore, it is not surprising that our survey 
results indicate that a high proportion of general practices use the items of medical 
equipment included in our survey (Table 5.3). Specifically, 83 per cent of practices 
                                                 
63
 See Bourke and Bradley (2010) for the Medical Equipment and IT in General Practice survey 
report. 
64
 The explanatory variables, which measure equilibrium, disequilibrium and learning-by-using 
concepts, used in the empirical analysis of use and extent of use of medical equipment and ICT are 
described in Chapters 6 and 7. 
65
 In the cover letter in the survey instrument pack, we request that a principal in the practice 
completes the questionnaire. While we cannot confirm that this was the case, given the information 
required to complete the survey and the low levels of item non-response, we are reasonably confident 
that practice principals completed this survey. 
66
 It is not always possible to make direct comparisons due to differences in research objectives and 
the survey instruments used. 
 125 
have an ECG machine, 80 per cent have a 24 hour blood pressure monitor, 64 per 
cent have a spirometer, 84 per cent have cryotherapy equipment, 76 per cent have 
minor surgery equipment, 2 per cent have dexas scanning equipment
67
, and 81 per 
cent have foetal monitor equipment. 
 
Table 5.3: GP Practices with Medical Equipment 
Item of Medical Equipment 
 
Total 
Observations 
Positive 
Observations 
Percentage 
 
 
ECG Machine 601 
 
498 82.86% 
24 Hr Blood Pressure Monitor 601 
 
478 79.53% 
 
Spirormeter 601 
 
384 63.39% 
Cryotherapy Equipment 601 
 
505 84.03% 
Minor surgery Equipment 601 
 
455 75.71% 
Dexas Scanning Equipment 601 
 
12 2.00% 
 
Foetal Monitor 601 
 
486 80.87% 
 
When compared to previous surveys of general practices in Ireland, our results also 
indicate the proportion of general practices investing in equipment is increasing. For 
instance, in 2005 less than 60 per cent of GPs had ultrasound equipment in their 
practices, whereas 80 per cent of practices have this equipment in 2010. In 2005, 65 
per cent of GPs had a 24 hour blood pressure monitor in their practices; this figure 
has increased to 80 per cent of practices having this equipment. Similarly, in 2010 
more general practices have minor surgery and cryotherapy equipment and ECG 
machines than in 2005 (O‟Dowd et al., 2006). 
 
                                                 
67
 Dexas scanners are a relatively new item of equipment within general practices. GPs can refer 
patients for bone density scans to secondary care centres.  
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Table 5.4 outlines, on average, the year each item of equipment was obtained by 
practices. It is important to note that not all practices provided the year their practice 
obtained this equipment. The average year of adoption of ECG machines is 1997, 
with ECG machines being first adopted in 1964. These variables enabled the 
drawing of diffusion curves illustrating the level of adoption of each item of 
equipment over time (see Chapter 6, Figures 6.1a-f). 
 
Table 5.4: Year of Adoption of Medical Equipment 
Variable Name 
 
Observations 
 
Year of 
Adoption 
 
Std. 
Dev. 
 
       Min 
 
    Max 
 
 
ECG Machine 439 1997.27 8.34 1964 2010 
 
24 Hr Blood Pressure Monitor 410 2002.96 4.45 1986 2010 
 
Spriormeter 312 2001.84 6.68 1977 2010 
 
Cryotherapy 413 1997.67 7.07 1980 2010 
 
Minor surgery equipment 348 1993.69 10.18 1960 2010 
 
Dexas Scanning  10 2003.80 4.26 1998 2009 
 
Foetal Monitor 391 1998.35 7.18 1965 2009 
      
 
In relation to all seven items of medical equipment, respondents were asked how the 
purchase of this equipment was funded – by the practice, the HSE, a private 
company or another source. Across all seven items of equipment, they are 
predominately funded by the practice (Table 5.5), ranging from 58 per cent of 
practices funding dexas scanning equipment to 94 per cent of  practices funding 
cryotherapy and minor surgery equipment. 
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Table 5.5: Purchase of Medical Equipment 
 ECG 24 Hr 
BPM 
Spiro-
meter 
Cryo-
therapy 
Minor 
Surgery 
Dexas 
Scanning 
Foetal 
Monitor 
Practice 
 
 
79.07% 
 
55.65% 
 
67.72% 
 
94.23% 
 
94.26% 
 
58.33% 
 
75.76% 
HSE 
 
 
10.66% 
 
13.81% 
 
4.99% 
 
3.38% 
 
1.10% 
 
- 
 
3.93% 
Practice & 
HSE / Co. 
 
2.81% 
 
4.81% 
 
1.84% 
 
0.99% 
 
1.10% 
 
8.33% 
 
2.19% 
 
Co. / 
HSE & Co. 
 
 
5.83% 
 
 
23.64% 
 
 
23.09% 
 
 
1.00% 
 
 
0.66% 
 
 
33.33% 
 
 
1.75% 
 
Other 
 
 
0.60% 
 
0.84% 
 
1.57% 
 
- 
 
- 
 
- 
 
0.44% 
Missing 1.01% 1.26% 0.79% 0.10% 2.87% - 15.94% 
 
Total 
 
497 
 
478 
 
381 
 
503 
 
453 
 
12 
 
458 
Note: Co. = Private Company, HSE = Health Service Executive 
 
Respondents were also asked to rate the importance of a number of different factors 
in informing their decision to purchase medical equipment. The majority of 
respondents (62 per cent) consider other GPs and primary care workers to be 
important in the decision to purchase medical equipment (see Table 5.6). Likewise, a 
large number of respondents (57 per cent) considered conferences and/or Continuing 
Medical Education meetings to be important in the decision to purchase medical 
equipment.  
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Table 5.6: Factors influencing Medical Equipment Purchase Decisions 
 
 
Not  
Important 
                      Very  
              Important  
Total 
Responses 
1 2 3 4 5 
Other GPs/ 
Primary Care Workers  
 
10.27% 
 
6.37% 
 
22.12% 
 
34.87% 
 
26.37% 
 
565 
 
Internet 
 
39.69% 
 
20.61% 
 
24.05% 
 
13.17% 
 
2.48% 
 
524 
 
Flyers in the Post 
 
18.35% 
 
22.84% 
 
33.27% 
 
19.24% 
 
6.29% 
 
556 
 
Medical Equipment Suppliers 
 
18.35% 
 
22.84% 
 
33.27% 
 
19.24% 
 
6.29% 
 
556 
 
Conferences/ CME 
 
8.66% 
 
8.13% 
 
26.33% 
 
39.93% 
 
16.96% 
 
566 
 
5.5.2 ICT Use Variables 
A European-wide survey of ICT use among general practices categorised Irish 
general practices as „average‟ performers in terms of ICT use (Dobrev et al., 2008). 
Our survey results indicate that levels of use of the different ICT applications is 
generally high, although there are variations in use. For example, in relation to 
patient care ICT applications, high levels of use (89 and 84 per cent) are reported in 
relation to repeat prescriptions and consultation records. 84 per cent use of 
computerised consultation records indicates a marked improvement on 2003 figures, 
when 51 per cent of GPs kept the majority of their notes on a computer, with 49 per 
cent of GPs in general using paper records (Irish College of General Practitioners, 
2003).  
 
However, there is also evidence of low levels of use in relation to patient care ICT 
applications, with approximately 40 and 41 per cent of practices using ICT for 
coding of diseases and audit/quality assurance purposes respectively. This means 
that only four in ten general practices in Ireland use ICT to classify patient‟s diseases 
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and conditions and identify patterns in the practices population, and to review and 
evaluate current practices. 
 
Table 5.7: General Practice’s ICT Use for patient care and administrative 
purposes 
 
Variable Name 
 
Observations 
 
Percentage 
 
 
Patient Care Functions 
Repeat Prescriptions 601 88.85% 
Consultation Records 601 84.40% 
Download Lab Reports 601 80.20% 
Internet Research 601 75.71% 
Scan Correspondence 601 74.38% 
Recall of Items 601 73.38% 
Audit/Quality Assurance 601 41.76% 
Coding of Diseases 601 40.10% 
 
Administrative Functions 
Patient Registration 601 90.35% 
Referral Letters 601 88.52% 
Word Processing 601 87.69% 
Email 601 79.53% 
Appointment 601 77.54% 
Accounts 601 63.89% 
Billing 601 59.40% 
Calendar 601 39.77% 
Practice Website 601 28.12% 
 
There are similar variations with respect to ICT use for administrative purposes. For 
example, more than 87 per cent of practices use ICT for word processing, patient 
registration and referral letters, although only 29 per cent of practices in Ireland have 
a practice website. Therefore, more than seven in ten general practices in Ireland do 
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not use the internet to promote their practices. However, this does indicate an 
increase from 2003 when only 16 per cent of GPs had a practice website (Irish 
College of General Practitioners, 2003). 
 
Respondents were also asked the importance of different factors in informing how 
they use ICT for both administrative and patient care purposes. Most respondents 
identify other GPs and primary care workers, conferences/CME meetings and the 
General Practice Information Technology (GPIT) group as important with respect to 
informing their ICT use. The GPIT group, among other functions, provides advice 
and support to GPs on all issues relating to IT in General Practice (Irish College of 
General Practitioners, 2004).  
 
Table 5.8: Factors influencing Extent of ICT Use 
 
 
Not  
Important 
                        Very  
                  Important  
Total 
Responses 
1 2 3 4 5 
Other GPs/ 
Primary Care Workers  
 
8.50% 
 
5.06% 
 
21.88% 
 
37.25% 
 
27.31% 
 
553 
 
Internet 
 
33.46% 
 
22.24% 
 
24.41% 
 
14.96% 
 
4.92% 
 
508 
 
Flyers in the Post 
 
55.82% 
 
26.10% 
 
15.46% 
 
1.81% 
 
0.80% 
 
498 
 
IT Suppliers 
 
18.71% 
 
19.28% 
 
32.14% 
 
22.12% 
 
7.75% 
 
529 
 
Conferences/CME  
 
8.12% 
 
8.67% 
 
30.07% 
 
36.53% 
 
16.61% 
 
542 
 
GPIT 
 
13.12% 
 
12.74% 
 
25.67% 
 
34.03% 
 
14.45% 
 
526 
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5.5.3 Practice and GP Characteristics  
This section briefly describes the structure of the general practices surveyed, in 
relation to practice staff, practice location, practice size and interaction with external 
agents.  
 
On average, there are 2.7 GPs per practice (Table 5.9). However, one in four 
practices is a solo-practitioner practice. This is approximately a 10 per cent reduction 
from 2005, when 35 per cent of GPs were categorised as solo-practitioners (O'Dowd 
et al., 2006), and in line with the Primary Care Strategy proposals (Department of 
Health and Children, 2001). In fact, more than one in eight practices comprise of 5 or 
more GPs. 
  
Respondents were also asked approximately how many public and private patients 
are on the practice list. As presented in Table 5.9, the average number of public 
patients per practice is 1,399, with the average number of private patients per 
practice being 2,800. The average year of establishment of the practices surveyed is 
1984. 
 
With respect to the gender profile of GPs in the practices surveyed, on average, there 
are 1.4 male full-time equivalent (FTE) GPs in the practices surveyed, with 1.14 
female FTE GPs per practice (see Table 5.9). In 18.5 per cent of practices, there is a 
gender balance with an equivalent number of male and female GPs in the practice. In 
51.2 per cent of practices, there is a higher proportion of male GPs to female GPs, 
and in 30.4 per cent of practices, there is a higher proportion of female GPs to male 
GPs. These figures reflect current trends of more females entering the profession 
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than ever before, In fact, 70 per cent of GP graduates were female between 1997 and 
2003 (Competition Authority, 2010). On average, there are more male principals 
(1.2) than female principles (0.7) per practice (Table 5.9).
 68
  
 
Respondents were asked to specify how many GPs in their practice are in four age 
categories. The majority of general practices comprise of GPs within the 30-59 age 
categories, with a slightly higher percentage in the 30-40 age category (78 per cent) 
compared to the 40-49 (73 per cent) and 50-59 (73 per cent) age categories (Table 
3.9). Approximately, 11 per cent of general practices include GPs of less than 30 
years of age. One-third of general practices include GPs of more than 60 years of 
age.   
 
31 per cent of general practices deem a city to be the main location of the practice, 
with 21 and 29 percent of general practices located in large and small towns 
respectively. 18 per cent of practices report the main location of their practice to be a 
village or rural location. 12 per cent of practices are in receipt of a rural practice 
allowance (Table 5.9). O‟Dowd et al. (2006) also report that one in eight practices 
are in receipt of this allowance.  
 
 
  
                                                 
68
 A practice principal usually owns (or part-owns) the practice and holds the GMS contract in the 
practice 
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Table 5.9: Profile of General Practices  
Variable Name Observations Percentage 
Size of Practice & Year of Establishment 
GPs per practice (average number) 596 2.70 
Solo Practitioner Practice 596 25.17% 
2 GP Practice 596 29.1% 
3 GP Practice 596 22.2% 
4 GP Practice 596 11.5% 
5+ GP Practice 596 11.9% 
Public Patients (average number) 583 1399.32 
Private Patients (average number) 564 2800.09 
Year of Establishment (average number) 555 1984.28 
Gender of GPs and Principals 
Male GPs per practice (average number) 600 1.40 
Female GPs per practice (average number) 600 1.14 
Male Principles per practice (average number) 595 1.20 
Female Principles per practice (average number) 595 0.72 
Male Dominated Practice 600 50.92% 
Female Dominated Practice 600 30.28% 
Gender Balance Practice 600 18.80% 
Age of GPs 
Less than 30 years 597 10.64% 
30-39 years 596 77.60% 
40-49 years 597 72.86% 
50-59 years 597 73.70% 
60 years plus 597 35.18% 
Location of Practice 
City 601 31.45% 
Large Town 601 21.13% 
Small Town 601 28.95% 
Village/Rural 601 18.47% 
Rural Practice Allowance 593 12.48% 
Nursing and Administrative Support 
Nurse Support 597 80.74% 
Clerical Support 593 87.35% 
Managerial Support 595 53.78% 
Administrative Support 601 91.35% 
Professional & Academic Involvement 
Committee Member 597 41.21% 
Academic Affiliation 590 37.80% 
Research Project 597 23.62% 
ICGP Course 592 31.25% 
Additional Practice Characteristics 
Training Practice 595 29.08% 
Dispensing Practice 561 7.13% 
Primary Care Team 592 46.79% 
Co-Location 273 20.51% 
Practice holds clinic(s) 595 49.42% 
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In relation to support staff, 80 per cent of practices employ nursing support. 54 per 
cent of practices employ a practice manager. This is a significant increase from 2005 
when approximately 30 per cent of practices employed a practice manager (O‟Dowd 
et al., 2006). 87 per cent of practices employ clerical support. As some practices may 
employ either a clerical worker or a practice manager but not both, the administrative 
support variable captures whether a practice has administrative support in the form 
of either a clerical worker or a practice manager. 91 per cent of practices employ 
some form of administrative support (Table 5.9).  
 
In the last three years, 41 per cent of respondents have been or are currently a 
committee member of a professional organisation, such as the ICGP or the Irish 
Medical Organisation (IMO). 38 per cent of respondents are affiliated with an 
academic department, with 24 per cent of respondents actively involved in research 
projects. While these figures for academic and research involvement are high, 44 per 
cent of recent graduates work at least one non-clinical session a week, undertaking 
teaching, research and continuing education; and 24 per cent of recent graduates 
combine general practice with another area of medicine, usually in the area of 
academic activity (O'Kelly et al., 2008). As is evident from Table 5.9, 31 per cent of 
respondents are completing or have completed an ICGP course or its equivalent in 
the last three years.  
 
29 and 7 per cent of practices act as a training practice for postgraduate GP trainees 
and as a dispensing practice respectively. 49 per cent of practices hold at least one 
clinic, such as physiotherapy and dietetics. 46 per cent of practices surveyed 
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participate in a primary care team and, of those, one-fifth of practices are co-located 
with the primary care team (Table 5.9).  
 
Within the sample, attendance at CME meetings is high, with 91 per cent of 
respondents attending six or more such meetings each year (see Table 5.10). 
Pharmaceutical representatives are frequent visitors, with 93 per cent of practices 
visited by pharmaceutical company representatives six or more times a year. In 
hindsight, it may have been more prudent to ask respondents how many times a 
month, or even a week, they see pharmaceutical representatives. Visits from 
suppliers of medical equipment and IT are less frequent, in fact, 55 and 41 per cent 
of practices report no visits from suppliers of medical equipment and IT equipment 
respectively (see Table 5.10).  
 
Table 5.10: Frequency of Attendance at CME meetings and Supplier Visits 
 
 
Finally, respondents were also asked how important they consider a number of 
different factors in informing their decision to prescribe a new drug for the first time. 
As is evident from Table 5.11, there is a wide distribution across most factors in 
terms of their influence on prescribing decisions. However, in general, other GPs and 
 Number of 
Responses 
None 1 to 2 3 to 5 6 + 
CME Meetings  601 8.49% 7.15% 30.45% 53.91% 
Suppliers of  
Medical Equipment 
589 55.01% 36.50% 7.30% 1.19% 
Suppliers of  
IT Equipment 
591 40.78% 36.55% 15.74% 6.94% 
Drug Company 
Representatives 
598 3.85% 0.84% 1.84% 93.48% 
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primary care workers, hospital consultants, conferences and/or CME meetings and 
journals are deemed more important than the internet and pharmaceutical company 
representatives in terms of influencing the decision to prescribe a new drug for the 
first time. 
 
Table 5.11: Factors influencing the Decision to Prescribe a New Drug 
 
 
Not  
Important 
 
 
                      Very 
            Important 
Total 
Responses 
1 2 3 4 5 
Other GPs/ 
Primary Care Workers  
 
7.26% 
 
11.36% 
 
25.33% 
 
34.45% 
 
21.60% 
 
537 
 
Internet 
 
54.25% 
 
20.85% 
 
16.22% 
 
6.56% 
 
2.12% 
 
518 
 
Hospital Consultants 
 
3.29% 
 
5.20% 
 
25.30% 
 
46.27% 
 
19.93% 
 
577 
 
Drug Representatives 
 
13.39% 
 
25.22% 
 
38.61% 
 
17.57% 
 
5.22% 
 
575 
 
Conferences/CME  
 
3.42% 
 
3.76% 
 
18.46% 
 
51.28% 
 
23.08% 
 
585 
 
Journals 
 
4.80% 
 
7.20% 
 
26.75% 
 
43.36% 
 
17.90% 
 
542 
 
It is worth mentioning that an ideal scenario would be to link this survey data to the 
prescribing dataset discussed in Chapters 3 and 4, which would enable many of the 
rank and epidemic effects variables collected in this primary data collection to be 
included in our prescribing analysis. However, this is not possible given the lack of 
identifiers common to both datasets.  
 
5.6 Conclusion 
This chapter describes the design and administration of the Medical Equipment and 
IT in General Practice questionnaire. Completed questionnaires were received from 
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601 general practices, and a description of the survey data is presented in the 
previous section. 
 
We estimate that our sample size of 601 represents about one-third of the general 
practice population (Wren, 2003). As discussed in Section 5.4.3, our sample of 601 
is also reasonably representative by HSE region. We also compare our survey 
characteristics with population characteristics for Irish GPs and general practices, 
obtained from a number of different sources, to further illustrate the 
representativeness of our survey sample (see Table 5.12). 
 
From our survey data, it is possible to form a view of what constitutes a „typical‟ 
general practice in Ireland in 2010 from the survey data. Such a practice comprises 
of 2½ GPs, one of which is female, within the age bracket of 30-59. An urban 
practice with nursing and administrative support, it serves over 4,000 patients, a third 
of which are public patients. The practice is well equipped with medical equipment, 
and uses a broad range of administrative and patient care ICT applications. 
Pharmaceutical representatives regularly visit the practice; whereas the practice is 
rarely visited by IT suppliers and never by suppliers of medical equipment.  
 
The Medical Equipment and IT in General Practice survey data is employed in the 
analysis of the use of medical equipment and intensity of ICT use in Irish general 
practice in Chapters 6 and 7 respectively.  
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Table 5.12: Representativeness of Survey Sample 
 
 Survey Characteristics Population Characteristics 
Rural Practice Allowance One in eight general practices are in receipt of a 
rural practice allowance. 
This is in line with ICGP estimates (O'Dowd et al., 2006) and our 
GP characteristics database described in Chapter 3.  
   
Gender With respect to practice composition, the 
breakdown between male and female GPs is 55 
to 45 per cent (1.40 male FTE/1.14 female FTE).  
According to recent ICGP data, approximately 40 per cent of GPs 
are female (ICGP, 2008). 
 
   
Age Profile of GPs The majority of GPs in the practices surveyed 
are between the ages of 30 to 59.  
O‟Dowd et al. (2006) report that most GPs are between the ages of 
35 and 60 years of age. 
   
Academic Affiliation & 
Research Involvement 
A high proportion of respondents to our survey 
indicate an academic affiliation (38%) and 
involvement in a research project (24%) 
A recent report finds that 44 per cent of recent graduates work are 
involved in teaching, research and continuing education, and 24 
per cent of recent graduates combine general practice with some 
element of academic activity (O'Kelly et al., 2008). 
   
Solo-Practitioner Practices One in four practice are solo-practitioner 
practices 
O‟Dowd et al. (2006)  reported that, in 2005, approximately one in 
three practices were solo-practitioner practices. However, a key 
change in general practice is a move away from solo-practitioner 
to multi-partner practices (Competition Authority, 2010; Thomas 
and Layte, 2009), as proposed by the Primary Care Strategy 
(Department of Health and Children, 2001). Therefore, we would 
expect to see a decline in the proportion of such practices since 
2005.  
   
Public (GMS) Patients  53 per cent of practices have between 500 and 
1500 public patients 
In 2005, 57 per cent of practices had between 500 and 1500 public 
patients.  
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CHAPTER 6: USE OF MEDICAL EQUIPMENT IN                                                   
IRISH GENERAL PRACTICES 
 
6.1 Introduction 
In our exploration of innovative behaviour in general practices in Ireland, our overall 
objective is to explain the adoption, use and intensity of use of innovations by GPs. 
In chapter 4, we determine the influence of practice heterogeneity (rank effects), 
strategic behaviour (stock and order effects), experience from previous adoption 
decisions (learning-by-using effects), and learning and knowledge spillovers 
(epidemic effects) on the timing of first prescription of new drugs by Irish GPs. 
Using the Medical Equipment and IT in General Practice survey data described in 
Chapter 3, this chapter  addresses our second research question:  what influences the 
use of medical equipment in Irish general practices? 
 
In previous chapters, particular aspects of the Irish general practice environment 
have been described in detail, such as the prescribing autonomy of Irish GPs. 
However, an additional important characteristic of general practice in Ireland is the  
strong gate-keeper role of Irish GPs. In fact, along with Denmark, the Netherlands 
and the UK, Ireland is identified as one of the European countries where GPs are 
predominately the first point of contact with health care services (Boerma and 
Dubois, 2006). Therefore, Irish GPs provide a comprehensive mix of services, in 
fact, to a greater extent than many of their European counterparts (Boerma and 
Dubois, 2006). Consequently, general practices in Ireland require a broad range and 
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mix of medical equipment to provide these services. In the mid-1990‟s, a survey of 
European GPs asked them to indicate, from a list of 25 types of medical equipment, 
whether their practice used such equipment. Ireland was included in the second 
highest group in terms of GPs‟ range of medical equipment (Boerma and Dubois, 
2006). As discussed in Chapter 5, a high proportion of general practices surveyed 
use the items of medical equipment examined in our survey.
69
 There is also evidence 
that, since 2005, increasingly more practices are investing in medical equipment 
(O'Dowd et al., 2006; Bourke and Bradley, 2010). However, as outlined in Chapter 
5, there still remains variation across general practices in terms of their uptake of 
medical equipment.  
 
Along with the discretion which Irish GPs have concerning the nature and location 
of their practice, they also have considerable autonomy in terms of how they equip 
and staff their practices. The commercial autonomy which characterise Irish general 
practice suggests that decisions to invest in medical equipment may reflect both 
medical and commercial factors. Acquiring new medical technologies may enable 
GPs to provide more effective treatment to their patients, but may also influence 
their attractiveness to mobile and commercially valuable private and public patients. 
These distinguishing characteristics of Irish general practice, as well as our empirical 
findings presented in Chapter 4, validate the extension of our encompassing 
equilibrium, disequilibrium and learning-by-using theoretical model to an 
examination of what influences the use of medical equipment. 
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 Dexas-scanning equipment being the exception, with only 12 practices investing in this equipment.  
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This study is the first to examine the adoption of multiple medical technologies by 
small health care practices. The empirical approach is to apply multivariate Probit 
analysis to a group of medical technologies to try to identify commonalities in the 
determinants of the probability of use of such equipment. Primary data, through a 
self-administered postal questionnaire, was collected, which provides us with 
information relating to practice characteristics and medical equipment for a sample 
of 601 general practices in Ireland. This survey data is discussed in detail in Chapter 
5. 
 
The rest of the chapter is organised as follows. Section 6.2 briefly revisits the main 
influences on adoption decision-making, as discussed in detail in Chapter 2. This 
section also discusses previous empirical studies of adoption and use of medical 
equipment by GPs, as well as emphasising the potential for informational, 
commercial, strategic and learning-by-using influences on the adoption of medical 
equipment by general practices. Section 6.3 describes our primary data source, 
presents diffusion curves for the items of medical equipment examined, and outlines 
our econometric approach. Section 6.4 presents and discusses the econometric 
results, and Section 6.5 concludes this chapter.  
 
6.2 Theoretical & Empirical Research on Adoption and Use of 
Technologies & Medical Equipment 
Our unit of analysis here is the general practice, and our focus is on the factors which 
influence the use of medical equipment by general practices. The medical equipment 
being examined comprises of ECG machines, 24 hour blood pressure monitors, 
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spirometers, cryotherarpy equipment, minor surgery equipment, and foetal 
monitors.
70
 This section will briefly revisit the theoretical models of adoption, and 
discuss previous empirical research on the adoption and use of technologies and 
medical equipment by firms and general practices. We also justify the use of these 
models in relation to examining the use of medical equipment in general practices. 
 
As discussed in Chapter 2, three complementary theoretical approaches have been 
used to explain the timing of innovation decisions.
71
 Disequilibrium models reflect 
the learning and informational influences on timing of adoption (Rogers, 2003), 
whereas equilibrium models take account of how organisational characteristics and 
strategic interactions, specifically rank, stock and order effects, influence timing of 
adoption (Karshenas and Stoneman, 1993); and learning-by-using effects reflect 
cumulative learning experience from previous adoption decisions influencing timing 
of adoption (McWilliams and Zilbermanfr, 1996).  
 
Previous studies have empirically tested the influence of rank, stock, order, epidemic 
and learning-by-using effects on the adoption of new technologies (Karshenas and 
Stoneman, 1993; McWilliams and Zilbermanfr, 1996; Baptista, 1999; Battisti and 
Stoneman, 2005). These studies are discussed in Chapter 2. However it is useful to 
briefly recall their findings in the context of this empirical chapter. There is 
substantial evidence of rank effects influencing timing of adoption of new 
technologies. Specifically there is evidence that firm size, R&D investment and 
human capital positively influence the adoption of new technologies (Karshenas and 
Stoneman, 1993; Baptista, 2000; Battisti et al., 2007). There is some evidence of 
                                                 
70
 These six technologies were identified following a literature review and expert interviews (see 
Chapter 5). A description of each item of medical equipment is provided in Section 5.2. 
71
 See Table 2.1 for a summary of the influences on timing of adoption. 
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stock and order effects influencing adoption of new technology, particularly in 
relation to adoption of multiple technologies (Karshenas and Stoneman, 1993; 
Baptista, 2000). Specifically, Stoneman and Kwon (1994) find evidence of both 
stock and order effects, although greater support for order effects, in relation to the 
adoption of complementary technologies. Stoneman and Toivanen (1997), in an 
examination of multiple technology adoption, find mixed evidence of stock effects 
and no evidence of order effects.
72
  
 
There is a substantial diffusion and adoption literature which highlight the influence 
of epidemic learning effects on the adoption of new innovations (Hall and Khan, 
2003; Rogers, 2003). Many studies examined the influence of equilibrium effects on 
the adoption of new technologies, simultaneously test for the influence of epidemic 
effects. There is considerable empirical evidence of epidemic learning effects 
positively influencing the adoption of new technologies (Karshenas and Stoneman, 
1993; Stoneman and Kwon, 1994; Stoneman and Toivanen, 1997; Baptista, 2000; 
Burton et al., 2003). Likewise, there is empirical evidence of learning-by-using 
effects, i.e. learning from previous adoption decisions, influencing adoption of new 
technologies (Stoneman and Kwon, 1994; Colombo and Mosconi, 1995; 
McWilliams and Zilbermanfr, 1996; Stoneman and Toivanen, 1997; Arvantis and 
Hollenstein, 2001). 
 
To reiterate, empirical studies report evidence of equilibrium, disequilibrium and 
learning-by-using effects influencing the adoption of new technology. Previous 
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 Stoneman and Kwon (1994) examined the adoption of numerically controlled machine tools and 
coated carbide tools, two complementary goods, in the UK. Stoneman and Toivanen (1997) also 
examined the adoption of these two technologies, in addition to computer numerically controlled 
machine tools, computers and microprocessors, in the UK. 
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studies examining the adoption of medical equipment by general practices have not 
used these theoretical influences on adoption as a conceptual framework for their 
empirical analyses (Bosanquet and Leese, 1988; Baker and Thompson, 1995; Leese 
and Bosanquet, 1995; Boerma et al., 1998; O'Dowd et al., 2006; Nic Gabhainn et al., 
2001; Ni Shuilleabhain et al., 2007). In fact, previous studies are distinctly 
atheoretical. Nonetheless, empirical studies have reported how GP and practice 
characteristics, which are identified as rank effects in the equilibrium models, have 
influenced a practice‟s portfolio of medical equipment. There is also evidence that 
practice location and whether the practice is a training practice, factors generally 
identified as epidemic or learning effects in the disequilibrium models, impact on the 
adoption of medical equipment. These studies are discussed below. 
 
A study of UK GPs outlines how practice characteristics can influence „innovative‟ 
behaviour (Bosanquet and Leese, 1988). Bosanquet and Leese (1988)  subdivided 
practices as innovative, traditional or intermediate, according to whether they 
employed a nurse and participated in the cost rent scheme and the vocational training 
scheme. Practices were defined as being innovative if they fulfilled at least two of 
these criteria, traditional if they fulfilled none, and the remainder were classified as 
intermediate. Bosanquet and Leese (1988) report that innovation is related to the size 
of the practice. Practices with four or more partners were more likely to be 
innovative than those with fewer partners. Innovative practices were more common 
in partnerships with a younger partner average age. Innovative practices were also 
much more likely to employ practice managers. GPs in the innovative practices were 
also more likely to have further qualifications and to be members of professional 
bodies. This study was not conducted within the framework of the equilibrium model 
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of adoption; however it identifies practice characteristics, which could be considered 
rank effects, as impacting on innovative behaviour in general practice. However, it 
must be observed that this study reported no statistical analysis, and merely 
presented the study‟s findings in cross-tabulations.  
 
In a study of 30 European countries, Boerma et al. (1998) report that the availability 
of medical equipment and ancillary staff are positively related, with practices with 
nursing and administrative support more likely to obtain medical equipment. Boerma 
et al. (1998) found that the proportion of GPs working in solo practices was greater 
in rural practices in all 30 countries. Leese and Bosanquet (1995) report that in the 
UK in the mid-1990s fewer singlehanded GPs employed a practice nurse than group 
practices. Both these studies highlight evidence of rank effects (support staff and 
practice size) impacting directly and indirectly on the use of medical equipment. 
However, neither study is testing the equilibrium model of adoption, nor conducting 
complex statistical analysis. Leese and Bosanquet (1995) use descriptive statistics 
and crosstabulations to identify differences between categories of general practices, 
and in Boerma et al. (1998) t-tests are used to determine if the differences reported 
between categories are significantly different.  
 
While previous studies have not explicitly tested whether rank effects impact on 
general practices‟ adoption and use of medical equipment, there is evidence that 
practice characteristics, such as the number of GPs, the qualification and age mix of 
GPs in the practice and whether the practice employs nursing and administrative 
support, influence this decision (Bosanquet and Leese, 1988; Leese and Bosanquet, 
1995; Boerma et al., 1998). There is also evidence that these practice characteristics 
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may influence Irish GPs‟ willingness to embrace preventative programmes. A study 
examining attitudes of Irish GPs on screening for cervical cancer found that if a 
national prevention programme was introduced the majority of GPs would 
participate (McDonald et al., 2001). Those who were less likely to participate 
included those were in single-handed practice, aged over 44 years, with no ancillary 
staff, no computer and in rural practice. 
 
Previous studies have not examined the adoption of medical equipment through the 
lens of the disequilibrium model of adoption. However, previous studies have 
examined the influence of practice location and interaction with external agents, 
factors which can be considered measures of epidemic effects, on adoption and use 
of medical equipment in general practice. These studies will now be discussed. A 
study examining the range of services provided by GPs in 30 European countries 
reports that the variation in services provided is not only related to personal 
characteristics and features of the country‟s health care system but also to practice 
location (Boerma et al., 1998). In relation to the range of services provided by GPs, 
Boerma et al. (1998) specifically examined procedure tasks (the application of minor 
surgery and medical techniques) and treatment tasks (the treatment and follow-up of 
diseases). Scores of procedure and treatment tasks were higher for rural GPs and 
those practicing furthest from the nearest hospital.  
 
Boerma et al. (1998) report a higher availability of medical equipment in rural 
practices, and found that rural practices provided more comprehensive services 
regardless of the type of health care system. Boerma et al. (1998) state that GPs with 
an estimated overrepresentation of socially deprived people and elderly in the 
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practice population provide a wider range of services. Nic Gabhainn et al. (2001)  
found that medical equipment, namely ECG machines, oxygen, defibrillator, minor 
surgery instruments, ambulatory blood pressure monitor, foetal Doppler, glucometer 
and cryosurgery equipment, was more frequently available in rural practices in 
Ireland. Smaller, more rural practices may be acquiring this equipment to 
recompense for less access to secondary care services (Ni Shuilleabhain et al., 2007), 
although there is evidence that rural practitioners report a higher level of contact 
with hospital services (Nic Gabhainn et al., 2001).  Nic Gabhainn et al. (2001) report 
that rural GPs, in comparison with their urban counterparts, work longer hours, have 
more socio-economically deprived patients, and participate more in, and depend 
financially to a greater extent on, the public health system. Nic Gabhainn et al. 
(2001) stress that their study cannot describe the quality of care provided by this 
equipment. It is also worth noting that analyses consisted of descriptive statistics and 
t-tests.  
 
Baker and Thompson (1995) examined whether training practices in the UK 
developed faster than non-training practices between 1982 and 1990. They found 
that training practices were more likely to develop than non-training practices in 
relation to personnel, aspects of practice organisation, educational activities, clinical 
activities and equipment. Baker and Thompson (1995) put forward three reasons that 
may explain the different rates of innovation among the two practice groups. Firstly, 
the doctors and staff in training practices may be inherently more innovative. 
Secondly, they may face fewer obstacles to the introduction of innovations. Finally, 
the accreditation procedure that training practices undertake may serve as a stimulus 
for innovation. Whether a practice engages in training or not may be considered a 
148 
 
proxy for learning or epidemic effects, and therefore Baker and Thompson‟s (1995) 
findings may suggest evidence of epidemic effects in the adoption of medical 
equipment. However, it is must be noted that Baker and Thompson (1995) conducted 
logistic regression analysis on a relatively small sample of 124 practices. 
 
The studies discussed above do not explicitly test the disequilibrium model of 
adoption, we can deduce that their findings, in relation to practice location and 
training practices, suggests the likelihood of an epidemic effect influencing use of 
medical equipment (Baker and Thompson, 1995; Boerma et al., 1998; Nic Gabhainn 
et al., 2001). Previous research reports that rural practices have a wider portfolio of 
medical equipment. Therefore, better equipped rural practices suggest a negative 
epidemic effect. However, the positive influence of training practices on innovative 
behaviour emphasises the potential importance of informational effects. Our survey 
data includes a number of measures of informational effects which will allow us to 
empirically test the use of medical equipment in Irish general practices within the 
disequilibrium model of adoption framework.  
 
In addition to disequilibrium influences on use of medical equipment, the 
commercial autonomy of Irish GPs suggests the potential for equilibrium influences 
on the adoption of medical equipment. In Chapter 4, our findings support the 
application of the equilibrium model of adoption to an examination of timing of 
prescribing innovation. As discussed previously, GPs are self-employed 
professionals, who engage in service commitments with the HSE to provide care and 
treatment to public patients and provide services directly to private patients. They 
have considerable autonomy concerning where they set up practice, who they 
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employ and any additional services they provide (Caulfield, 2001; Wren, 2003; 
Department of Health and Children, 2001; Thomas and Layte, 2009). A European 
study reports that in countries where GPs are largely self-employed they have greater 
involvement in disease management and in applying medical techniques than in 
those countries where they are employees (Boerma et al., 1997). Boerma et al. 
(1997) suggest that this independence may encourage doctors to develop services in 
addition to those basic to general practice. Therefore, we would expect practice 
characteristics to influence the decision to obtain medical equipment.  
 
Given the commercial autonomy of general practice in Ireland, it also seems 
appropriate to test whether stock and order effects impact on the decision-making 
concerning practice development. In Chapter 4, we find that strategic behaviour, 
measured as stock and order effects, strongly and consistently influences first 
prescription of new drugs. In line with these findings and given that the costs 
incurred from medical equipment investments are borne by the practice, we expect 
that stock and order effects influence use of medical equipment. Unfortunately, due 
to the nature of our survey data, we do not model stock effects.
73
  However, we 
include order effects in our empirical analysis, that is, we examine whether adopting 
medical equipment later in the adoption order adversely impacts on the benefit from 
adoption.  
 
There is a distinct lack of literature in relation to learning-by-using effects from other 
innovations within health care organisations. Nonetheless, given the strong evidence 
of such effects within other industries and sectors (Stoneman and Kwon, 1994; 
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 In Section 6.3.1, the difficulties with constructing a stock effects variable are discussed. 
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Colombo and Mosconi, 1995; McWilliams and Zilbermanfr, 1996; Stoneman and 
Toivanen, 1997; Arvantis and Hollenstein, 2001), we expect cumulative learning-by-
using to positively influence use of medical equipment. In fact, Colombo and 
Mocsoni (1995), in their examination of adoption patterns within the Italian 
metalworking industry, highlighted that technological interdependencies and 
cumulative learning-by-using effects are important determinants of firms‟ adoption 
decisions. Colombo and Mosconi (1995) concluded that “interactions among 
different innovations and learning-by-using effects arising from experience with 
previously available technologies are a pervasive phenomena that significantly shape 
the pace and direction of technical change”. 
 
6.3 Data and Methods 
Section 6.3.1 identifies the six items of medical equipment to be included in our 
empirical analysis, and presents diffusion curves graphically depicting the uptake of 
these items of medical equipment by general practices over time. Our empirical 
analysis is based on survey data, collected through a self-administered postal 
questionnaire - Medical Equipment and IT in General Practice- distributed to all 
general practices in Ireland in February and March 2010. The survey data is 
discussed in detail in Chapter 5.
74
 Nonetheless, a description of the survey data 
employed in this empirical analysis is presented in Section 6.3.1. Section 6.3.2 
describes the econometric analysis employed to address our research question. 
 
                                                 
74
 Chapter 5 describes the survey questions used to measure use of medical equipment in general 
practices, and provides a detailed description of the data obtained. 
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6.3.1 Description of Survey Data 
As discussed in Chapter 5, the following items of medical equipment were identified 
for inclusion in the Medical Equipment and IT in General Practice questionnaire. 
Respondents were asked if they have the following medical equipment: ECG 
machine, 24 hour blood pressure monitor, spirometers, cryotherapy equipment, 
minor surgery equipment, and foetal monitors; and the year in which it was 
obtained.
75
 These items of medical equipment were chosen to include in our 
examination of what influences the use of medical equipment in Irish general 
practices, and were identified from previous surveys and literature and also from 
interviews with Prof. Bradley and Dr. Ryan. Both Prof. Bradley and Dr. Ryan 
advised that these six items of medical equipment would be widely available and 
used in general practices in Ireland, although they expected variation in use across 
practices. This expectation was realised when our questionnaires were returned with 
high proportions of general practices confirming that their portfolios of medical 
equipment included these six items of medical equipment (see Table 6.1). 
Consideration was also given to the fact that these six items of equipment are used to 
diagnose, monitor and treat different therapeutic conditions and their inclusion in the 
analysis should eliminate any potential inter-relationships between adoption patterns 
which might stem from individual GPs having a particular interest in a certain 
therapeutic area or medical condition. 
 
Table 6.1 briefly summarises the adoption patterns in relation to these six items of 
medical equipment: the year the equipment was first adopted by a practice in our 
sample, the average year the equipment was adopted across all 601 general practices 
                                                 
75
 A description of these items of medical equipment is presented in Chapter 5. Dexas-scanning 
equipment was also included in the questionnaire. However, only twelve practices had adopted this 
equipment, so it is not included in the analysis.  
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examined, and the percentage of users in 2010. Our survey results clearly indicate 
that by 2010 a high proportion of Irish general practices use a wide range of medical 
equipment: 83 per cent of practices have ECG machines, 80 per cent have 24 hour 
blood pressure monitors, 63 per cent have spirometers, 84 per cent have cryotherapy 
equipment, 76 per cent have minor surgery equipment, and 81 per cent have foetal 
monitors (Table 6.1).  
 
Table 6.1: Medical Equipment Adoption Patterns   
Medical Equipment Year of 
First Adoption 
Average Year 
of Adoption 
% of Users 
in 2010 
ECG Machine 1964 1997 82.86% 
24Hr Blood Pressure Monitor 1986 2003 79.53% 
Spirometer 1977 2002 63.39% 
Cyrotherapy Equipment 1980 1998 84.03% 
Minor Surgery Equipment 1960 1994 75.71% 
Foetal Monitor Equipment 1965 2004 80.87% 
 
However, there is clear variation with respect to initial adoption and the year most 
practices adopted these six items of medical equipment (Table 6.1). It is generally 
accepted that the contribution of new technology to economic welfare is only 
realised when and if the new technology is widely diffused and used. Diffusion 
results from a series of individual decisions to begin using the new technology, i.e. to 
adopt the new technology (Hall and Khan, 2003). Given the nature of our survey 
data, we are able to derive diffusion curves for our sample of general practices, 
which are presented in Figures 6.1a-f. Diffusion curves and what they represent is 
briefly revisited and described below.  
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As discussed in Chapter 2, the epidemic models of adoption generally assume that a 
potential user will adopt a new technology upon learning of its existence. Rogers 
(2003) found that when the number of adopters of a new product or technology is 
plotted on a cumulative frequency basis over time, the resulting distribution is an S-
shaped curve. Stoneman (1983), examining adoption within the equilibrium model, 
also states “if one can explain the date of adoption by individual firms, then by 
aggregation one should have the inter-firm or intrasectoral diffusion curve”. These 
„diffusion curves‟ generally follow an S-shaped pattern, whether examining the 
adoption of agricultural innovations, a new prescription drug or public health 
initiatives (Rogers, 2003). At first, only a few individuals/households adopt the 
innovation in each time period. Soon the diffusion curve begins to climb, as more 
and more entities adopt the innovation in each succeeding time period. Eventually, 
the trajectory of the curve begins to level off, as fewer and fewer entities remain who 
have not adopted the innovation. Given that our survey asked respondents the year 
they adopted each of the six technologies examined, we can also derive diffusion 
curves for our sample. Rogers‟ (2003) S-shaped curve is evident in the diffusion 
curves depicting the level of adoption of the six types of medical equipment among 
the sample of general practices over time (Figure 6.1a-f).  
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Figure 6.1a: Proportion of General Practices with ECG Machines 
 
 
Figure 6.1b: Proportion of General Practices with 24Hr BP Monitors 
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Figure 6.1c: Proportion of General Practices with Spirometers 
 
 
Figure 6.1d: Proportion of General Practices with Cryotherapy Equipment 
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Figure 6.1e: Proportion of General Practices with Minor Surgery Equipment 
 
 
Figure 6.1f: Proportion of General Practices with Foetal Monitors 
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To elucidate, a description of the diffusion curve illustrating the uptake of ECG 
machines is described. As previously established from Table 6.1, ECG machines 
were first adopted in 1964. As illustrated in Figure 6.1a, take-up of ECG machines 
was initially slow among practices, with less than 10 per cent of practices adopting 
ECG machines in the first 20 years of their adoption. However, by 2000, 
approximately 50 per cent of the practices examined had adopted ECG machines, 
with adoption of ECG machines increasing to more than 80 per cent by the end of 
the time period. There is also some evidence of a levelling-off of the diffusion curve 
in the last two years of the time period. The diffusion curves for the 24hr blood 
pressure monitor (Figure 6.1b), the spirometer (Figure 6.1c), cryotherapy equipment 
(Figure 6.1d), minor surgery equipment (Figure 6.1e) and foetal monitor equipment 
(Figure 6.1f) depict similar patterns, with low levels of adoption initially, followed 
by a „take-off‟ in adoption rates, and eventually a levelling off as fewer non-adopter 
practices remain.
76
 
 
As previously discussed, general practices bear the monetary cost of acquiring 
medical equipment. While there may be variation in the prices of individual items of 
equipment as well as variation in price due to the timing of adoption of the 
equipment, we assume that the monetary cost of purchasing the equipment is 
constant across practices.  However, it is important to note that the cost of acquiring 
these six items of medical equipment can vary across the range of items of medical 
equipment, with the cost of purchasing equipment such as 24hr blood pressure 
monitors being greater relative to equipment such as minor surgery kits. Therefore, 
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 In these graphs, there appears to be an increase in the adoption of all six items of medical 
equipment around 1990. This is a result of the data collection process. A number of respondents 
provide answers such as „circa. 1990‟ or ‟20 years ago‟ when asked the year their practice obtained 
each item of equipment. 
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the uptake of an item of medical equipment is likely to be influenced by the 
monetary cost to the practice of acquiring that equipment. The purpose of this 
analysis is to identify commonalties in the use of medical equipment. However, 
given the range of medical equipment being examined, we also consider how the 
cost of these individual items of medical equipment may influence uptake in the 
interpretation of our econometric results, particularly in relation to factors such as 
practice size.  
 
The diffusion curves in Figure 6.1 clearly depict a similar adoption pattern across all 
six items of medical equipment, in line with Rogers‟ S-shaped diffusion curve 
(Rogers, 2003). In Chapter 4, the diffusion curves illustrating GPs adoption of six 
new prescription drugs also demonstrate a similar pattern. In Chapter 4, we explore 
the factors which shape the timing of the first prescription of six new drugs by GPs. 
Our analysis is based on a dataset which matches prescription data with survey data 
on GP characteristics. The survey data allows us to match GP characteristics 
collected in 2001, the midpoint of the 54 month panel data, with prescribing patterns. 
However, the practice characteristics obtained in the Medical Equipment and IT in 
General Practice survey relate to the practice in 2010 and may vary substantially 
from the date the equipment was obtained. As a result, dynamic analysis of the 
adoption of medical equipment is ill-advised. A cross-sectional analysis of the 
determinants of the use of medical equipment by general practices is considered 
more appropriate.  
 
Empirically, we will examine the determinants of the probability of a practice 
obtaining these six items of medical equipment. Dummy variables are used for the 
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six dependent variables, which take a value of one if the general practice has the 
medical equipment. These binary dependent variables are necessary as multivariate 
Probit analysis is employed to estimate the probability of a practice adopting these 
six items of medical equipment. The rationale for choosing this technique is 
discussed in detail in Section 6.3.  As is evident from Table 6.2, these six dependent 
variables are positively related to each other, although the relationship is generally 
weak in magnitude.  
 
Table 6.2: Correlation Matrix of Equipment Use 
 ECG 24Hr BPM Spirometer Cryotherapy 
Equipment 
Minor 
Surgery 
Foetal 
Monitor 
ECG 
 
1.0000      
24Hr BPM 
 
0.3712 1.0000     
Spirometer 
 
0.3052 0.3251 1.0000    
Cryotherapy 
Equipment 
0.2476 0.1953 0.1967 1.0000   
Minor Surgery 
  
0.3087 0.2127 0.1978 0.3355 1.0000  
Foetal Monitor 
 
0.1604 0.1726 0.1221 0.1805 0.1880 1.0000 
 
Next, the explanatory variables, in the context of equilibrium, learning-by-using and 
disequilibrium models, are discussed. In the equilibrium model of adoption tradition, 
rank effects are measured by a number of variables as outlined in Table 6.3. On 
average there are 2.7 GPs per practice. The average number of patients is 4218, and 
on average 37 per cent of those patients are public patients. Nursing and 
administrative support are reported in 81 and 91 per cent of practices respectively. 
We also include the GP age and gender profile of the practice. Two dummy variables 
were created; the first which takes a value of one if all GPs in the practice are 40 
years of age or older, and the second which takes a value of one if there are more 
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male than female GPs in the practice. In 25 per cent of practices, all GPs are 40 years 
or older. In 51 per cent of practices, there are more male than female GPs. These 
variables are included to capture practices‟ heterogeneity which have been identified 
as one of the key drivers in explaining technology adoption decisions (Karshenas and 
Stoneman, 1993; Bosanquet and Leese, 1988; Boerma et al., 1998). In our analysis 
of prescribing new drugs, we found that nursing and secretarial support, as well as a 
GPs‟ increasing age, positively influenced the decision to prescribe a new drug for 
the first time (Chapter 4). Therefore, we expect these rank effect variables to 
positively influence the use of medical equipment in general practices. There is also 
evidence that practices with large patient numbers are more extensive users of new 
drugs (Tamblyn et al., 2003), so it is likely that practices with large patient numbers 
will positively influence use of medical equipment. In general, investments in 
practice development are borne by the practice, therefore, it is also likely that 
practices with more GPs have a greater capacity to invest in medical equipment. 
Table 6.4 provides a symbolic summary of our anticipated results. 
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Table 6.3: Descriptive Statistics of Explanatory Variables 
Variable Name N Mean St. Dev. 
Rank Effects 
Number of GPs 596 2.701 1.667 
Log of Patients 559 8.072 0.749 
Public Patients/ Total Patients 559 0.375 0.201 
Nursing Support 597 0.807 0.395 
Administrative Support 601 0.914 0.281 
Age >40 601 0.250 0.433 
Male Dominated 601 0.509 0.500 
Learning-by-using Effects 
Portfolio 601 0.899 0.302 
Order Effects 
Order ex. ECG 601 0.306 0.461 
Order ex. BPM 601 0.293 0.455 
Order ex. Spirometer 601 0.311 0.463 
Order ex. Cryotherapy 601 0.293 0.455 
Order ex. Minor Surgery 601 0.300 0.458 
Order ex. Foetal Monitor 601 0.301 0.460 
Epidemic Effects 
Rural 601 0.185 0.388 
Town 601 0.501 0.500 
City 601 0.315 0.465 
HSE Dublin Mid-Leinster 600 0.235 0.424 
HSE Dublin North East 600 0.152 0.359 
HSE South 600 0.352 0.478 
HSE West 600 0.262 0.440 
Training Practice  595 0.291 0.455 
Clinic 601 0.494 0.500 
Supplier Visits = 0 589 0.408 0.492 
Supplier Visits = 1.5 589 0.366 0.482 
Supplier Visits = 4 589 0.157 0.364 
Supplier Visits = 7 589 0.039 0.194 
Supplier Visits = 10 589 0.031 0.172 
Committee Member 597 0.412 0.493 
Academic Department 590 0.378 0.485 
Research Project 597 0.236 0.425 
ICGP Course 592 0.313 0.464 
CME Meetings = 0 601 0.085 0.279 
CME Meetings = 1.5 601 0.072 0.258 
CME Meetings = 4 601 0.305 0.461 
CME Meetings =7 601 0.539 0.499 
Note: The Supplier Visits variable consists of 5 numeric categories, which represent midpoints of 
ordered categories: 0, 1.5, 4, 7 and 10. The CME Meetings variable consists of 4 numeric categories 
which represent midpoints of ordered categories: 0, 1.5, 4 and 7. N differs due to item non-response. 
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Within the equilibrium model of adoption, strategic behaviour is measured by stock 
and order effects. As mentioned in the previous section, we do not model stock 
effects in this empirical study. Given the cross-sectional nature of our survey data, 
we are unable to construct a stock effects variable, which is a time-variant measure 
of the stock of previous adopters.
77
 However, we are able to construct an order 
effects variable, as respondents provided the year their practice obtained each item of 
medical equipment.  
 
Six order variables were constructed for each medical technology being examined. 
The order effects variable takes a value of one if a practice is a first-mover, i.e. in the 
first 16 per cent of adopters, in at least one of the other five items of medical 
equipment. Rogers (2003) identifies five adopter categories based on the relative 
speed at which an innovation is adopted by members of the social system: 
innovators, early adopters, early majority, late majority and laggards. When the rate 
of adoption is plotted along a normal distribution, the first 16 per cent of adopters are 
classified as innovators (2.5 per cent) and early adopters (13.5 per cent), and so for 
the purposes of this study, we deem the first 16 per cent of adopters as „first-
movers‟. Across all six items of medical equipment, approximately 30 per cent of 
practices are „first-movers‟ in at least one of the remaining five technologies.  
 
Order effects capture strategic behaviour reflecting trade-offs between the costs and 
benefits of adoption by co-related agents. Previous studies report conflicting 
evidence in relation to order effects: some studies have found no evidence of order 
effects (Karshenas and Stoneman, 1993; Stoneman and Toivanen, 1997), some have 
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 In Chapter 4, in our panel prescribing dataset, the stock effects variables were time-variant. The 
survey data, which provided the GP characteristics, was collected in 2001 – the midpoint of our panel 
data.     
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found some evidence of such effects (Stoneman and Kwon, 1994; Baptista, 2000) 
and others have chosen not to include such variables in their models (Burton et al., 
2003; Hollenstein, 2004). In view of the free-market elements of general practice in 
Ireland, in which practice development costs are borne by the practice, we expect 
evidence of strategic behaviour with respect to decision-making where GPs incur a 
monetary cost from adoption. Also, in relation to order effects and prescribing 
innovation, we find that GPs who are early adopters of at least one drug are early 
adopters of other drugs. Therefore, we can hypothesise it is probable that a positive 
relationship exists between order effects and use of medical equipment.  
 
To model learning-by-using effects, a portfolio variable was created, which takes a 
value of 1 if the practice has adopted three or more of the six items of medical 
equipment. Ninety per cent of practices have adopted three or more of this range of 
medical equipment (Table 6.3). Previous theoretical and empirical studies have 
highlighted the impact of cross-technology effects and cumulative learning-by-using 
from other or previous technologies on technology adoption (Stoneman and Kwon, 
1994; Colombo and Mosconi, 1995; McWilliams and Zilbermanfr, 1996; Arvantis 
and Hollenstein, 2001). In Chapter 4, learning-by-using effects are also examined. 
Slower adoption is found for GPs with narrower prescribing portfolios. This finding 
is strongly statistically significant and consistent across all six drugs examined. 
Therefore, we expect to find positive learning-by-using effects in relation to use of 
medical equipment. 
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Table 6.4: Symbolic Summary of Anticipated Effects on Medical Equipment 
Use 
 
Rank Effects 
 
Number of GPs + 
Log of Patients + 
Prop. of Public Patients + 
Nursing Support  + 
Admin Support  + 
All GPs  > 40 - 
Male Dominated + 
 
Order Effects 
 
Order Effects + 
 
Learning-By-Using Effects 
 
Portfolio + 
 
Epidemic Learning Effects 
 
Town + 
Rural - 
HSE Dublin North East + 
HSE South - 
HSE West - 
Clinic + 
Training Practice + 
Supplier Visits + 
Committee Member + 
Academic Department + 
Research Project + 
ICGP Course + 
CME Meetings + 
Notes: „+„ denotes a positive and significant effect on use of medical equipment, „-„ denotes a 
negative and significant effect on use of medical equipment. 
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In the disequilibrium model of adoption tradition, epidemic effects are measured by 
practice location in terms of urban and rural classifications and HSE region. 31 per 
cent of practices are located in a city, 50 per cent in a town, and 19 per cent in a rural 
location. 24 and 15 per cent of practices are located in the HSE Dublin Mid-Leinster 
and Dublin North East regions respectively, and 35 and 26 per cent of practices are 
located in the HSE South and HSE West regions respectively. Epidemic effects are 
also measured by whether the practice is a training practice or holds a clinic, and 
how often it is visited by suppliers of medical equipment. 29 per cent of practices are 
training practices and 49 per cent of practices hold a clinic delivered by a health care 
professional. 55 per cent of practices receive no visits from suppliers of medical 
equipment, 36 per cent receive 1.5 visits per year, and the remainder receive 4 or 
more visits a year. 
 
Respondents were also asked if they are a committee member of a professional 
organisation, such as the ICGP or IMO, affiliated with an academic department, 
involved in research projects and have completed or are completing an ICGP course 
or its equivalent. 41 per cent of respondents are committee members, 38 per cent are 
affiliated with an academic department, 23 per cent are involved in research projects, 
and 31 per cent have completed or are completing an ICGP course or its‟ equivalent. 
Respondents were also asked how many CME meetings they attend each year. Eight 
per cent attend no CME meetings, seven per cent attend between one and two, 30 per 
cent attend between three and five, and 54 per cent attend six or more. These 
variables are also included to measure epidemic learning effects.  
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In line with previous studies, we expect epidemic effects to impact on the adoption 
of medical technologies (Baker and Thompson, 1995; Boerma et al., 1998; Nic 
Gabhainn et al., 2001). In line with previous studies it is more likely that rural 
practices will have the items of medical equipment examined (Boerma et al., 1998; 
Nic Gabhainn et al., 2001).
78
 We also expect interaction with other health care 
professionals and suppliers of medical equipment and continuing education and 
research to positively influence medical equipment use. 
 
6.3.2 Econometric Methodology for Multiple Technology Adoption 
Previous econometric studies examining technology adoption have employed 
duration analysis (Stoneman and Kwon, 1994; Baptista, 2000).
79
 Duration, or 
failure-time, analysis focuses on the factors which determine the probability that a 
household or a firm will adopt a new technology by a specific point in time, and also 
allows researchers to model the S-shaped diffusion curves discussed earlier. 
However, duration analysis requires panel data. As previously discussed, given the 
cross-sectional nature of our data, we focus on the determinants of the probability of 
a practice using these items of medical equipment, rather than time to adoption. 
McWilliams and Zilbermanfr (1996), also using cross-sectional survey data, attempt 
to overcome this constraint by employing a tobit model. In their study, the dependent 
variable takes a value of zero for non-adopters and a positive value, which is the 
number of years since first adoption, for the adopters. Their survey instrument 
determines the time of adoption of a new technology, if adopted, and both adopter 
and non-adopter characteristics. However, the implicit assumption of this approach is 
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 We find evidence of epidemic effects in relation to prescribing patterns, in that; rural practices are 
less likely to be early adopters of new drugs. However, we do not expect a similar relationship in 
relation to use of medical equipment, as there is substantial evidence in the literature that rural 
practices are often better equipped than their urban counterparts.  
79
 In Chapter 4, we employ duration analysis to examine time to adoption of six prescription drugs.  
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that individual characteristics do not differ from when the technology was adopted 
and the present, when these characteristics are documented through the survey 
process. This raises questions about the direction of causality as adopter 
characteristics may change following the adoption of a new technology. Therefore, 
we do not employ such a technique as the adopter characteristics at time of adoption, 
in some cases decades prior to data collection, may differ fundamentally from the 
practice characteristics collected through the survey process in 2010. Therefore, we 
consider the adoption decision as a binary process whereby a practice chooses „use‟ 
or „non-use‟. Probit models are an appropriate estimation methodology to investigate 
the effects of explanatory variables on dichotomous dependent variables (Greene, 
2003). 
 
A probit model is a binary choice model: 
 
                   
   
  
          
     [Eqn. 6.1] 
 
where the practice either adopts the medical equipment (Yi = 1) or does not adopt the 
medical equipment (Yi = 0) and the choice depends on a vector of independent 
variables (X). The standard normal distribution is notated as Φ(·). The coefficients 
are estimated using the method of maximum likelihood.  
 
Therefore, it would be possible to run six adoption regressions where the binary 
dependent variable (Yi) takes a value of one if one particular type of medical 
equipment is adopted and zero if that specific medical equipment is not adopted. To 
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illustrate, a Probit model is presented below specifically for the ECG machine 
adoption equation: 
 
                   
   
  
          
     [Eqn. 6.2] 
 
where the practice either adopts an ECG machine (Yi = 1) or does not adopt an ECG 
machine (Yi = 0) and the choice depends on a vector of independent variables (X).  
 
However, suppose the random components of all six adoption equations are 
correlated. This means that potentially there are unobservable factors that influence 
the adoption of all six types of medical equipment. Hence, it is necessary to take into 
account the unobservable individual-specific heterogeneity in the estimation 
procedure in order to ensure consistent estimates of the coefficients (Greene, 
2003).The general specification for a multivariate probit is: 
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        [Eqn. 4.4] 
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Therefore, given the likelihood that the random components of the six Probits 
suggested above are correlated, we model the use of these six items of medical 
equipment using a multivariate Probit analysis. The dependent variables in the 
multivariate probit model are: 
 
   = 1 if practice has an ECG machine, 0 otherwise. 
   = 1 if practice has a 24Hr blood pressure monitor, 0 otherwise. 
   = 1 if practice has a spirometer, 0 otherwise. 
   = 1 if practice has cryotherapy equipment, 0 otherwise. 
  = 1 if practice has minor surgery equipment, 0 otherwise. 
   = 1 if practice has a foetal monitor, 0 otherwise. 
 
This econometric technique allows for the extension of our encompassing theoretical 
model to an analysis of multiple technology adoption. Variables which measure the 
equilibrium, learning-by-using and disequilibrium effects, which have previously 
been discussed, form the independent variables in the multivariate Probit analysis. 
The coefficients are estimated using the Geweke-Hajivassilou Keane simulator for 
probabilities and a maximum simulated likelihood procedure.
80
 The results of the 
multivariate Probit are presented in Section 6.4. 
 
6.4 Econometric Results for Use of Medical Equipment 
A multivariate Probit model is used to examine the probability of a general practice 
using six items of medical equipment: ECG machines, 24 hour blood pressure 
                                                 
80
 The Stata command „mvprobit‟ is used to obtain the multivariate Probit regression. 
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monitors, spirometers, cryotherapy equipment, minor surgery equipment, and foetal 
monitors.
81
 As discussed in Section 6.3.2, we adopt this econometric approach as we 
assume the random components of all six adoption equations are correlated. The 
variance covariance matrix presented in Table 6.5 provides justification for this 
approach, as the statistically significant covariance coefficients illustrate that these 
dependent variables vary together. The multivariate Probit regression results are 
presented in Table 6.6. In interpreting the multivariate Probit estimates, we are 
restricted to interpreting the sign and significance of the coefficients (Greene, 2003). 
The overall model is statistically significant. 
 
 
Table 6.5: Variance Covariance Matrix  
 ECG 24Hr BPM Spirometer Cryotherapy 
Equipment 
Minor 
Surgery  
Foetal 
Monitor 
ECG 
 
1 0.03 -0.03 -0.08 0.20* 0.26* 
24 Hr BPM 
 
0.03 1 0.26** -0.37** -0.34*** -0.13 
Spirometer 
 
-0.03 0.26** 1 -0.13 -0.03 0.00 
Cryotherapy 
 
-0.08 -0.37** -0.13 1 0.35*** -0.08 
Minor Surgery 0.20* -0.34*** -0.03 0.35** 1 0.06 
 
Foetal Monitor 
 
 
0.26* 
 
-0.13 
 
0.00 
 
-0.08 
 
0.06 
 
1 
 
 
 
 
                                                 
81
 Initially, six Probit models were estimated including all explanatory variables. Subsequently, in a 
„stepwise‟ fashion, variables with z-statistics of less than |0.5| were excluded from the models. We 
tested the robustness of the preferred models by ensuring that the significant variables did not differ in 
terms of sign or significance from the initial models. The explanatory variables from the preferred 
Probit models are included in the multivariate Probit model. The baseline and preferred Probit models 
are presented in Appendices 5 and 6. 
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Table 6.6: Multivariate Probit of Medical Equipment Use 
 ECG 
 
24 Hr 
BPM 
Spiro-
meter 
Cryo-
therapy 
Minor 
Surgery 
Foetal 
Monitor 
 
Equilibrium Effects – Rank Effects 
Number of GPs 
 
 0.280*** 0.077 0.041 0.067 -0.064 
 (0.088) (0.066) (0.080) (0.070) (0.063) 
Log of Patients 
 
0.261* -0.195 0.291** 0.452*** -0.083 0.227 
(0.155) (0.164) (0.145) (0.169) (0.152) (0.153) 
Proportion of 
Public Patients 
0.935* 0.715 0.479 0.418 -0.792** 0.302 
(0.498) (0.435) (0.376) (0.431) (0.404) (0.394) 
Nursing Support  
 
0.465** 1.033*** 0.274 -0.505** 0.331 0.113 
(0.226) (0.204) (0.192) (0.240) (0.203) (0.205) 
Administrative  
Support 
  -0.428 0.11 0.339 0.327 
  (0.276) (0.288) (0.266) (0.261) 
All GPs > 40 
 
0.22    -0.175 -0.222 
(0.224)    (0.190) (0.190) 
Male Dominated 
 
0.382** -0.059 0.292** -0.263 0.383** -0.186 
(0.188) (0.164) (0.133) (0.163) (0.151) (0.146) 
 
Equilibrium Effects – Order Effects 
Order 
 
0.318 0.135 0.426*** 0.223 0.239 -0.239 
(0.209) (0.179) (0.141) (0.186) (0.160) (0.155) 
 
Learning-By-Using Effects  
Portfolio 
 
1.908*** 1.407*** 1.567*** 1.503*** 1.516*** 1.128*** 
(0.279) (0.267) (0.327) (0.253) (0.259) (0.240) 
 
Disequilibrium Effects – Epidemic Effects 
Town 
 
0.288 -0.318*   0.2 0.349** 
(0.176) (0.190)   (0.160) (0.162) 
Rural 
 
 -0.336   0.129 0.354 
 (0.246)   (0.224) (0.231) 
HSE Dublin 
North East 
  -0.327 -0.139 -0.273  
  (0.213) (0.256) (0.218)  
HSE South 
 
0.386* -0.346* -0.145 0.172 0.267 0.366** 
(0.202) (0.190) (0.180) (0.215) (0.192) (0.172) 
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Table 6.6 (continued): Multivariate Probit of Medical Equipment Use  
 ECG 
 
24 Hr 
BPM 
Spiro-
meter 
Cryo-
therapy 
Minor 
Surgery 
Foetal 
Monitor 
HSE West 
 
0.825*** 0.198 0.091 0.135 0.223 0.326* 
 (0.256) (0.213) (0.193) (0.228) (0.204) (0.186) 
Clinic 
 
0.578*** 0.231 0.07  0.133 0.126 
(0.185) (0.161) (0.131)  (0.145) (0.152) 
Training Practice 0.684**  0.384** 0.143 -0.13 -0.162 
(0.282)  (0.169) (0.221) (0.186) (0.185) 
Supplier Visits 
 
0.078   0.172**  -0.076 
(0.071)   (0.082)  (0.048) 
Committee 
Member 
 -0.063  0.193 -0.186 0.189 
 (0.162)  (0.168) (0.146) (0.148) 
Academic 
Department 
0.211  0.144 0.17 0.226 0.084 
(0.207)  (0.147) (0.191) (0.166) (0.166) 
Research Project  0.564** 0.131 0.103 0.203 0.128 
 (0.227) (0.164) (0.216) (0.183) (0.183) 
ICGP Course 
 
 -0.238 0.212 0.159 0.194 -0.282* 
 (0.176) (0.146) (0.194) (0.161) (0.154) 
CME  
Meetings 
-0.033  -0.024 0.024   
(0.040)  (0.028) (0.034)   
 Chi- Square = 600.633 P value = 0                 
Notes: Coefficients are reported with standard errors in parentheses. *** denotes 
significance at the 1 per cent level; ** at the 5 per cent level and * at the 10 per cent level.  
Variable definitions are given in Table 6.3. The explanatory variables included are taken 
from the preferred Probit models presented Appendix 6. Explanatory variables with z-
statistics of less than |0.5| were removed from the initial „baseline‟ Probit models. 
 
In the model we represent potential rank effects using a series of variables reflecting 
the characteristics of general practices. The number of GPs in a practice is found to 
positively impact on the probability of a practice obtaining a 24 hour blood pressure 
monitor. Therefore, the more GPs in the practice, the more probable it is for the 
practice to have this equipment. This finding is statistically significant at the 1 per 
cent level. This finding is not particularly surprising as a 24 hour blood pressure 
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monitor is a particularly expensive piece of equipment, and a larger practice would 
be able to share the cost of purchasing this equipment between a number of GPs. 
Previous studies have also reported that firm size impacts on adoption of 
technologies (Karshenas and Stoneman, 1993; Baptista, 2000). There is no evidence 
that the number of GPs in a practice influences the use of the other items of medical 
equipment examined. 
 
When examining the effect of the number of patients on the probability of a practice 
obtaining medical equipment, we find that the log of the number of patients 
positively impacts on the probability of a practice having spirometry and cryotherapy 
equipment. This finding is statistically significant at the 5 and 1 per cent levels for 
spirometers and cryotherapy equipment respectively. Larger practices, with respect 
to the number of patients, are likely to be seeing patients with a greater variety of 
conditions and illnesses, and therefore may be more likely to see the need to invest in 
equipment to cater for their patients‟ needs. Given that most practices have both 
public and private patients, we also include a variable to determine the proportion of 
public patients to total patients in each practice. A higher proportion of public 
patients negatively impacts on the likelihood of a practice having minor surgery 
equipment. This result is statistically significant at the 5 per cent level for minor 
surgery equipment. Minor surgery often involves elective procedures which public 
patients are entitled to access in hospitals free of charge. Private patients are required 
to pay, directly or through their private health insurance providers, for elective 
procedures in hospitals. Therefore, practices with a large proportion of public 
patients may not consider a minor surgery kit an integral part of their service 
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provision, as they can direct their public patients to secondary care, either through 
Accident and Emergency (A&E) or as a referral to a consultant.  
 
A practice which employs a nurse is more likely to have both an ECG machine and a 
24 hour blood pressure monitor. These findings are statistically significant at the 5 
and 1 per cent levels respectively. Previous studies have also reported that human 
capital impacts on the adoption of technologies (Karshenas and Stoneman, 1993; 
Baptista, 2000), and specifically that nursing support positively impacts on the use of 
medical technologies (Boerma et al., 1998). In Chapter 4, we also find that nursing 
support positively influences the decision to prescribe a new drug for the first time. 
Contrastingly, a practice with the support of a nurse is less likely to have cryotherapy 
equipment. This finding is significant at the 5 per cent level. Administrative support 
does not influence the use of medical equipment by general practices. 
 
We also examine the age and gender profile of GPs in the practices surveyed, and 
their influence on use of medical equipment. The age profile variable takes a value 
of one if all GPs in the practice are 40 years of age or older. There is no evidence of 
a relationship between this variable and the use of medical equipment in general 
practices. However, the GP gender profile in general practices does influence the use 
of medical equipment.  Practices that have more male GPs than female GPs are more 
likely to obtain ECG machines, spirometers and minor surgery equipment. These 
findings are statistically significant at the 5 per cent level. Previous studies 
examining ICT use among doctors report higher levels of use among male doctors in 
comparison with their female counterparts (Masters, 2008; Meade et al., 2009). 
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To recap, there is some evidence of rank effects influencing the use of medical 
equipment by general practices. In general, the number of GPs positively influences 
the use of medical equipment. Likewise, nursing support appears to positively 
impact on the use of medical equipment; this finding relates to two of the 
technologies.  Also, practices with more male GPs than female are more likely to use 
medical equipment. This relationship is reported in relation to three of the six items 
of medical equipment examined. Therefore, rank effects in the form of patient 
numbers, nursing support and male dominated practices positively impact on the 
adoption of medical equipment by general practices. However, it is worth noting that 
the proportion of public patients and nursing support negatively impact on the use of 
at least one type of medical equipment. It is also apparent that no one rank effects 
variable influences the use of all six technologies. While previous studies examining 
the adoption of one particular technology report evidence of rank effects (Karshenas 
and Stoneman, 1993; Baptista, 2000), it is worth noting that Stoneman and Kwon‟s 
(1994) study of multiple technology adoption report little evidence of rank effects.  
 
As previously discussed, we include a „portfolio‟ variable to capture learning-by-
using effects. The „portfolio‟ variable is consistently signed and significant across all 
six items of medical equipment. Practices that have adopted at least three items of 
medical equipment are more likely to adopt each type of medical equipment 
examined.
82
 Evidence of this relationship is consistent across all six items of medical 
equipment and consistent at the 1 per cent level. Therefore, it is clear that general 
practices are likely to differ in the probability of adopting a new technology given 
differences in their previous adoption decisions. Although there is a limited body of 
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 We initially included a ratio portfolio variable which measured how many of the six medical 
equipments each practice had in its portfolio of equipment. However, inclusion of this variable meant 
that the Multivariate Probit model did not converge.  
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empirical work examining the influence of learning-by-using effects on the uptake of 
new technologies, the research to date provides strong evidence of learning-by-using 
effects positively influencing the adoption of technologies, particularly when 
examining multiple technology adoption (Stoneman and Kwon 1994, Colombo and 
Mosconi 1995, McWilliams and Zilbermanfr 1996, Stoneman and Toivanen 1997, 
Arvantis and Hollenstein 2001). In Chapter 4, we also find evidence of learning-by-
using effects positively influencing prescribing innovation. 
 
An order effect variable was constructed to determine if early adoption of at least 
one item of medical equipment positively influences use of other items of medical 
equipment. Evidence of order effects is somewhat indeterminate in relation to the 
adoption of medical equipment, as there is only one statistically significant 
relationship observed. Being a „first-mover‟ positively impacts on the probability of 
a practice obtaining a spirometer. This finding is significant at the 1 per cent level. 
However, our somewhat indeterminate evidence of order effects is in line with 
previous empirical studies, with some studies reporting no evidence of order effects 
(Karshenas and Stoneman, 1993; Stoneman and Toivanen, 1997) and others 
reporting some evidence of such effects (Stoneman and Kwon, 1994; Baptista, 
2000). 
 
In the multivariate Probit model, we represent potential epidemic effects using a 
series of variables reflecting location and interaction effects. We categorise practices 
as being located in a city, town or rural location, and also in which HSE region they 
are located: HSE Dublin Mid-Leinster, HSE Dublin North East, HSE South, and 
HSE West. Practices located in the HSE West regions are more likely to have foetal 
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monitors than practices located in the HSE Dublin Mid Leinster and the HSE Dublin 
North East region. It is worth mentioning that the HSE West region has a greater 
proportion of small, rural practices than the HSE Dublin Mid-Leinster and HSE 
Dublin North East regions. Also there are fewer hospitals in these regions. Previous 
studies examining general practices‟ use of medical equipment also report that rural 
practices are more likely to obtain medical equipment (Boerma et al., 1998; Nic 
Gabhainn et al., 2001). It may be the case that smaller, more rural practices acquire 
this equipment to compensate for reduced access to secondary care services (Ni 
Shuilleabhain et al., 2007), and therefore the HSE West variable may, in fact, be 
capturing „compensation‟ effects. There is a direct financial incentive for general 
practices to acquire foetal monitors. The Maternity and Infant Care Scheme (MIS) 
provides an agreed programme of care to all expectant mothers (public and private 
patients) who are ordinarily resident in Ireland. This service is provided by a GP and 
a hospital obstetrician, and even those who do not have a medical card are entitled to 
this service. In general, the scheme allows for seven GP visits during pregnancy and 
two post-natal GP visits (Department of Health and Children, 2001).  
 
We also include the following variables in the model to capture epidemic effects: 
practices that hold a clinic, training practices, supplier visits, committee member, 
affiliation with an academic department, involvement in research projects, 
participation in ICGP courses, and attendance at CME meetings.  Practices that hold 
a clinic delivered by a health care professional are more likely to have an ECG 
machine. This finding is statistically significant at the 1 per cent level. Training 
practices are also more likely to have an ECG machine, and more likely to have 
spirometers. These findings are statistically significant at the 5 per cent level. Both 
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these findings indicate evidence of epidemic learning effects. A UK study also 
reported that training practices were more likely to use medical equipment than their 
non-training counterparts (Baker and Thompson, 1995).  
 
Surprisingly, frequency of visits from suppliers of medical equipment only 
influences the use of one item of medical equipment, cryotherapy equipment. As the 
frequency of supplier visits increases, practices are more likely to obtain cryotherapy 
equipment. This finding is statistically significant at the 5 per cent level. Also, 
practices involved in research projects are more likely to obtain a 24 hour blood 
pressure monitor. This finding is statistically significant at the 5 per cent level. None 
of the other epidemic effects variables influence the use of the six items of medical 
equipment examined. Therefore, practices in which at least one of the GPs is a 
committee member of a medical organisation, affiliated to an academic department, 
completing an ICGP course and regularly attending CME meetings are no more 
likely to use medical equipment than other practices. Interestingly, a mid-1990s 
study reported that Irish GPs collaboration with other GPs and health care 
professionals was low relative to their European counterparts (Boerma and Dubois, 
2006). 
 
Therefore, in relation to the influence of epidemic learning effects on the use of the 
six items of medical equipment examined, we find limited evidence of location and 
interaction effects influencing the use of medical equipment. In relation to the 
practice location variables, there appears to be a „compensation‟ effect, whereby GPs 
located in the HSE West region are more likely to adopt medical equipment, perhaps 
to recompense for less access to secondary care. However, the „interaction‟ variables 
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have little influence on the use of the items of medical equipment examined; with the 
exception being training practices, which positively influence the use of two items of 
medical equipment.  
 
6.6 Conclusion 
The purpose of this chapter is to explain the determinants of use of medical 
equipment in general practices. The Irish primary health care system provides a 
distinctive setting for such an examination. Firstly, the commercial autonomy which 
characterise Irish general practice suggests that investment decisions concerning 
medical equipment may reflect both medical and commercial factors. Secondly, in 
relation to their European counterparts, Irish GPs provide a more comprehensive mix 
of services (Boerma and Dubois, 2006) and, therefore, require  a broad range and 
mix of medical equipment to provide these services. As is evident from our survey 
data, a high proportion of general practices surveyed use the six items of medical 
equipment examined in our survey, although considerable variation remains across 
general practices in terms of their uptake of medical equipment.  
 
Within a multiple technology adoption framework, we examine the use of six items 
of medical equipment across Irish general practices through the lens of equilibrium, 
disequilibrium and learning-by-using models of adoption, specifically modelling the 
influence of rank, order, learning-by-using and epidemic effects on medical 
equipment use. The Medical Equipment and IT in General Practice survey provides 
the data for this study, and a multivariate Probit is employed to estimate the 
influence of the aforementioned factors on the use of six items of medical 
equipment.  
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We find some evidence of rank effects. The number of patients, the proportion of 
public patients, nursing support and male (GP) dominated practices positively 
influence the use of medical equipment. However, it is clear these effects are not 
consistent across all six items of medical equipment, indicating the benefit to 
examining the adoption of a range of technologies rather than one technology in 
isolation (Stoneman and Kwon, 1994). There is consistent evidence of learning-by-
using effects in relation to all six items of medical equipment examined. Therefore, 
practices that have a broader portfolio of medical equipment are more likely to use 
another medical technology. There is little evidence of order effects, with being a 
„first-mover‟ positively influencing the use of only one item of medical equipment. 
We find little evidence of epidemic learning effects, although training practices are 
more likely to use medical equipment. Table 6.7 provides a symbolic summary of 
these results. 
 
As previously outlined, this study is the first to examine the adoption of multiple 
medical technologies by small health care practices. Our results provide evidence of 
some commonalties in the determinants of medical equipment use in Irish general 
practices. However neither the equilibrium (rank and order) nor the disequilibrium 
(epidemic) effects are consistent in their influence of medical equipment use. A 
possible reason for this finding is that the use of medical equipment in general 
practices is technology-specific. Therefore, it is necessary to examine adoption and 
use of technologies within a multiple-technology framework as it may be imprudent 
to make generalisations with respect to findings concerning use of a single 
technology.  
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Table 6.7: Symbolic Summary of Effects on Medical Equipment Use 
 
                                Anticipated Effects A B C D E F 
 
Equilibrium Effects – Rank Effects 
Number of GPs +  +     
Log of Patients + +  + +   
Prop. of Public Patients + + +   -  
Nursing Support  + + +  -   
Admin Support  +       
All GPs  > 40 -       
Male Dominated + +  + - +  
 
Equilibrium Effects – Order Effects 
Order Effects +   +    
 
Learning-by-using Effects  
Portfolio + + + + + + + 
 
Disequilibrium Effects – Epidemic Effects 
Town -  -    + 
Rural +       
HSE Dublin North East -       
HSE South +      + 
HSE West + +     + 
Clinic + +      
Training Practice + +  +    
Supplier Visits +       
Committee Member +       
Academic Department +       
Research Project +       
ICGP Course +   +   - 
CME Meetings +    +   
Table Key: A – ECG; B – 24Hr Blood Pressure Monitor; C – Spriometer; D - Cryotherapy 
Equipment; E – Minor Surgery Equipment; F – Foetal Monitor. Notes: „-‟ denotes a negative and 
significant effect (at the 10 per cent level or above); „+‟ denotes a positive and significant effect.  
 
 
However, our empirical results reveal that learning-by-using effects consistently 
influence the use of all six items of medical equipment; practices with a broader 
portfolio of medical equipment are more likely to use another medical technology. 
This finding is strongly statistically significant and consistent across all six items of 
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medical equipment examined. This finding is also consistent with the positive 
relationship reported between learning-by-using effects and adoption of new drugs 
by GPs (Chapter 4). 
 
Our empirical findings in relation to use of medical equipment by Irish GPs, as well 
as our empirical results pertaining to prescribing innovation in Chapter 4, support the 
application of our encompassing theoretical model to examining Irish GPs 
innovative behaviour. Our empirical findings, as presented in this chapter, also 
support the extension of our theoretical model to multiple technology adoption. We 
further explore GP‟s innovative behaviour in Chapter 7, with an examination of the 
determinants of ICT use in general practices. The results from all three empirical 
exercises are discussed collectively in Chapter 8. 
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CHAPTER 7: INTENSITY OF ICT USE IN IRISH                                 
GENERAL PRACTICES 
 
7.1 Introduction 
The general aim of this thesis is to explain the timing and intensity of adoption of 
innovations in general practices in Ireland. In our previous empirical exercises, we 
identified the influence of equilibrium, disequilibrium and learning-by-using effects 
on timing of prescribing innovation (Chapter 4) and use of medical equipment 
(Chapter 6) by Irish GPs. This chapter continues our exploration of innovative 
behaviour amongst Irish GPs, focusing on the determinants of intensity of ICT use in 
Irish general practices. General practices use ICT for a variety of reasons ranging 
from billing patients and writing referral letters to keeping consultation records and 
coding diseases. Therefore, practices differ in terms of the intensity of their ICT use, 
and, this in turn, influences practice management and patient care. This chapter 
addresses our third research question: what factors influence intensity of ICT use in 
Irish general practices? 
 
In previous chapters, the autonomy enjoyed by Irish GPs with respect to prescribing 
new drugs and investing in new equipment has been discussed in detail. In addition, 
general practices in Ireland also enjoy considerable autonomy in terms of their use of 
ICT. The national Health Information Strategy (NHIS) commits to modernise ICT 
infrastructure in the health sector and to optimise development and utilisation of 
health information (Department of Health and Children, 2004). However, a 
European-wide survey of ICT use among general practices categorised Irish general 
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practices as „average‟ performers in terms of ICT use (Dobrev et al., 2008). In fact, 
almost all general practices who responded to our survey use ICT, although the 
variation in the extent of ICT use is considerable.
83
 It is this variation in ICT use that 
we are concerned with and the purpose of this chapter is to identify the determinants 
of intensity of ICT use. 
 
Recent innovation literature has argued that an understanding of the extent of use of 
new technologies is of as much importance as understanding the initial decision to 
use the technology (Mansfield, 1963; Battisti and Stoneman, 2003; Hollenstein, 
2004; Battisti and Stoneman, 2005; Battisti et al., 2007). Conversely, there is limited 
data on within firm use of a new technology over time, resulting in few empirical 
studies of intra-firm diffusion (Battisti et al., 2007). However, a small number of 
studies examining the extent of use of new technologies by firms report that „use‟ 
and „intensity of use‟ are driven by different factors (Hollenstein, 2004; Battisti et 
al., 2007). Such empirical results indicate that when examining the diffusion of new 
technologies, it is necessary to examine the overall adoption process, i.e. the 
adoption decision and, following this decision, intensity of use. 
 
As discussed in Chapter 2, there is a substantial body of theoretical and empirical 
literature examining decision making concerning the use of new technologies and 
innovations. The main theoretical approaches to timing of adoption have been 
extended to examinations of intensity of adoption. Drawing on the complementary 
disequilibrium, equilibrium and learning-by-using approaches, these studies report 
that intensity of use is partly determined by learning from previous adoption 
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 Fifteen of the 601 general practices surveyed did not use ICT at all. The variation with respect to 
extent of use is discussed in more detail later in the chapter.  
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decisions and interaction with external agents and partly determined by profitability 
considerations (Battisti et al., 2007; Hollenstein, 2004; Battisti and Stoneman, 2005). 
We also adopt this approach, and investigate the influences of rank, epidemic and 
learning-by-using effects on the intensity of ICT use in Irish general practices.  
 
As previously mentioned, general practices use ICT for a variety of purposes, 
ranging from administrative to patient care purposes. Therefore, using ICT for 
accounts and billing purposes may influence the efficient running of the practice as a 
business, whereas using ICT for coding of diseases and audit/ quality assurance 
reasons clearly influences health care provision. This suggests that decisions 
concerning ICT use may reflect both medical and commercial factors, and implies 
the value of considering both informational and commercial factors as determinants 
of intensity of ICT use by general practices.  
 
To our knowledge, this study is the first to examine intensity of ICT use by small 
health care organisations. We examine general practices‟ ICT use for both 
administrative functions and patient care functions, and categorise practices as being 
„basic‟, „intermediate‟ or „enhanced‟ users of ICT for both these purposes.  We apply 
ordered Probit analysis to both types of ICT use and identify the determinants of the 
probability of practices being extensive ICT users. The data source used in this study 
is the Medical Equipment and IT in General Practice survey data. Described in 
Chapter 5, this survey data provides information relating to practice characteristics 
and ICT use for a sample of 601 general practices in Ireland.  
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The rest of the chapter is organised as follows. Section 7.2 outlines the potential for 
extending our encompassing theoretical model to intensity of ICT use by general 
practices. This section also describes previous studies examining intensity of ICT 
use, as well as focusing on empirical research on ICT use by GPs. Section 7.3 
describes our primary data source and outlines our econometric approach. Section 
7.4 presents and discusses the econometric results, and Section 7.5 concludes this 
chapter.  
 
7.2 Theoretical & Empirical Influences on Intensity of Adoption 
Our aim here is to examine the determinants of intensity of ICT use among general 
practices. As discussed in Chapter 2, there is an argument presented in the 
innovation literature that an understanding of the extent of use by adopting firms is 
of as much importance as understanding the decision to adopt an innovation in the 
first instance (Mansfield, 1963; Battisti and Stoneman, 2003; Hollenstein, 2004; 
Battisti and Stoneman, 2005; Battisti et al., 2007). In the diffusion literature, the 
extent of use of an innovation is referred to as intra-firm diffusion, whereas the 
decision to adopt an innovation initially is referred to as inter-firm diffusion. Battisti 
and Stoneman (2003) stress that inter-firm diffusion patterns alone are a poor 
indicator of overall diffusion and argue that much greater emphasis should be placed 
on intra-firm issues in future diffusion research. A number of studies argue that the 
theoretical propositions made in the inter-firm diffusion literature should also be 
applied to studies of intra-firm diffusion (Battisti, 2000; Battisti and Stoneman, 
2003; Hollenstein, 2004; Battisti and Stoneman, 2005). In general, there is a paucity 
of intra-firm diffusion studies, however, there are a small number of studies that 
examine intensity of ICT use (Hollenstein, 2004; Battisti et al., 2007). 
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Battisti et al. (2007) examined intensity of ICT use among UK and Swiss firms, 
measured as ICT use at a basic or enhanced level.
84
 Specifically, Battisti et al. (2007) 
categorise firms as non-users, basic users and enhanced users in relation to their 
adoption of the internet. Drawing on an integrated equilibrium and disequilibrium 
model of diffusion, Battisti et al. (2007) report evidence of positive epidemic 
learning effects and organisational factors, such as the introduction of process 
innovations and conducting R&D, in relation to enhanced internet usage. 
Interestingly, firm size does not impact on intra-firm diffusion in either the UK or 
Switzerland, indicating that smaller firms, having adopted ICT, use it to the same 
extent as larger firms.  
 
Using the same Swiss survey data as Battisti et al. (2007),  Hollenstein (2004) also 
examined intensity of ICT use among Swiss firms. Hollenstein (2004), focusing on 
the adoption of nine ICT elements, examines both the timing and intensity of ICT 
adoption.
 85
 Hollenstein (2004) calculated a four-level ordinal measure of intensity of 
ICT use: level 0 for less than three ICT elements (including zero), level 1 for three or 
four elements, level 2 for five or six elements, and level 3 for seven to nine elements. 
Hollenstein (2004) also examined the extent of internet usage, measured as the 
proportion of employees regularly using the internet. Hollenstein (2004) drawing on 
a conceptual framework incorporating both rank and epidemic learning effects, uses 
an ordered Probit model to examine intensity of ICT and internet usage. In relation 
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 The UK data derives from the Community Innovation Survey (CIS) which surveyed businesses 
with 10 or more employees across a broad range of industries (10-74 of the SIC 92 industrial 
classification). The Swiss data derives from a survey conducted on businesses with five or more 
employees across 28 industries.  
85
 The specific ICT elements include digital assistants, laptop, PCs, Workstations, terminals, E-mail, 
Internet, EDI, LAN/WAN, intranet, and extranet. 
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to firm size, Hollenstein (2004) report positive size effects in relation to overall ICT 
intensity; however, there is hardly any size dependence in relation to intensity of 
internet usage. In fact, the propensity to adopt seems to be highest in the case of 
medium-sized firms in relation to internet usage. Hollenstein (2004) report that the 
capacity to absorb external knowledge is important in relation to intensity of ICT 
use, distinctly more important than its‟ impact on adoption in the first instance. 
Hollenstein (2004) purports the plausibility of this finding given the more complex 
problems to be solved when a large set of ICT elements have already been adopted.  
 
Hollenstein (2004) also reports that know-how deficiencies, managerial problems 
and costs of ICT are the most important obstacles to the introduction of ICT. There 
is no evidence of a negative impact from uncertainty and switching costs. 
Hollenstein (2004), acknowledging that these results differ from previous studies of 
technology adoption, concludes that the relative importance of the explanatory 
variables are technology-specific. Hollenstein (2004) reports that absorptive 
capacity, firm size, cost of technology and anticipated benefits from improved 
internal processes are more important with respect to intra-firm diffusion, whereas 
quality-orientated and customer-related advantages are more relevant for timing 
decisions. Hollenstein (2004) reasons that a firm‟s resource commitment may be low 
at earlier stages of adoption (inter-firm diffusion) than later stages (intra-firm 
diffusion).  
 
To date, we are not aware of previous empirical research examining the influences of 
learning-by-using effects on intensity of ICT use. However, Battisti and Stoneman 
(2005) report positive learning-by-using effects on the intensity of use of CNC 
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machines. They found that learning-by-using effects, reflecting stock of knowledge 
and technical skills, positively influence the benefit a firm obtains from use of a new 
technology.  
 
In line with the empirical research discussed above, we incorporate the equilibrium, 
disequilibrium and learning-by-using models of adoption to our examination of 
intra-practice diffusion of ICT. To our knowledge, this encompassing theoretical 
model has not previously been applied to intensity of ICT use in small health care 
practices. However, there are a number of examinations of ICT use among GPs, 
some of which are documented below.  
 
In 2007, the European Commission surveyed primary care physicians regarding their 
use of ICT for eHealth purposes (Dobrev et al., 2008). In this study, 6,789 interviews 
were conducted across all 27 Member States of the European Union, Norway and 
Iceland. Dobrev et al. (2008) report that basic ICT infrastructure consisting of 
computers and internet connections is available in most GP practices in Europe. 
They also report that the electronic storage of administrative and medical patient 
data, the use of a computer during consultation with patients and other uses of ICT in 
the health area are becoming more and more a daily experience in practices.  
 
Dobrev et al. (2008) report that 87 per cent of GP practices in the EU use a 
computer, with larger practices more likely to have a computer (93 per cent) 
compared to smaller practices (84 per cent). 69 per cent of practices have an internet 
connection, increasing from 61 per cent for single GP practices to 81 per cent among 
practices with four or more GPs. Dobrev et al. (2008) also report that European GPs 
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believe that ICT use in general practices improves the quality of healthcare services. 
Similarly, a qualitative study examining the attitudes of Irish and Northern Irish GPs 
towards computerisation reported an overall positive attitude towards 
computerisation, particularly in terms of ease of access to information, legibility, 
increased efficiency, and increased quality of care (Lordan and Normand, 2005). 
 
Dobrev et al. (2008) categorise Ireland‟s general practices as „average‟ performers in 
terms of ICT use.
86
 However, in terms of infrastructure, Ireland scores slightly below 
the European average. Approximately two-thirds of Irish GP practices store 
administrative patient data and use local electronic health records (EHR). However, 
a relatively low proportion of Irish GPs transfer electronic patient data (40 per cent) 
or administrative data (17 per cent). 
 
A recent Irish study specifically examined the use of electronic patient records (EPR) 
by Irish GPs (Meade et al., 2009). Following surveys conducted in 2000 and 2003, 
Meade et al. (2009) report a significant increase in the use of EPRs by Irish GPs over 
this three year time interval.
87
 Table 7.1 summarises the findings in relation to ICT 
use presented in Meade et al. (2009). For example, in 2000 half of all GPs surveyed 
always use a computer to write repeat prescriptions; however, by 2003 almost three-
quarters of GPs were always using a computer to complete this task.  
 
In terms of identifying which GPs are more likely to use ICT, Meade et al. (2009) 
report that young, male GPs and those working in group practices are most likely to 
use EPRs. Also, GPs based in a rural location and involved in GP vocational training 
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 Interviews were conducted with 206 Irish GPs. 
87
 The sample sizes for 2000 and 2003 were 1543 and 1408 respectively. 
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are most likely to use EPRs. While most GPs accept the benefit of EPR systems over 
manual ones, the major perceived obstacle preventing the migration from manual to 
electronic records by GPs was lack of time rather than lack of financial resources.  
 
Table 7.1: Computer Use for Common Clinical Tasks 
Task Always Carried out on a Computer 2000 2003 
Patient Registration 66% 79% 
Vaccination records 59% 73% 
Repeat Prescriptions 50% 74% 
Referral Letters 39% 53% 
Consultation Notes 39% 52% 
Acute Prescriptions 36% 56% 
Administration 30% 56% 
Accounts 27% 30% 
Recall 23% 30% 
 Source: Meade et al. 2009 
 
A previous Irish study also collected survey data on the structure of Irish general 
practices, and presented some rudimentary statistics in relation to ICT use (O'Dowd 
et al., 2006). However, there was no attempt to differentiate between users and non-
users or low- and high-users. Meade et al.‟s (2009) study is the most in-depth study 
to date of ICT use among Irish GPs, however it is worth noting that the study is 
atheoretical and mainly descriptive in nature. 
 
Masters (2008) also identifies similar patterns to Meade et al. (2009) in relation to 
ICT use, specifically internet usage, among doctors.
88
 Masters (2008) reports that 
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 In a systematic review of the literature, Masters (2008) examined the purpose and reasons for which 
doctors use the internet. All of the studies reviewed were in the developed world, primarily North 
America. Masters (2008) reports that most internet activity among doctors focuses on email and 
searching in journals and databases. Professional email with colleagues and patients is low. 
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males use the internet more than females, young more than old, and specialists more 
than generalists. However, these differences are not across the board and there is 
variation between studies (Masters, 2008).  
 
In summary, Irish general practices are not considered frontrunners in terms of ICT 
use for administrative and patient care purposes (Dobrev et al., 2008). However, 
there is a commitment to modernise ICT infrastructure in the health sector as 
outlined in the national Health Information Strategy (NHIS) (Department of Health 
and Children, 2004). Part of the NHIS‟s strategy includes the introduction of an 
Electronic Health Record by 2009. However, such a system has not been 
implemented largely because there is no agreement between IT providers on sharing 
information (Information Society Commission, 2004). Dobrev et al. (2008) criticised 
the long-term planning of the strategy as being a possible reason as to why ICT use 
among Irish GPs is currently at an average level.  
 
7.3 Data and Methods 
The data (7.3.1) and econometric methodology (7.3.2) employed in our analysis of 
intensity of ICT use by general practices are discussed in this section. 
  
7.3.1 Description of Survey Data 
Our empirical analysis is based on survey data, collected through a self-administered 
postal questionnaire - Medical Equipment and IT in General Practice- distributed to 
all general practices in Ireland in February and March 2010. The purpose of our data 
collection was to collect data relating to the structure of the practice, support staff, 
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educational and training activities, clinics, and use of medical equipment and ICT.  A 
response rate of 42 per cent resulted in a sample size of 601. 
 
The purpose of this chapter is to examine the factors impacting on the intensity of 
ICT use in general practices, i.e. the intra-practice ICT diffusion. Battisti and 
Stoneman (2003) highlight a paucity of studies in the area of intra-firm diffusion, 
due in part to the limited data available. However, our survey data allows us to 
measure the extent of ICT use. As discussed in Chapter 5, our survey asked 
respondents for which administrative and patient care functions their practice uses 
ICT. With respect to administrative functions, respondents were asked for which of 
the following functions their practice uses ICT: accounts, word processing, billing, 
patient registration, referral letters, appointments, staff calendar, email, and practice 
website. Respondents were also asked for which patient care functions their practice 
uses ICT: recall of items, repeat prescriptions, download hospital laboratory reports, 
coding of diseases, consultation records, internet research, scan hospital and/or 
consultant correspondence, and audit/quality assurance.
89
 
 
These variables allow us to measure intensity of ICT use for both administrative and 
patient care functions. As previously discussed in Section 2.4, the costs of a practice 
incorporating additional ICT applications to their current system is likely to vary 
substantially given the individual ICT applications. The costs of adoption of 
additional ICT applications(s), in terms of time, effort and money, will differ relative 
to the individual ICT application(s) being adopted and also relative to the practice‟s 
current ICT use. Similarly the benefits of adopting different ICT applications to the 
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 See Chapter 5 for a full description of practices‟ ICT use for both administrative and patient care 
functions. 
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patient and the practice are likely to be dependent on the individual ICT application. 
Consequently, we decided to rescale the count data into ordered categories, as the 
various ICT applications are not equivalent in economic terms. Hollenstein (2004), 
in the examination of intensity of ICT use among Swiss firms, also grouped a range 
of ICT applications into an ordinal measure of intensity of ICT use.  
 
Therefore, practices are categorised within a three-level ordinal measure of intensity 
of ICT use for administrative purposes, basic, intermediate, and enhanced users. 
Basic users use ICT for between zero and four administrative functions, intermediate 
users for five to seven functions, and enhanced users for eight or nine functions. As 
presented in Table 7.2, 21 per cent of practices are categorised as basic users of ICT 
for administrative purposes, 45 per cent as intermediate users, and 34 per cent as 
enhanced users. Similarly, practices are categorised as basic, intermediate, and 
enhanced users of ICT for patient care purposes. Basic users use ICT for between 
zero and four functions, intermediate users for five or six functions, and enhanced 
users for seven or eight patient care functions. 24 per cent of practices are basic users 
of ICT for patient care purposes, 33 per cent are intermediate users and 43 per cent 
are enhanced users (Table 7.2). 
90
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 The pattern of explanation from estimates with an alternative number of response levels were 
similar for both types of ICT use, and the threshold parameters presented in Tables 7.9a and 7.9b 
indicate the appropriateness of  these ordered categories of the dependent variables. 
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Table 7.2: Intensity of ICT Use for Administrative and Patient Care Purposes 
 Number of ICT 
Elements 
Positive 
Observations 
Percentage 
of Users 
Intensity of ICT Use for Administrative Purposes 
Basic Users  0-4 126 20.97% 
Intermediate Users 5-7 273 45.42% 
Enhanced Users 8-9 202 33.61% 
  601 100.00% 
Intensity of ICT Use for Patient Care Purposes 
Basic Users  0-4 146 24.29% 
Intermediate Users 5-6 197 32.78% 
Enhanced Users 7-8 258 42.93% 
  601 100.00% 
 
Table 7.3 presents a cross-tabulation of these two dependent variables, indicating 
that 15.8 per cent of practices are basic users of ICT for both purposes, 21.6 per cent 
of practices are intermediate users of ICT for both purposes, and 25.8 per cent of 
practices are enhanced users of ICT for both administrative and patient care 
purposes.  
 
Table 7.3: Crosstabulation of ICT User Categories for Administrative and 
Patient Care Purposes – Percentage of Total Practices  
  Administrative ICT Use  
 
  Basic  
User  
Intermediate 
User 
Enhanced  
User 
 
 
 
Patient Care ICT Use 
    
Basic User 
 
15.8% 7.5% 1.0% 
Intermediate User 
 
4.3% 21.6% 6.8% 
Enhanced User 0.8% 16.3% 25.8% 
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Next, the explanatory variables used in this analysis, presented in Table 7.4, are 
briefly discussed. The rank effect variables used in our examination of intensity of 
ICT use are consistent with those used in our medical equipment use analysis. As 
before, these variables include nursing and administrative support, size of practice 
with respect to number of GPs and patients, the proportion of public patients to total 
patients, and the age and general profile of GPs in the practice. These rank effects 
variables have previously been discussed in Section 6.3.1; descriptive statistics are 
presented in Table 7.4. 
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Table 7.4: Descriptive Statistics of Explanatory Variables 
Variable Name N Mean St. Dev. 
Rank Effects 
Number of GPs 596 2.701 1.667 
Log of Patients 559 8.072 0.749 
Public Patients/ Total Patients 559 0.375 0.201 
Nursing Support 597 0.807 0.395 
Administrative Support 601 0.914 0.281 
Age >40 601 0.250 0.433 
Male Dominated 601 0.509 0.500 
 
Learning-by-using Effects 
ICT Use for Patient Care Purposes  
(3 or more patient care ICT functions) 
601 
 
0.875 
 
0.331 
 
ICT Use for Administrative Purposes 
(3 or more administrative ICT functions) 
601 
 
0.905 
 
0.293 
 
 
Epidemic Effects 
Rural 601 0.185 0.388 
Town 601 0.501 0.500 
City 601 0.315 0.465 
HSE Dublin Mid-Leinster 600 0.235 0.424 
HSE Dublin North East 600 0.152 0.359 
HSE South 600 0.352 0.478 
HSE West 600 0.262 0.440 
Training Practice  595 0.291 0.455 
Clinic 601 0.494 0.500 
Supplier Visits = 0 591 0.408 0.492 
Supplier Visits = 1.5 591 0.366 0.482 
Supplier Visits = 4 591 0.157 0.364 
Supplier Visits = 7 591 0.039 0.194 
Supplier Visits = 10 591 0.031 0.172 
Committee Member 597 0.412 0.493 
Academic Department 590 0.378 0.485 
Research Project 597 0.236 0.425 
ICGP Course 592 0.313 0.464 
CME Meetings = 0 601 0.085 0.279 
CME Meetings = 1.5 601 0.072 0.258 
CME Meetings = 4 601 0.305 0.461 
CME Meetings =7 601 0.539 0.499 
Note: The Supplier Visits variable consists of 5 numeric mid-point categories: 0, 1.5, 4, 7 and 10. The 
CME Meetings variable consists of 4 midpoint numeric categories: 0, 1.5, 4, and 7. 
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These variables are included to capture practices‟ heterogeneity which has been 
identified as an explanatory factor in intensity of technology and ICT use among 
firms, although findings reported are not consistent (Hollenstein, 2004; Battisti and 
Stoneman, 2005). In our previous empirical exercises we find support staff and 
practice size positively influence innovative behaviour. Therefore, we expect nursing 
and administrative support to positively impact on intensity of ICT use. However, 
previous studies have reported little evidence of size effects in relation to intensity of 
adoption, therefore we do not expect practice size with respect to number of GPs or 
number of patients to influence intensity of ICT use in general practices. In relation 
to medical equipment use, we find a positive relationship between the proportion of 
public patients and use of medical equipment. It is likely that a similar relationship 
exists in relation to intensity of ICT use. In relation to the age and gender of GPs, in 
previous chapters, we find male-dominated practices are more likely to use medical 
equipment and older GPs are slower to adopt new drugs. Also, there is previous Irish 
evidence that ICT use is greater among younger, male GPs (Meade et al., 
2009),therefore we anticipate similar findings in relation to this study.
91
 Table 7.5 
provides a symbolic summary of our anticipated results in relation to intensity of 
ICT use. Given the nature of the survey data, i.e. we do not ask the time of practices‟ 
adoption of ICT applications, we are unable to capture stock and order effects. 
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 However, we are aware that the factors influencing adoption and use of innovations in general 
practices may differ with respect to their influence on intensity of ICT use. 
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Table 7.5: Symbolic Summary of Anticipated Effects on Intensity of ICT Use  
 
 
Rank Effects 
 
Nursing Support + 
Number of GPs - 
Prop. of Public Patients + 
(Log) Number of Patients - 
Administration Support + 
All GPs  >40 years - 
Male (GP) Dominated  + 
 
Learning-by-Using Effects 
 
ICT Use for 3 or more Patient Care Functions + 
Medical Equipment Portfolio + 
 
Epidemic Learning Effects 
 
HSE Dublin Northeast - 
HSE South + 
HSE West + 
Town Practice - 
Rural Practice + 
Training Practice + 
Visits from It Suppliers + 
Practice Holds a Clinic + 
Committee Member + 
Academic Department + 
Research Projects + 
ICGP Course + 
CME Meetings + 
Notes: „-‟ denotes a negative and significant effect; „+‟ denotes a positive and significant effect. 
 
There is little evidence of learning-by-using effects being incorporated in intra-firm 
diffusion studies, although Battisti and Stoneman (2005) report that use of 
complementary technologies impacts on firms‟ extent of use with respect to CNC 
machines. There is also evidence that learning-by-using effects impact on inter-firm 
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diffusion of technologies (Stoneman and Kwon, 1994; Colombo and Mosconi, 1995; 
McWilliams and Zilbermanfr, 1996; Stoneman and Toivanen, 1997; Arvantis and 
Hollenstein, 2001), and previous studies have argued that the theoretical propositions 
made in the inter-firm diffusion literature should also be applied to studies of intra-
firm diffusion (Battisti, 2000; Battisti and Stoneman, 2003). Therefore, we include 
learning-by-using effects in our examination of intensity of ICT use for 
administrative and patient care purposes. To that end, we create two dummy 
variables, which measure if practices are using ICT for at least three administrative 
functions and at least three patient care functions. The learning-by-using ICT for 
administrative purposes variable will be included in the analysis examining the 
factors impacting on the probability of the extent of ICT use for patient care 
purposes. 90 per cent of practices use ICT for three or more administrative functions. 
Similarly, the learning-by-using ICT for patient care purposes variable will be used 
in the analysis examining the factors impacting on the probability of the extent of 
ICT use for administrative purposes. 87 per cent of practices use ICT for three or 
more patient care functions. The portfolio of medical equipment variable was 
strongly significant and consistently signed in relation to use of medical equipment 
(see Chapter 6). Therefore, we include this variable to examine if learning-by-using a 
portfolio of medical equipment impacts on intensity of ICT use. 90 per cent of 
practices use three or more of the six items of medical equipment. 
 
As in our medical equipment use analysis, epidemic effects are measured by 
variables relating to practice location and interaction and education factors. Practice 
location is provided for with respect to urban and rural classifications and HSE 
region. Epidemic effects variables also included whether the practice is a training 
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practice, holds clinic and is frequently visited by suppliers of IT. Factors such as 
being a committee member of a professional organisation, affiliated with an 
academic department, involved in research projects, completing an ICGP course and 
attendance at CME meetings are also considered. These variables are described in 
detail in Section 6.3.1. Descriptive statistics for these variables are also included in 
Table 7.4. 
 
There is a lack of consensus in the literature in terms of the impact of epidemic 
learning effects on intra-firm diffusion (Hollenstein and Woerter, 2004; Battisti and 
Stoneman, 2005). However, we would expect interaction with external agents to 
have some positive influence on extent of ICT use among general practices, and it is 
likely that rural, training practices use ICT to a greater extent (Meade et al., 2009). 
Also, in our medical equipment study, we find that practices located in HSE West 
are more likely to invest in medical equipment. Therefore, it is likely that these 
practices are also more intensive users of ICT.  
 
Interestingly, in 2001, the Southern Health Board developed an ICT strategy to 
improve service delivery, for which it received the European Commission‟s “Best 
Practices in eService Delivery” award. It is likely that knowledge spillovers from 
this strategy may positively influence intensity of ICT use among general practices 
in the HSE South.
9293
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 Prior to January 2005, the Irish health care system comprised of eight regional health boards. In 
2005, the Southern Health Board was subsumed into the HSE South region. 
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 This ICT Strategy is discussed in more detail in Section 8.4.1, where policy implications of this 
thesis are discussed.  
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As previously discussed in Section 2.4, intensity of adoption decision-making differs 
from adoption decision-making with respect to costs and benefits. The cost of 
adopting ICT in the first instance would be considerable for an individual practice. 
However, the cost of becoming a more intensive user of ICT, in terms of time, effort 
and money, is likely to be very much dependent on the individual ICT applications 
and the practice‟s current portfolio of ICT applications. For example, if a practice 
chooses to use additional ICT applications from their current software package, the 
costs of such decision-making are likely to be relatively low. On the other hand, use 
of some ICT applications, such as coding of diseases, would require considerable 
effort regardless of whether or not the application was readily available to the 
practice. Likewise, in order for some practices to move from being „basic‟ or 
„intermediate‟ ICT users to „enhanced‟ ICT users may require the purchase of new 
software. Similarly, the development of a practice website may incur considerable 
monetary and effort costs.   
 
It is important to note that although more intensive ICT use may require additional 
investments and training; in general, risks of adoption reduce with ownership and 
use of technologies. Therefore, we assume costs of intensity of ICT use to be 
constant across practices in our econometric analysis. However, we do consider the 
cost implications of adoption when interpreting our empirical results. 
 
A correlation matrix of all variables used in this analysis is also presented in Table 
7.6, illustrating that the explanatory variables, in general, are not strongly correlated 
with each other. We also present descriptive statistics for all explanatory variables in 
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relation to the three categories of ICT users for both administrative and patient care 
purposes (see Tables 7.7 and 7.8). 
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Table 7.6: Correlation Matrix of Dependent and Independent Variables 
 
Admin 
ICT Use 
Patient Care 
ICT Use 
Nurse 
Support 
No. of 
GPs 
Public 
Patients 
No. of 
Patients 
Admin 
Support 
All GPs 
> 40yrs Male 
≥ 3 Admin 
ICT 
≥ 3 PC 
ICT 
Med. Eq. 
Portfolio 
Patient Care ICT Use 0.64 1.00 
          Nurse Support 0.26 0.29 1.00 
         No. of GPs 0.38 0.36 0.28 1.00 
        Public Patients -0.14 -0.06 0.14 -0.06 1.00 
       No. of Patients 0.36 0.33 0.35 0.70 -0.31 1.00 
      Admin Support 0.19 0.18 0.27 0.13 0.02 0.27 1.00 
     All GPs >40 yrs -0.37 -0.42 -0.20 -0.53 0.06 -0.39 -0.15 1.00 
    Male  -0.13 -0.18 -0.01 -0.05 0.15 -0.08 -0.10 0.18 1.00 
   ≥ 3 Admin ICT 0.47 0.42 0.21 0.21 -0.08 0.28 0.19 -0.26 -0.07 1.00 
  ≥ 3 PC ICT  0.67 0.91 0.34 0.38 -0.05 0.36 0.24 -0.42 -0.16 0.55 1.00 
 Med. Eq. Portfolio 0.28 0.26 0.37 0.22 -0.01 0.31 0.23 -0.22 -0.01 0.25 0.30 1.00 
HSE Northeast 0.02 -0.01 0.08 -0.01 -0.08 0.13 0.03 -0.04 -0.03 0.05 0.00 0.02 
HSE South 0.09 0.10 0.10 0.09 0.08 -0.01 0.05 -0.06 -0.04 0.04 0.08 -0.03 
HSE West -0.07 -0.07 -0.14 -0.14 0.19 -0.21 -0.10 0.08 0.07 -0.07 -0.05 0.00 
Town 0.02 0.05 0.18 0.20 0.07 0.21 0.06 -0.07 0.04 0.02 0.07 0.07 
Rural -0.09 -0.09 0.00 -0.24 0.12 -0.28 0.03 0.17 0.04 -0.02 -0.09 0.04 
Training 0.31 0.33 0.24 0.41 0.01 0.27 0.08 -0.40 -0.07 0.15 0.33 0.18 
Supplier Visits 0.23 0.21 0.09 0.17 0.02 0.21 0.10 -0.05 -0.12 0.17 0.24 0.17 
Clinic 0.13 0.14 0.18 0.23 -0.01 0.19 0.12 -0.11 0.01 0.15 0.14 0.21 
Committee 0.07 0.14 0.06 0.02 0.05 -0.02 0.01 -0.08 0.03 -0.03 0.13 0.11 
Academic 0.29 0.28 0.17 0.22 -0.09 0.14 0.04 -0.23 -0.09 0.13 0.26 0.16 
Research Projects 0.20 0.23 0.11 0.14 -0.04 0.09 0.03 -0.15 0.07 0.10 0.24 0.15 
ICGP course 0.17 0.19 0.08 0.10 -0.10 0.08 0.07 -0.11 -0.10 0.08 0.18 0.11 
CME 0.02 0.13 0.06 0.08 0.04 0.02 0.03 -0.02 0.06 0.07 0.12 0.11 
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Table 7.6 (continued): Correlation Matrix of Dependent and Independent Variables 
 
 
HSE 
Northeast 
HSE 
South 
HSE 
West 
Town 
 
Rural 
 
Training 
 
Supplier 
Visits 
Clinic 
 
Committee 
 
Academic 
 
Research 
Projects 
ICGP 
Course 
CME 
             
 
HSE Northeast 1.00 
           
 
HSE South -0.31 1.00 
          
 
HSE West -0.25 -0.46 1.00 
         
 
Town 0.02 0.02 -0.01 1.00 
        
 
Rural -0.08 -0.01 0.18 -0.48 1.00 
       
 
Training 0.04 -0.08 0.03 0.12 -0.02 1.00 
      
 
Supplier Visits -0.04 0.05 -0.06 0.01 -0.07 0.06 1.00 
     
 
Clinic 0.11 0.01 -0.07 0.08 0.14 0.15 0.10 1.00 
    
 
Committee -0.02 -0.02 0.01 0.00 -0.05 0.14 0.04 -0.04 1.00 
   
 
Academic 0.06 0.01 -0.05 -0.06 -0.01 0.36 0.12 0.11 0.17 1.00 
  
 
Research Projects 0.02 -0.03 0.03 -0.02 0.07 0.28 0.03 0.08 0.16 0.31 1.00 
 
 
ICGP course 0.03 -0.05 0.03 0.04 0.00 0.11 0.08 0.10 0.17 0.21 0.18 1.00  
CME -0.18 0.05 0.00 0.05 -0.06 0.05 0.00 0.03 0.10 0.08 0.06 0.10 1.00 
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Table 7.7: Descriptive Statistics of Explanatory Variables for ICT User 
Categories for Administrative Purposes  
 
 Basic  
Use 
Intermediate 
Use 
Enhanced 
Use 
Variable Name Mean Mean Mean 
 
Rank Effects 
Nursing Support 0.58 0.85 0.89 
Number of GPs 1.76 1.42 3.50 
Public Patients/ Total Patients 0.42 0.20 0.34 
Log of Patients 7.60 8.04 8.37 
Administrative Support 0.77 0.22 0.96 
Age >40 0.74 0.50 0.25 
Male Dominated 0.63 0.50 0.48 
 
Learning-by-using Effects 
ICT Use for Patient Care Purposes 
(3 or more administrative ICT 
functions) 
0.49 0.20 1.00 
Portfolio of Medical Equipment 
(3 or more medical equipments) 
0.71 0.25 0.97 
 
Epidemic Effects 
HSE Dublin Mid-Leinster 0.26 0.23 0.22 
HSE Dublin North East 0.16 0.35 0.15 
HSE South 0.29 0.48 0.39 
HSE West 0.29 0.44 0.23 
City 0.29 0.28 0.37 
Rural 0.21 0.42 0.11 
Town 0.50 0.50 0.51 
Training Practice  0.06 0.45 0.45 
Clinic 0.33 0.50 0.55 
Supplier Visits = 0 0.61 0.38 0.32 
Supplier Visits = 1.5 0.33 0.39 0.35 
Supplier Visits = 4 0.05 0.16 0.22 
Supplier Visits = 7 0.00 0.03 0.07 
Supplier Visits = 10 0.01 0.03 0.05 
Committee Member 0.31 0.41 0.47 
Academic Department 0.21 0.31 0.53 
Research Project 0.13 0.15 0.36 
ICGP Course 0.19 0.26 0.43 
CME Meetings = 0 0.11 0.07 0.09 
CME Meetings = 1.5 0.08 0.07 0.07 
CME Meetings = 4 0.33 0.32 0.28 
CME Meetings =7 0.48 0.55 0.55 
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Table 7.8: Descriptive Statistics of Explanatory Variables for ICT User 
Categories for Patient Care Purposes 
 
 Basic  
Use 
Intermediate 
Use 
Enhanced 
Use 
Variable Name Mean Mean Mean 
 
Rank Effects 
Nursing Support 0.59 0.84 0.91 
Number of GPs 1.77 2.59 3.32 
Public Patients/ Total Patients 0.37 0.41 0.35 
Log of Patients 7.66 8.02 8.32 
Administrative Support 0.79 0.95 0.95 
Age >40 0.75 0.46 0.23 
Male Dominated 0.62 0.51 0.44 
 
Learning-by-using Effects 
ICT Use for Administrative Purposes 
(3 or more administrative ICT 
functions) 
0.64 0.98 1.00 
Portfolio of Medical Equipment 
(3 or more medical equipments) 
0.74 0.92 0.97 
 
Epidemic Effects 
HSE Dublin Mid-Leinster 0.25 0.23 0.23 
HSE Dublin North East 0.17 0.15 0.14 
HSE South 0.27 0.38 0.38 
HSE West 0.31 0.25 0.25 
City 0.30 0.29 0.34 
Rural 0.23 0.22 0.13 
Town 0.47 0.49 0.53 
Training Practice  0.08 0.22 0.46 
Clinic 0.36 0.51 0.56 
Supplier Visits = 0 0.59 0.39 0.32 
Supplier Visits = 1.5 0.35 0.36 0.37 
Supplier Visits = 4 0.06 0.17 0.20 
Supplier Visits = 7 0.00 0.05 0.02 
Supplier Visits = 10 0.01 0.03 0.05 
Committee Member 0.31 0.41 0.47 
Academic Department 0.21 0.31 0.53 
Research Project 0.13 0.15 0.36 
ICGP Course 0.19 0.26 0.43 
CME Meetings = 0 0.12 0.09 0.06 
CME Meetings = 1.5 0.11 0.07 0.05 
CME Meetings = 4 0.30 0.33 0.29 
CME Meetings =7 0.47 0.51 0.60 
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7.3.2 Econometric Methodology for Intensity of ICT Use 
Intensity of ICT use for both administrative and patient care functions are 
ordered categorical variables and, in line with Hollenstein (2004), can be 
analysed using the ordered probit model. The ordered probit model can be used 
to model a discrete dependent variable that takes ordered multinomial outcomes 
for each individual i, for example yi = 1, 2......, m (Jones et al., 2007). This 
applies to our measure of ICT use, which has categorical outcomes: basic user, 
intermediate user, and enhanced user.  
 
The ordered probit model can be expressed as: 
 
                  
                   
         [Eqn. 7.1] 
where the latent variable,   , is assumed to be a linear function of a vector of 
explanatory variables x, plus a random error term Ɛ: 
 
 
   
                       
         [Eqn. 7.2] 
and                        Given the assumption that the error term is 
normally distributed, the probability of observing a particular value of y is: 
 
                                    
         [Eqn. 7.3] 
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where      is the standard normal distribution function. It is important to note 
that the coefficient values from the ordered probit model should not be given a 
quantitative interpretation (Jones et al., 2007). However, marginal effects can be 
calculated for each of the categorical outcomes which can be interpreted 
quantitatively.  
 
It is also worth noting that the dependent variables being examined show a high 
level of correlation with each other (ρ =0.6395; see Table 7.5) indicating that a 
simultaneous equation model should perhaps be considered. However, given that 
both dependent variables are ordered categorical variables, we are not aware of 
an estimation technique that would allow us to estimate these models 
simultaneously while retaining the current structure of the variables. It is also 
likely that there may be endogeneity issues with some of the explanatory 
variables such as nursing support or administrative support. An instrumental 
variables approach would overcome such an issue, however, from the survey 
data it would be extremely difficult to identify appropriate instruments. It is also 
worth noting that these explanatory variables, indeed all explanatory variables in 
the models, are not strongly correlated with each other (see Table 7.6).  
 
7.4 Econometric Results for Intensity of ICT Use 
Ordered probit models are used to examine the determinants of intensity of ICT 
use for administrative and patient care purposes in Irish general practices. The 
ordered probit model estimations are presented in Tables 7.9a and 7.9b. Initial 
baseline models were estimated. Subsequently, in a „stepwise‟ fashion, variables 
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with z-statistics of less than |0.5| were excluded from the models.
94
 The ordered 
probit models examining intensity of ICT use for administrative and patient care 
purposes are statistically significant and with R-squared values of 24 and 22 per 
cent respectively. Also, the statistical significance of the threshold parameters in 
the preferred ordered Probit models indicate the appropriateness of  the model 
given ordered categories of the dependent variables (see Tables 7.9a and 7.9b). 
Given the restrictions in interpreting the ordered probit model coefficients (Jones 
et al., 2007), these results will be discussed briefly in Section 7.4.1. 
Subsequently, marginal effects will be presented and discussed in detail in 
Section 7.4.2. 
  
                                                 
94
 In a robustness check, comparison of significant coefficients in initial models and preferred 
models suggests that the exclusion of a number of insignificant variables has no effect on 
direction of significant coefficient values (see Tables 7.9a and 7.9b). 
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Table 7.9a: Intensity of ICT Use for Admin Functions – Ordered Probits   
 Saturated Model Model (ii) Model (iii) Preferred Model 
 b/se b/se b/se b/se 
Rank Effects 
Nursing Support 
0.171 0.172 0.182 0.183 
(0.170) (0.170) (0.167) (0.166) 
Number of GPs 
0.118** 0.118** 0.127*** 0.131*** 
(0.054) (0.054) (0.043) (0.043) 
Proportion of Public 
Patients 
-1.042*** -1.041*** -1.078*** -1.081*** 
(0.321) (0.321) (0.294) (0.294) 
Log of Number of Patients 
0.037 0.037   
(0.125) (0.124)   
Administration Support 
0.32 0.32 0.335 0.335 
(0.243) (0.243) (0.237) (0.237) 
All GPs  >40 years 
-0.183 -0.184 -0.182 -0.181 
(0.135) (0.134) (0.134) (0.134) 
Male (GP) Dominated  
-0.064 -0.063 -0.063 -0.062 
(0.112) (0.111) (0.111) (0.111) 
Learning-by-using Effects 
IT Use for Patient Care 
Functions 
1.842*** 1.842*** 1.843*** 1.836*** 
(0.251) (0.251) (0.251) (0.250) 
Portfolio of Medical 
Equipment 
0.383* 0.384* 0.393* 0.403* 
(0.224) (0.224) (0.222) (0.221) 
Epidemic Effects 
HSE Dublin Northeast 
0.175 0.175 0.18 0.188 
(0.186) (0.186) (0.186) (0.185) 
 HSE South 
0.376** 0.375** 0.372** 0.372** 
(0.152) (0.152) (0.152) (0.152) 
HSE West 
0.308* 0.308* 0.305* 0.300* 
(0.165) (0.165) (0.165) (0.164) 
Town Practice 
-0.215 -0.215 -0.213 -0.205 
(0.130) (0.130) (0.130) (0.129) 
Rural Practice 
-0.276 -0.277 -0.283 -0.263 
(0.178) (0.178) (0.177) 
(0.172) 
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Table 7.9a (continued): Intensity of ICT Use for Admin Functions – Ordered Probits  
 
Training Practice 
0.292** 0.293** 0.292** 0.293** 
(0.141) (0.141) (0.141) (0.141) 
Visits from It Suppliers 
0.074*** 0.074*** 0.075*** 0.075*** 
(0.026) (0.025) (0.025) (0.025) 
Practice Holds a Clinic 
0.055 0.055 0.054  
(0.114) (0.114) (0.114)  
Committee Member 
0.01    
(0.114)    
Academic Department 
0.255** 0.256** 0.252** 0.254** 
(0.125) (0.124) (0.124) (0.124) 
Research Projects 
0.219 0.22 0.219 0.22 
(0.136) (0.136) (0.136) (0.136) 
ICGP Course 
0.153 0.155 0.154 0.156 
(0.121) (0.121) (0.120) (0.120) 
CME Meetings 
-0.021 -0.02 -0.021 -0.021 
(0.024) (0.024) (0.024) (0.024) 
Summary Statistics 
Threshold Parameter 1 
 
1.858* 1.852* 1.596*** 1.593*** 
(0.961) (0.959) (0.405) (0.404) 
Threshold Parameter 2  
3.620*** 3.614*** 3.358*** 3.355*** 
(0.966) (0.964) (0.419) (0.418) 
N 
523 523 523 523 
Chi-Square 
270.223 270.215 270.128 269.906 
P - value 
0 0 0 0 
Bayesian Information 
Criterion 
 
973.108 
 
966.857 
 
960.684 
 
954.647 
 
Notes: Coefficients are reported with standard errors in parentheses. *** denotes 
significance at the 1 per cent level; ** at the 5 per cent level and * at the 10 per cent 
level.   
 
 
 
 
 
 
 
 
 
213 
 
Table 7.9b: Intensity of ICT Use for Patient Care Functions Ordered 
Probits  
 Saturated 
Model 
Model 
(ii) 
Model 
(iii) 
Preferred  
Model 
 b/se b/se b/se b/se 
Rank Effects 
Nursing Support 
 
0.387** 0.389** 0.375** 0.389** 
(0.166) (0.166) (0.161) (0.158) 
Number of GPs 
0.059 0.058 0.055 0.054 
(0.055) (0.055) (0.054) (0.054) 
Prop. of Public Patients 
-0.117 -0.108   
(0.320) (0.318)   
(Log) Number of Patients 
0.084 0.086 0.103 0.11 
(0.125) (0.125) (0.115) (0.114) 
Administration Support 
0.183 0.179 0.173 0.181 
(0.245) (0.245) (0.244) (0.243) 
All GPs  >40 years 
-0.417*** -0.418*** -0.418*** -0.424*** 
(0.134) (0.134) (0.134) (0.133) 
Male (GP) Dominated  
-0.281** -0.282** -0.287** -0.287** 
(0.114) (0.114) (0.113) (0.113) 
Learning-by-using Effects 
IT Use for 3 or more Admin 
Functions 
1.710*** 1.709*** 1.717*** 1.725*** 
(0.284) (0.284) (0.284) (0.283) 
Medical Equipment Portfolio  
0.107 0.105 0.106  
(0.218) (0.217) (0.217)  
Epidemic Effects 
HSE Dublin Northeast 
0.045    
(0.186)    
 HSE South 
0.311** 0.293** 0.289** 0.289** 
(0.152) (0.132) (0.132) (0.132) 
HSE West 
0.2 0.182 0.174 0.178 
(0.166) (0.147) (0.145) (0.145) 
Town Practice 
-0.13 -0.13 -0.135 -0.133 
(0.132) (0.132) (0.132) (0.131) 
Rural Practice 
-0.267 -0.268 -0.271 -0.264 
(0.180) (0.180) (0.180) (0.179) 
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Table 7.9b (continued): Intensity of ICT Use for Patient Care Functions – Ordered Probits 
 
Training Practice 
0.367** 0.366** 0.364** 0.362** 
(0.145) (0.145) (0.145) (0.145) 
Visits from It Suppliers 
0.052** 0.051** 0.051** 0.052** 
(0.025) (0.025) (0.025) (0.025) 
Practice Holds a Clinic 
0.085 0.088 0.089 0.096 
(0.116) (0.115) (0.115) (0.115) 
Committee Member 
0.202* 0.201* 0.200* 0.205* 
(0.116) (0.116) (0.116) (0.116) 
Academic Department 
0.116 0.118 0.121 0.125 
(0.127) (0.127) (0.127) (0.126) 
Research Projects 
0.348** 0.349** 0.351** 0.356** 
(0.142) (0.141) (0.141) (0.141) 
ICGP Course 
0.234* 0.235* 0.239* 0.239* 
(0.125) (0.125) (0.124) (0.124) 
CME Meetings 
0.040* 0.039* 0.038* 0.039* 
(0.024) (0.023) (0.023) (0.023) 
Summary Statistics 
Threshold Parameter 1 
 
2.400** 2.393** 2.540*** 2.544*** 
(0.989) (0.988) (0.889) (0.888) 
Threshold Parameter 2  
3.686*** 3.679*** 3.826*** 3.829*** 
(0.994) (0.993) (0.894) (0.893) 
N 
523 523 523 523 
Chi-Square 
253.217 253.159 253.045 252.808 
P – value 
0 0 0 0 
Bayesian Information 
Criterion 
 
1006.45 
 
1000.25 
 
994.1 
 
988.077 
 
Notes: Coefficients are reported with standard errors in parentheses. *** denotes 
significance at the 1 per cent level; ** at the 5 per cent level and * at the 10 per cent 
level.   
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7.4.1 Ordered Probit Estimations for Intensity of ICT Use 
This section discusses the ordered probit estimations for intensity of ICT use for 
administrative and patient care purposes, firstly, with respect to rank effects, 
then, learning-by-using effects and, finally, epidemic effects. There is evidence 
that the equilibrium model rank effects variables impact on intensity of ICT use 
for both administrative and patient care functions. However, different rank effect 
variables impact on intensity of use for both purposes. For instance, as the 
number of GPs in a practice increases, intensity of ICT use for administrative 
purposes increases. Also, as the proportion of public patients in the practice 
relative to the total number of patients increases, intensity of ICT use for 
administrative purposes decreases. Both these relationships are statistically 
significant at the 1 per cent level. Neither of these variables impact on intensity 
of ICT use for patient care purposes. Nursing support positively impacts on 
intensity of ICT use for patient care purposes. However, practices dominated by 
male GPs and by older GPs negatively impact on the intensity of ICT use for 
patient care purposes. None of these three variables impact on intensity of ICT 
use for administrative purposes. The remaining rank effect variables, the number 
of patients and administrative support, do not impact on either type of ICT use. 
   
There are more consistent findings for both types of ICT use in relation to 
learning-by-using effects. As discussed in the previous section, we use a variable 
measuring learning-by-using ICT for at least three administrative functions in the 
patient care ICT analysis and a variable measuring learning-by-using ICT for at 
least three patient care functions in the administrative ICT analysis. There is 
clear evidence of learning-by-using effect in both models. Practices which use 
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ICT for at least three patient care and administrative functions are more likely to 
extensively use ICT for administrative and patient care purposes respectively. 
These effects are statically significant at the 1 per cent level.
 95
   
 
There is also strong evidence of epidemic effects in relation to intensity of ICT 
use. In relation to practice location, practices located in the HSE South indicate a 
greater propensity to intensively use ICT for both administrative and patient care 
purposes relative to practices located in the HSE Dublin Mid-Leinster region. 
This relationship is statistically significant at the 5 per cent level for both types of 
ICT use. There is also evidence that practices in the HSE West region have a 
greater propensity to intensively use ICT for administrative purposes. This 
relationship is statistically significant at the 10 per cent level. Interestingly, 
practice location, with respect to city, town and rural location, does not impact on 
intensity of ICT use. 
 
There is evidence of consistent epidemic effects with respect to both intensity of 
ICT use for administrative and patient care purposes. In relation to visits from IT 
suppliers, as the number of visits increases, propensity to intensively use ICT for 
both administrative and patient care purposes also increases. These findings are 
statistically significant at the 1 and 5 per cent levels respectively. Training 
practices are also more likely to intensively use ICT for both purposes. These 
                                                 
95
 There is evidence of a positive relationship between a practices‟ portfolio of medical 
equipment and intensity of ICT use for administrative purposes. This result indicates that learning 
which takes place within a practice from experience with one type of technology may positively 
influence adoption and intensity of adoption of seemingly unrelated technologies. However, this 
relationship is statistically significant at the 10 per cent level. 
 
217 
 
findings are statistically significant at the 5 per cent level. There is no evidence 
that practices that hold clinics are more likely to be intensive users of ICT.   
There is further evidence of epidemic effects; however, they are not consistent in 
relation to both types of ICT use. For instance, practices affiliated with an 
academic department have a greater propensity to intensively use ICT for 
administrative purposes. This finding is statistically significant at the 5 per cent 
level. However, such an affiliation does not impact on intensity of ICT use for 
patient care purposes. Active involvement in research projects positively impacts 
on propensity to intensively use ICT for patient care purposes. This finding is 
statistically significant at the 5 per cent levels respectively. However, 
involvement in research projects does not influence intensity of ICT use for 
administrative purposes. 
 
The ordered probit estimations for intensity of ICT use for administrative and 
patient care purposes illustrate interesting results in relation to rank, learning-by-
using and epidemic effects. There is evidence of rank effects, however these is a 
clear distinction with respect to the rank effects variables influencing intensity of 
ICT use for administrative purposes and those influencing intensity of ICT use 
for patient care purposes. The number of GPs in a practice positively impacts on 
intensity of ICT use for administrative purposes, and the proportion of public 
patients relative to total patients negatively impacts on intensity of ICT use for 
administrative purposes. However, in relation to intensity of ICT use for patient 
care purposes, nursing support has a positive influence, whereas male dominated 
practices and practices with older GPs negatively influence intensity of ICT use. 
There is more consistent evidence of learning-by-using effects with respect to 
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both types of ICT use. Learning from using ICT for administrative purposes 
positively impacts on intensity of ICT use for patient care purposes and, likewise, 
learning from using ICT for patient care purposes positively impacts on intensity 
of ICT use for administrative purposes.  
 
There is also evidence of epidemic effects, some common to both types of ICT 
use, others relevant to only one type of ICT use. Practices in the HSE South 
region use ICT more intensively for administrative and patient care purposes. 
Visits from IT suppliers and being a training practice positively influences 
intensity of ICT use for both purposes. An academic affiliation positively 
impacts ICT use for administrative purposes. Whereas being actively involved in 
research projects positively impacts on intensity of ICT use for patient care 
purposes.  
 
From the results discussed above, it is clear that equilibrium, disequilibrium and 
learning-by-using effects influence general practices‟ intensity of ICT use for 
administrative and patient care purposes. When interpreting ordered probit 
coefficients, we are restricted to interpreting the sign and significance of the 
coefficients. However, the next section presents marginal effects for the three 
categories of ICT user for administrative and patient care purposes, which allows 
us to determine the probability of a practice being in these categories of ICT use.   
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7.4.2 Ordered Probit Marginal Effects for Intensity of ICT Use 
Marginal effects are calculated for each of the three outcomes, basic user, 
intermediate user, and enhanced user, for intensity of ICT use for administrative 
purposes and patient care purposes, and presented in Tables 7.10a and 7.10b 
respectively.  
 
As discussed in the previous section, the number of GPs and the proportion of 
public patients influence intensity of ICT use for administrative purposes. Table 
7.10a presents the marginal effects for these relationships. The more GPs in a 
practice, the less likely a practice is to be a basic user or intermediate user of ICT 
for administrative purposes and the more probable the practice is an enhanced 
user. However, the size of the marginal effects is relatively small indicating that 
the number of GPs in practice does not considerably influence intensity of ICT 
use. The proportion of public patients in a practice influences intensity of ICT 
use for administrative purposes, in that, the higher the proportion of public 
patients, the more likely a practice is to be a basic or intermediate user and less 
likely to be an enhanced user of ICT for administrative purposes. As is evident 
from the marginal effects, the size of this effect is relatively large.   
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Table 7.10a: Intensity of ICT use for Administrative Purposes – Marginal 
Effects 
 
 Basic User Intermediate User Enhanced User 
  
dy/dx 
 
dy/dx 
 
dy/dx 
 
Rank Effects 
Nursing Support 
-0.031 -0.022 0.053 
Number of GPs 
-0.022*** -0.016*** 0.038*** 
Prop. of Public Patients 
0.183*** 0.129*** -0.311*** 
Administration Support 
-0.057 -0.040 0.097 
All GPs >40 yrs 
0.031 0.022 -0.052 
Male Dominated 
0.010 0.007 -0.018 
 
Learning-by-using Effects 
Patient Care IT Use 
-0.310*** -0.219*** 0.529*** 
Medical Equip. Portfolio 
-0.068* -0.048* 0.116* 
 
Epidemic Effects 
HSE Dublin Northeast 
-0.032 -0.022 0.054 
 HSE South 
-0.063** -0.044** 0.107** 
HSE West 
-0.051* -0.036* 0.086* 
Town Practice 
0.035 0.024 -0.059 
Rural Practice 
0.044 0.031 -0.076 
Training Practice 
-0.050** -0.035** 0.084** 
Visits from It Suppliers 
-0.013*** -0.009*** 0.022*** 
Academic Department 
-0.043** -0.030** 0.073** 
Research Projects 
0.037 -0.026 0.063 
ICGP Course 
-0.026 -0.019 0.045 
CME Meetings 
0.004 0.003 -0.006 
Notes: *** denotes significance at the 1 per cent level; ** at the 5 per cent level and * at 
the 10 per cent level.   
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Table 7.10b: Intensity of ICT use for Patient Care Purposes – Marginal 
Effects 
 
 Basic User Intermediate User Enhanced User 
  
dy/dx 
 
dy/dx 
 
dy/dx 
 
Rank Effects 
Nursing Support 
-0.077*** -0.039*** 0.116*** 
Number of GPs 
-0.011 -0.005 0.016 
 (Log) Number of Patients 
-0.022 -0.011 0.033 
Administration Support 
-0.036 -0.018 0.054 
All GPs >40 yrs 
0.083*** 0.043*** -0.126*** 
Male Dominated 
0.056** 0.029** -0.085** 
 
Learning-by-using Effects 
Administrative IT Use 
-0.339*** -0.174*** 0.513*** 
 
Epidemic Effects 
HSE Dublin Northeast 
-0.057 -0.029 0.086 
HSE South 
-0.035** -0.018** 0.053** 
HSE West 
0.026 0.013 -0.040 
Rural Practice 
0.052 0.027 -0.079 
Training Practice 
-0.071** -0.037** 0.108** 
Visits from It Suppliers 
-0.010** -0.005** 0.154** 
Practice holds Clinics 
-0.019 -0.010 0.029 
Committee Member 
-0.040* -0.021* 0.061* 
Academic Department 
-0.025 -0.013 0.037 
Research Projects 
-0.070** -0.036** 0.106** 
ICGP Course 
-0.047* 0.024* 0.071* 
CME Meetings 
-0.008* 0.004* 0.017* 
Notes: *** denotes significance at the 1 per cent level; ** at the 5 per cent level and * at 
the 10 per cent level.   
 
 
As previously discussed, practice profile with respect to gender, age and nursing 
support influence intensity of ICT use for patient care purposes. If a practice has 
nursing support, it is 8 and 4 per cent less likely to be a basic and intermediate 
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user of ICT for patient care purposes respectively, and 12 per cent more likely to 
be an enhanced user (see Table 7.10b). In practices where all GPs are forty years 
of age or older, they are 8 and 4 per cent more likely to be a basic or intermediate 
user of ICT for patient care purposes respectively, and 12 per cent less likely to 
be an enhanced user. A similar pattern is evident in relation to male dominated 
practices. Practices with more male than female GPs are 6 and 3 per cent more 
likely to be basic and intermediate users of ICT for patient care purposes 
respectively and 9 per cent less likely to be enhanced users (see Table 7.10b).  
 
With respect to learning-by-using effects from ICT, the size of the marginal 
effects is quite large indicating a significant economic effect (Tables 7.10a and 
7.10b). A practice which uses ICT for three or more administrative functions is 
34 and 17 per cent less likely to be a basic or intermediate user of ICT for patient 
care purposes and 51 per cent more likely to be an enhanced user. Likewise, a 
practice which uses ICT for three or more patient care functions is 31 and 22 per 
cent less likely to be a basic or enhanced user of ICT for administrative purposes 
and 53 per cent more likely to be an enhanced user.  
 
The epidemic effects in relation to ICT use for administrative and patient care 
purposes are discussed, focusing on location effects initially. As previously 
discussed, there is a positive relationship between HSE South practices and 
intensity of ICT use. Practices located in the HSE South region are 6 and 4 per 
cent less likely to be basic and intermediate users of ICT for administrative 
purposes than practices in the HSE Mid-Leinster region and 11 per cent more 
likely to be enhanced users. These practices located are also 6 and 3 per cent less 
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likely to be basic and intermediate users of ICT for patient care purposes than 
practices in the HSE Mid-Leinster region and 9 per cent more likely to be 
enhanced users. 
 
As IT supplier visits increases, so too does intensity of ICT use for both 
administrative and patient care purposes. The greater the number of visits from 
suppliers, the less likely a practice is to be a basic and intermediate user of ICT 
for both administrative and patient care purposes and more likely to be an 
enhanced user for both types of ICT use. However, it is worth noting that the size 
of marginal effects are quite small, indicating low economic significance in 
relation to interaction with suppliers and intensity of ICT use. 
 
Being a training practice positively impacts on intensity of ICT use. If a practice 
is a training practice, it is 5 and 4 per cent less likely to be a basic and 
intermediate user of ICT for administrative purposes respectively, and 8 per cent 
more likely to be an enhanced user. Likewise, if a practice is a training practice, 
it is 7 and 4 per cent less likely to be a basic and intermediate user of ICT for 
patient care purposes respectively, and 11 per cent more likely to be an enhanced 
user. 
 
The remaining epidemic effects are evident in relation to one or other type of 
ICT use. In relation to ICT use for administrative purposes, practices with an 
academic affiliation are 4 and 3 per cent less likely to be basic and intermediate 
users respectively, and 7 per cent more likely to be enhanced users. In relation to 
ICT use for patient care purposes, practices actively involved in research projects 
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are 6 and 4 per cent less likely to be basic and intermediate users and 11 per cent 
more likely to be enhanced users.  
 
7.4.3 Discussion of Intensity of ICT Use Estimations 
The previous sections presented ordered probit estimations (7.4.1) and marginal 
effects (7.4.2) for intensity of ICT use for administrative and patient care 
purposes. There is clear evidence of equilibrium, disequilibrium and learning-by-
using effects, although these effects are not always consistent in how they are 
revealed in the different ICT usage models. This section will discuss our results 
in the context of our anticipated results and previous literature. 
 
Firstly, we will discuss the rank effects with respect to intensity of ICT use. In 
line with Hollenstein (2004) and Battisti et al. (2007), we find little evidence of 
size effects in relation to intensity of ICT use. The number of GPs in a practice 
does not impact on intensity of ICT use for patient care purposes, and only 
marginally positively impacts on intensity of ICT use for administrative 
purposes. The number of patients in a practice does not impact on intensity of 
ICT use. It is possible that once a practice adopts ICT, small and large practices 
use it to the same extent (Hollenstein, 2004). Interestingly, the higher the 
proportion of public patients a practice has, the more likely they are to be basic 
or intermediate users of ICT for administrative purposes. This may indicate that 
practices with a high proportion of public patients must fulfil certain 
requirements in terms of registering patients, but are not obliged to be intensive 
users of ICT for administrative purposes. In line with our previous findings of the 
positive influence of nursing support on prescription drugs and medical 
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equipment adoption, we find that nursing support positively influences intensity 
of ICT use for patient care purposes.  
 
The cost of adopting additional ICT applications has previously been discussed. 
The influence of these rank effects on intensity of ICT use may be capturing, to 
some extent, the cost of increasing intensity of ICT use. If becoming an 
„enhanced‟ user of ICT for administrative and patient care purposes requires a 
considerable monetary and effort outlay, then larger practices are more likely to 
be able to afford to take that step. Therefore, the positive influence of the number 
of GPs and proportion of private patients in a practice on intensity of ICT use for 
administrative purposes and nursing support on intensity of ICT use for patient 
care purposes may be portraying the ability of such practices to afford to become 
„enhanced‟ ICT users. 
 
The GP age and gender profile within practices does not impact on intensity of 
ICT use for administrative purposes. However, practices where all GPs are older 
than 40 years of age and practices that are predominately male are 13 and 9 per 
cent less likely to be enhanced users of ICT for patient care purposes. The 
finding that practices where all GPs are older than 40 year or age are less likely 
to be intensive ICT users is intuitive and in line with previous research (Masters, 
2008; Meade et al., 2009). Also, in our prescribing innovation analysis, we find 
that older GPs are slower to adopt new drugs. However, it is somewhat 
surprising that male dominated practices are less likely to be intensive users of 
ICT. Previous research indicated that male GPs were more likely to use ICT than 
female GPs (Masters, 2008; Meade et al., 2009). Also, in Chapter 6, we find that 
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practices that are predominately male are more likely to use at least three of the 
six types of medical equipment examined. This finding, that male (GP) 
dominated practices are less likely to be intensive users of ICT, may be further 
evidence that drivers of use are not necessarily drivers of intensity of use.  
 
Our empirical findings demonstrate the considerable influence of learning-by-
using effects on intensity of ICT use. A practice which uses ICT for three or 
more administrative functions is 51 per cent more likely to be an enhanced user 
of ICT for patient care purposes. Likewise, a practice which uses ICT for three or 
more patient care functions is 53 per cent more likely to be an enhanced user of 
ICT for administrative purposes. Therefore, practices that use ICT for one 
particular purpose are significantly more likely to become extensive users of ICT 
for another purpose. The implication being here that practices learn and benefit 
from complementary ICT use in terms of becoming intensive ICT users for a 
different purpose. There is also strong evidence that learning-by-using from a 
portfolio of medical equipment positively influences intensity of ICT use for 
administrative purposes. This is further evidence that learning- by-using effects 
positively influence intra-firm diffusion. These findings are in line with Battisti 
and Stoneman (2005) who report positive learning-by-using effects from 
complementary technologies in relation to extent of use of CNC machines, and 
with our previous empirical exercises which also illustrate the influences of 
learning-by-using effects on adoption of new drugs and use of medical 
equipment. 
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This study also presents strong evidence of epidemic effects. Epidemic effects 
are measured by a number of variables which measure practice location and 
interaction and education factors. Some of the epidemic effects variables 
influence both types of ICT use, and others influence one or other type of ICT 
use. There is some evidence of location effects, in that practices located in the 
HSE South are more likely to be intensive users of ICT for both purposes 
examined. In fact, practices are between 5 and 10 per cent more likely to be 
enhanced users of ICT for patient care and administrative purpose than practices 
in the HSE Dublin Mid-Leinster region. As previously mentioned, the HSE 
South has an independent ICT strategy. While this strategy pertains to all aspects 
of health care provisions, it is probable that knowledge spillovers are influencing 
the intensity of ICT use in general practices in the HSE South. Potential policy 
implications in relation to this finding are discussed in Chapter 8.  
 
Surprisingly, practice location with respect to city, town and rural distinctions 
does not influence intensity of ICT use. However, given that a high proportion of 
practices in the HSE South region are rural or town practices, it is likely that our 
findings in relation to intensity of ICT use and HSE South are capturing a rural 
influence. Previous empirical studies report that rural GPs were more likely to 
keep EPRs than their urban counterparts (Meade et al., 2009), and are better 
equipped than their urban counterparts, possibly to compensate for less access to 
secondary care services (Boerma et al., 1998; Nic Gabhainn et al., 2001). 
 
Now, focusing on how interaction and education factors influence intensity of 
ICT use. Epidemic effects, measured by training practice and supplier visits 
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variables, are evident in relation to both types of ICT use. Being affiliated with 
an academic institution positively influences a practice‟s propensity to 
intensively use ICT for administrative purposes, while active involvement in 
research projects positively influence intensity of ICT use for patient care 
purposes. In support of Mansfield‟s (1963) hypothesis that intra-firm diffusion is 
influenced by epidemic effects, we find evidence of epidemic effects with respect 
to intensity of ICT use. However, previous empirical studies, also drawing on a 
complementary equilibrium and disequilibrium framework, report conflicting 
evidence of epidemic effects (Hollenstein, 2004; Battisti et al., 2007). It is worth 
noting that studies use different variables to measure epidemic effects which may 
impact on findings (Battisti et al., 2007), and there is evidence that the 
importance of explanatory variables is technology-specific (Hollenstein, 2004). 
 
In summation, there is clear evidence that rank, learning-by-using and epidemic 
effects influence intensity of ICT use in Irish general practices.  
 
7.5 Conclusion 
The purpose of this chapter is to examine the intensity of ICT use in Irish general 
practices. The commercial autonomy which characterise Irish general practice 
suggests that decisions concerning ICT use may reflect both medical and 
commercial factors. In fact, there are clear „business‟ reasons for using certain 
ICT functions, such as patient registration and accounts, whereas the use of other 
ICT functions, such as coding and quality assurance, would indicate more 
altruistic decision-making. Extending our encompassing theoretical framework to 
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intra-practice ICT diffusion, we examine the influence of equilibrium, 
disequilibrium and learning-by-using effects on intensity of ICT use. 
 
There is clear evidence that practice heterogeneity influences intensity of ICT 
use, although the variables measuring rank effects are not consistent in their 
influence on both types of ICT use. To date, previous empirical studies have 
reported inconclusive evidence of rank effects with respect to intensity of use.  
Learning-by-using effects demonstrate a considerable influence on intensity of 
ICT use in this study. To date, there is little research on how learning-by-using 
effects impact on intensity of use, with the exception of Battisti and Stoneman 
(2005) who also report positive learning-by-using effects in relation to extent of 
use of CNC machines. In line with earlier examinations of intra-firm diffusion, 
we also find evidence of epidemic effects, particularly in relation to interaction 
with and learning from external agents. There also appears to be evidence in 
support of the HSE South‟s ICT strategy positively influencing ICT use in 
practices in that region. Table 7.11 provides a symbolic summary of our results 
in relation to intensity of ICT use. 
 
This study contributes to a limited body of research concerning intensity of 
adoption. Our research findings support the extension of our encompassing 
theoretical model to examinations of intensity of adoption. These research 
findings, along with our findings in relation to prescribing innovation and 
medical equipment use, will be discussed in the following chapter, thereby 
presenting a holistic view of Irish GPs innovative behaviour.  
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Table 7.11: Symbolic Summary of Anticipated Effects and Results 
 
 Anticipated 
Effect 
Intensity of ICT Use 
for Administrative 
Purposes 
Intensity of ICT Use 
for Patient Care 
Purposes 
 
Rank Effects 
Nursing Support 
+  + 
Number of GPs 
- +  
Prop. of Public Patients 
+ -  
(Log) Number of Patients 
-   
Administration Support 
+   
All GPs  >40 years 
-  - 
Male (GP) Dominated  
+  - 
 
Learning-by-using Effects 
IT Use for 3 or more 
Functions 
+ + + 
 
Medical Equipment 
Portfolio 
 
+ 
 
+ 
 
 
Epidemic Effects 
HSE Dublin Northeast 
-   
 HSE South 
+ + + 
HSE West 
+ +  
Town Practice 
-   
Rural Practice 
+   
Training Practice 
+ + + 
Visits from It Suppliers 
+ + + 
Practice Holds a Clinic 
+   
Committee Member + 
 + 
Academic Department + 
+  
Research Projects + 
 + 
ICGP Course + 
 + 
CME Meetings + 
 + 
Notes: „-‟ denotes a negative and significant effect (at the 10 per cent level or above); „+‟ denotes 
a positive and significant effect.  
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CHAPTER 8: CONCLUSION 
 
8.1 Introduction 
The aim of this thesis is to examine the timing and use of innovations in general 
practices in Ireland. The influence of practice heterogeneity (rank effects); 
strategic behaviour (stock and order effects); cumulative learning from previous 
adoption decisions (learning-by-using effects); and learning and knowledge 
spillovers (epidemic effects) on the perceived benefits of adopting and using 
innovations in general practices is investigated. In order to examine the 
innovative behaviour of Irish GPs, we addressed the following research 
questions:  
(i) What are the determinants of timing of adoption of new prescription 
drugs by Irish GPs? 
 
(ii) What influences the use of medical equipment in Irish general 
practices? 
 
(iii) What factors influence intensity of ICT use in Irish general practices? 
 
This thesis provides us with a holistic view of the innovativeness of Irish GPs. 
Our research suggests that the general practice environment in Ireland facilitates 
and incentivises innovative decision-making with respect to practice 
development and health care provision. Empirically, we identify the influence of 
informational and learning stimuli, as well as economic and commercial 
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motivations, on timing of adoption, multiple technology adoption and intensity of 
adoption of innovations in a health care setting. Furthermore, our empirical 
findings support the application of our encompassing theoretical model, which 
incorporates equilibrium, disequilibrium and learning-by-using effects, to an 
investigation of the timing of innovative behaviour in Irish general practices, and 
the extension of that model to multiple technology adoption and intensity of 
adoption.   
 
This chapter outlines the contribution of this thesis to knowledge (8.2) and theory 
(8.3), and discusses potential policy implications arising from this work (8.4). 
Research limitations are discussed in Section 8.5 and, finally, future research 
plans and possibilities suggested by the research are discussed (8.6). 
 
8.2 Contribution to Knowledge 
This thesis provides us with a distinctive understanding of Irish GPs, with a 
particular focus on what influences their prescribing and practice development 
decision-making. An important contribution of this work is the empirical 
evidence of learning-by-using effects and their influence on inter- and intra-
practice diffusion. We also provide considerable evidence in relation to the 
influence of equilibrium and disequilibrium effects on timing of adoption, 
multiple technology adoption and intensity of adoption in a health care setting. 
We discuss the importance of taking a multiple technology approach to studies of 
adoption decision-making. Furthermore, we employ three different econometric 
techniques to address our timing of adoption, multiple technology adoption and 
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intensity of adoption research questions. This section discusses how this thesis 
contributes to our understanding of Irish GPs innovative capabilities and to our 
broader understanding of the factors influencing adoption of innovations in 
health care and commercial settings.  
 
8.2.1 Irish GP’s Innovative Behaviour 
Our findings point to a group of health care professionals that exhibit notable 
innovative behaviour. In general, Irish GPs prescribe new drugs soon after they 
reach the Irish market, invest in a range of medical equipment, and are active 
users of ICT for administrative and patient care purposes. Our research 
demonstrates that Irish GPs respond to informational and learning stimuli in the 
development of their practices and prescribing behaviour. Furthermore, our 
findings also reveal that GPs are incentivised by commercial and market 
considerations.  
 
Given the nature of general practices in Ireland, it is very likely that the 
autonomy enjoyed by Irish GPs facilitates the adoption of health care 
technologies. Irish GPs enjoy certain independence in the running and staffing of 
their practices. They are, in fact, operating in a market where they compete for 
public and private patients. Therefore, like any small business unit, decisions 
concerning adoption and intensity of adoption of new innovations are influenced 
by the expected commercial outcomes for the business. The autonomy enjoyed 
by Irish GPs not only influences how they respond to commercial and market 
incentives, but also provides them with the freedom to learn from interactions 
with others and previous adoption decisions and incorporate this accumulated 
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knowledge in ensuing adoption decisions. With prescribing and practice 
development decision-making at the practice or individual GP level, Irish GPs 
are given ample incentives and opportunities to innovate. This innovative 
behaviour has positive consequences for their businesses and their patients.  
 
8.2.2 Learning-By-Using Effects on Adoption and Intensity of 
Adoption 
A particular insight from this research is the influence of learning-by-using 
effects on GP‟s innovative behaviour. The influence of learning-by-using effects 
is consistent and strongly significant across all innovative decision-making 
examined (see Table 8.1 for a symbolic summary of key empirical findings). 
Specifically, we find evidence of earlier adoption of new drugs by GPs with 
broader prescribing portfolios. Also, practices with a large portfolio of medical 
equipment are more likely to invest in new medical equipment. In relation to ICT 
use, we find that users of ICT for administrative purposes are more likely to be 
intensive users of ICT for patient care purposes. We also find practices that use 
ICT for patient care purposes and practices with a large portfolio of medical 
equipment are more likely to be intensive users of ICT for administrative 
purposes.  
 
In essence, the extent which a practice adopts technologies and learns from that 
experience influences ensuing adoption decisions. Therefore, Irish GPs 
demonstrate a capacity for accumulating knowledge and learning from adoption 
decisions, which they use to make informed decisions concerning the 
development of their practice and the health care provided to their patients. It is 
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likely that the autonomy enjoyed by Irish GPs in how they equip their practices 
and what drugs they prescribe to their patients provides them with the scope to 
benefit from this learning experience. The evidence of the impact of learning-by-
using effects on innovative behaviour indicates that learning from experience of 
previously adopted technologies within the practice is as important, if not more 
so, as learning from interactions with those external to the practice. To date, there 
is a paucity of studies on the influence of cumulative learning on adoption 
decisions (Stoneman and Kwon, 1994; Colombo and Mosconi, 1995; Arvantis 
and Hollenstein, 2001) and intensity of adoption decisions (Battisti and 
Stoneman, 2005). Therefore, our research contributes to the broader debate of the 
significance of learning-by-using effects on inter- and intra-firm diffusion. 
 
Table 8.1: Key Empirical Findings of Equilibrium, Disequilibrium and 
Learning-by-Using Effects on Timing of Adoption, Use and Intensity of Use 
of Innovations 
 Equilibrium Model 
 
Disequilibrium 
Model 
Learning-by-
Using Model 
Rank 
Effects 
Stock 
Effects 
Order 
Effects 
Epidemic 
Effects 
Learning-by-
Using Effects 
Timing of 
Prescription of 
New Drugs 
 
 
 
 
 
 
 
 
 
 
Use of Medical 
Equipment 
 
 
   
 
 
 
Intensity of 
ICT Use 
 
 
   
 
 
 
 indicates evidence of effect with respect to adoption of innovation.   indicates strong 
evidence of effect with respect to adoption of innovation. Shaded cell indicates that relevant 
effect was not tested in empirical exercise. 
 
8.2.3 Equilibrium Effects on Adoption and Intensity of Adoption 
Our findings suggest the commercial elements of the Irish general practice 
market incentivise innovative decision-making. Within the equilibrium model of 
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adoption, we examine the influence of rank, stock and order effects on GPs 
decision-making concerning adoption of innovations. In our three empirical 
exercises, we model the influence of rank effects, measured by GP and practice 
characteristics, on timing of adoption, use and intensity of use of innovations in 
general practices. There is considerable evidence of rank effects influencing 
adoption decisions (Stoneman and Kwon, 1994; Baptista, 2000; Battisti et al., 
2007). In line with this literature and considering the prescribing and commercial 
autonomy of Irish GPs, we expected rank effects to influence such innovative 
decision-making. This expectation is realised as our research demonstrates the 
influence of rank effects on timing of first prescription of new drugs, use of 
medical equipment and intensity of ICT use.  
 
In our empirical investigations, rank effects are measured by variables such as 
nursing and administrative support, patient numbers and GP age. It is important 
to note that as two datasets are used in our empirical analyses, rank effects are 
measured by different variables. In relation to prescribing innovation, younger 
GPs and those who work with the support of a nurse and secretary are early 
adopters of new drugs. With respect to medical equipment use, there is evidence 
that practices with nursing support, high patient numbers, and more male GPs are 
more likely to use medical equipment. Interestingly, there is no consistency in 
how the rank effect variables influence intensity of ICT use for administrative 
and patient care purposes. Increasing GP numbers and decreasing proportions of 
public patients in a practice positively influence intensity of ICT use for 
administrative purposes. Nursing support positively influences intensity of ICT 
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use for patient care purposes; whereas practices with older, male GPs are less 
likely to be intensive users of ICT for patient care purposes.  
 
Therefore, the influence of rank effects on innovative decision-making is clearly 
affected both by the specific innovation being examined and by how such effects 
are measured. However, the influence of some rank effects variables is evident in 
relation to a number of these decisions. For instance, nursing support positively 
affects innovative behaviour in relation to all three areas of decision-making 
considered. There may be a number of reasons why this is the case. Practices 
which employ nursing support may be larger, more profitable practices. It may 
also be the case that practices with nursing support may be more patient-focused 
and this may influence their prescribing and investment decisions. Previous 
studies also highlight the positive influence of human capital on decision-making 
concerning the adoption of innovations (Karshenas and Stoneman, 1993; 
Baptista, 2000). We also find that older GPs are less likely to prescribe new 
drugs and be intensive users of ICT for patient care purposes. This finding is in 
line with much of the literature concerning the negative influence of age on 
adoption of new technologies (Masters, 2008; Meade et al., 2009). 
 
In general, our research supports the hypothesis that rank effects influence inter- 
and intra-practice diffusion of innovations. The significance of rank effects may 
reflect the fact that Irish GPs have considerable economic independence: they 
choose whether they work with other GPs and/or primary care professionals; 
what support staff, if any, they employ; and the number and type (public and/or 
private) of patients they see. Therefore, the independence enjoyed by Irish GPs 
238 
 
may encourage innovative behaviour in the form of prescribing new drugs and 
developing their practice. Our research indicates that the free-market elements of 
the general practice environment in Ireland may incentivise innovative decision-
making; in turn, benefitting patient care.
96
 
 
One of the more surprising findings from this research is the influence of 
strategic behaviour on adoption and use of innovations by GPs. Stock and order 
effects are included in our analyses to reflect trade-offs between the costs and 
benefits of adoption by co-related agents (Karshenas and Stoneman, 1993). In 
view of the independence of general practices in Ireland and the prescribing and 
commercial autonomy enjoyed by GPs, a priori, we expected that these effects 
would be evident with respect to decision-making where GPs incur a monetary 
cost from adoption, such as investments in medical equipment and ICT, more so 
than in decision-making where GPs do not incur a monetary cost from adoption, 
for instance, when prescribing drugs to patients.  
 
Due to data restrictions, we do not test for either stock or order effects in relation 
to intensity of ICT use or for the stock effect in relation to medical equipment 
use. However we do test for order effects in relation to medical equipment use 
and both stock and order effects in relation to the timing of prescribing 
innovation. Our results in relation to the strategic behaviour stock and order 
effects are interesting and somewhat counter-intuitive. We find little evidence of 
an order effect in relation to the use of medical equipment. However, in our 
examination of the timing of the first prescription of new drugs by GPs, we find 
                                                 
96
 Previous European research also reports more innovative patient care by self-employed GPs 
than salaried GPs (Boerma et al., 1997) 
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consistently strong evidence of order and stock effects: GPs who have a track 
record of early adoption tend also to be early adopters of other drugs; and, the 
larger the proportion of GPs who have already adopted a new drug the slower 
subsequent adoption. 
 
Our investigation into the influence of strategic behaviour on adoption and use of 
health care innovations by GPs produces interesting results. Our results indicate 
that Irish GPs may be motivated by first-mover advantage in their prescribing 
decisions. Perhaps GPs perceived as being innovative are more likely to attract 
mobile public and private patients. Although another equally valid interpretation 
of this finding is that these stock and order effects may, in fact, be capturing 
informational and learning elements.
97
 It may be the case, for instance, that the 
rapid adoption of the six drugs examined is due to unobserved learning effects 
and, therefore: early adopters of one drug have learnt the benefits of early 
adopting and tend to be early adopters of other drugs (order effect); and 
subsequent adoption may be slow as the remaining GPs primarily comprise of 
non-adopters (stock effect). 
 
8.2.4 Disequilibrium Effects on Adoption and Intensity of 
Adoption 
Our research also highlights the influence of network externalities on timing of 
adoption, use and intensity of use of innovations by GPs. Across the three 
aspects of innovative behaviour examined, we find evidence of epidemic effects. 
                                                 
97
 We are restricted to one measure of epidemic effects, rural practice allowance, in our 
prescribing innovation analysis. 
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However, it is important to note that as distinct datasets are used in the 
econometric exercises; epidemic learning effects are measured by different 
variables. For instance, in relation to our examination of prescribing innovation, 
we are constrained to measuring epidemic effects with a rural practice allowance 
variable; whereas in our examination of medical equipment and ICT use, we use 
many variables to capture epidemic learning effects. These variables include 
practice location, interaction with academics, suppliers and other health care 
practitioners, and educational measures. Given the robust empirical evidence of 
individuals adopting a new technology upon learning of its existence (Karshenas 
and Stoneman, 1993; Baptista, 2000; Burton et al., 2003; Rogers, 2003), we 
expect to find evidence of these „word-of mouth‟ effects with respect to the 
adoption of health care technologies by Irish GPs. 
 
In relation to the timing of prescribing innovation, we find slower adoption of 
new drugs by rural GPs. It is likely that geographically remote GPs have less 
opportunity to interact with others and, consequently, are less likely to hear of 
new drugs. We find that training practices are more likely to use medical 
equipment and to be intensive users of ICT. It is likely that training practices are 
required to be well equipped. However, it is also likely that their involvement in 
education increases the likelihood of hearing of new technologies. We also find 
that practices frequently visited by IT suppliers are more likely to be intensive 
users of ICT. These findings reflect an epidemic effect, with opportunities for 
learning about ICT from others positively influencing ICT use. There is also 
evidence of education, research and academic affiliations positively influencing 
ICT use for administrative or patient care purposes.  
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While there is some inconsistency in the influence of specific epidemic effect 
variables on ICT use for administrative and patient care functions, our research 
illustrates that informational factors influence intra-practice diffusion. On the 
whole, we find evidence of interaction and „word-of-mouth‟ effects influencing 
if, when and to what extent Irish GPs adopt innovations.  
 
A particularly interesting aspect of our results in relation to epidemic learning 
effects is that their influence on intensity of adoption (intensity of ICT use) is 
more compelling than their influence on adoption (timing of adoption of new 
drugs and use of medical equipment). This indicates that the ability of a general 
practice to absorb external knowledge is distinctly more important in relation to 
intra-practice diffusion than inter-practice diffusion. This is important in our 
understanding of how interaction with external agents and information 
acquisition can assist in how a practice uses ICT, or indeed any health care 
technology, to its full advantage. Enhanced use of health care innovations 
ensures improved practice management and patient care. 
 
8.2.5 Adoption of Multiple Technologies 
An important contribution of this thesis is centring our empirical analysis on the 
adoption of multiple technologies. We do not examine any one technology in 
isolation, but identify commonalties in the adoption process across a range of 
innovations. Explicitly, we examine decision-making concerning the adoption of 
six new drugs and six items of medical equipment. In our interpretation of our 
results, we do not focus on the impact of different factors on the adoption of one 
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drug or one item of medical equipment in isolation, but attempt to identify 
commonalities in the adoption of the six drugs and the six items of medical 
equipment. The influence of rank, stock, order, epidemic and learning-by-using 
effects is not always consistent across innovations. Therefore, when interpreting 
our results, we conclude that the adoption of both new drugs and medical 
equipment by GPs is, to some extent, technology- specific, demonstrating the 
importance of examining the adoption of multiple technologies and not focusing 
on one technology.  
 
In addition to considering the adoption and use of a number of health care 
technologies, we use a multiple technology adoption approach to our analysis of 
use of medical equipment (Stoneman and Kwon, 1994; Colombo and Mosconi, 
1995; Stoneman and Toivanen, 1997). This multiple technology adoption 
approach allows us to identify commonalities in the adoption of multiple 
technologies, but also accounts for the unobservable factors which are common 
to the adoption of these items of medical equipment (see Section 6.4 for 
discussion of multivariate Probit model specification). Therefore, we ascertain 
the importance of, where possible, taking a multiple technology adoption 
approach to adoption and use of innovations.  
 
8.2.6 Econometric Analysis of Timing of Adoption, Multiple 
Technology Adoption and Intensity of Adoption in a Health Care 
Setting 
This thesis‟ overall contribution to knowledge is robust empirical evidence of the 
commercial and informational influences on timing of adoption, multiple 
243 
 
technology adoption and intensity of adoption of innovations by Irish GPs. This 
contribution was possible due to: access to a unique prescribing dataset; the 
collation of a timely profile of general practices in Ireland, along with 
information on decision-making concerning their use of medical equipment and 
ICT; and the econometric techniques employed.  
 
Our encompassing theoretical framework necessitated the application of 
multivariate econometric approaches. Furthermore, in our examination of timing 
of adoption, multiple technology adoption and intensity of adoption in Irish 
general practices, we apply novel econometric techniques to our empirical 
investigations. Ours is the first application of duration analysis to an examination 
of the timing of adoption of new prescription drugs by GPs. The nature of the 
prescribing dataset, which matches GPs prescribing history over a 4½ year time 
period with information on their characteristics, affords us the opportunity to 
employ duration analysis to determine the influences on first prescription of new 
drugs by Irish GPs. 
 
In the following section, we discuss how our empirical findings support the 
extension of our encompassing theoretical framework to multiple technology 
adoption and intensity of adoption analyses. However, it is also important to note 
that these approaches to examining GP‟s decision-making necessitated the 
application of multivariate and ordered Probit techniques.  
 
By applying a multivariate Probit analysis to our examination of medical 
equipment use, we are able to incorporate a multiple technology adoption 
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framework to our investigation. This approach allows us to identify 
commonalities in the adoption of multiple items of medical equipment, but also 
accounts for unobservable factors which may also be common to the adoption of 
these technologies. Individual econometric examinations of the factors 
influencing the adoption of each item of medical equipment potentially may 
over-or-under estimate the influence of the various theoretical effects. Therefore, 
our integrated approach prevents misspecification bias and allows for cross-
technology effects.
98
 
 
Furthermore, extending our encompassing theoretical model to intensity of ICT 
use, we use ordered Probit analysis. This econometric approach allows us to 
identify the determinants which influence whether a practice is a basic, 
intermediate or enhanced user of ICT. 
 
Drawing on our encompassing theoretical framework, using primary and 
secondary datasets and employing appropriate econometric techniques allowed 
us to make a number of contributions to knowledge as discussed above. The 
following section will discuss this thesis‟ contribution to theory.  
 
8.3 Contribution to Theory 
This section outlines the theoretical contributions of this thesis, such as support 
for learning-by-using effects and their influence on adoption behaviour, as well 
                                                 
98
 We did not take a multiple technology adoption approach in our examination of prescribing 
innovation as it is not possible to simultaneously model time to adoption econometric models. If 
a multivariate Probit approach was applied to our prescribing innovation analysis, the timing 
element of the analysis would be lost. 
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as support for examining adoption decision-making in a health care setting 
within a complementary equilibrium, disequilibrium and learning-by-using 
theoretical framework. 
  
8.3.1 Learning-by-Using Effects on Adoption Behaviour  
This study‟s principal theoretical contribution is the importance of experiential 
learning on adoption decision-making. We hypothesised that individual and 
corporate learning from previous adoption decisions influence subsequent 
decision-making concerning adoption, use and intensity of use of innovations. As 
discussed in section 8.2.2, our consistent empirical evidence of such effects 
illustrates the importance of experiential learning which takes place within the 
business unit on adoption and intensity of adoption.  
 
In previous economic adoption studies, measures of learning by using effects 
have focused on learning from the adoption of complementary technologies and 
earlier technology vintages (Colombo and Mosconi, 1995; Arvantis and 
Hollenstein, 2001). However, in this thesis, we extend earlier conceptualisations 
of learning-by-using effects with a broader definition of experiential learning. 
Therefore, our variable measurements of learning-by-using effects include 
learning from an individual GP‟s portfolio of drugs, learning from a general 
practice‟s portfolio of medical equipment, and learning from ICT use for 
contrasting purposes. 
 
The equilibrium and disequilibrium models of adoption are reasonably 
established in the innovation literature as a means to examining adoption 
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decision-making. As discussed in Section 4.2, attempts have been made to 
integrate learning-by using effects into both the equilibrium model and the 
disequilibrium model. However, our consistent evidence of the influence of 
experiential learning on adoption and use of innovations places these learning-
by-using effects at the centre of the theoretical debate.  
 
Our evidence of the influence of learning-by-using effects on adoption decision-
making is robust across the three types of innovations examined. As previously 
discussed, the trade-off between commercial and patient care motivations is 
greatly influenced by the nature of the innovation being adopted by general 
practices; nonetheless the influence of experiential learning is consistent for 
adoption decision-making concerning prescription drugs, medical equipment and 
ICT. Equally, there is robust evidence of the influence of learning-by-using 
effects on the different variants of adoption decision-making - timing of 
adoption, use and intensity of use.  
 
8.3.2 Encompassing Theoretical Model of Adoption  
Our empirical findings support the application of our encompassing theoretical 
model of adoption, incorporating the equilibrium, disequilibrium and learning-
by-using models of adoption, to examining innovative behaviour in a health care 
setting. Previously, Karshenas and Stoneman (1993) presented a theoretical 
advance in the diffusion literature with a model of adoption incorporating rank, 
stock, order and epidemic effects. Previous empirical studies support the full or 
partial application of this complementary equilibrium and disequilibrium model 
of adoption to examinations of adoption decision-making (Stoneman and Kwon, 
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1994; Stoneman and Toivanen, 1997; Hollenstein, 2004; Battisti et al., 2007). 
Also, theoretical models incorporating aspects of Karshenas and Stoneman‟s 
(1993) model and the emerging learning-by-using models of adoption have also 
emerged in the adoption literature (Colombo and Mosconi, 1995; Arvantis and 
Hollenstein, 2001). 
 
This is the first application of an encompassing equilibrium, disequilibrium and 
learning-by-using model of adoption to an examination of adoption in a health 
care setting. The general practice environment in Ireland provides us with a 
unique setting for applying our encompassing theoretical framework to gain an 
understanding of the adoption processes of GPs. Our research illustrates that 
adoption by GPs is a complex process, influenced by all of these elements. Thus, 
our empirical findings demonstrate the importance of incorporating all three 
models of adoption to theoretical frameworks in future studies of adoption 
decision-making in a health care setting.  
 
Sections 8.2 and 8.3 outlined this thesis‟ contributions to knowledge and theory. 
The following section outlines potential policy implications of this research. 
 
8.4 Implications for Policy 
Our holistic examination of the adoption process in Irish general practice 
highlights the innovative capabilities of Irish GPs. We discuss our findings in 
relation to the three areas of innovative behaviour examined and their potential 
policy implications (8.4.1). We also discuss the likely implications of our work 
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in the context of the proposed reforms of the Irish and UK health care systems 
(8.4.2). 
 
8.4.1 Policy Implications for Adoption and Use of Prescription 
Drugs, Medical Equipment and ICT by GPs 
The adoption of new prescription drugs is not uniform across all GPs suggesting 
the potential for targeted intervention to stimulate prescribing innovation. For 
example, older GPs and GPs practicing without the assistance of a nurse or 
secretary are in general slower to adopt new drugs suggesting these groups as a 
specific target for support. In addition, the influence of learning-by-using, stock, 
order and epidemic effects on prescribing of new drugs suggest the importance of 
GPs‟ ability to obtain information on new drugs. Pharmaceutical companies and 
continuing education provide GPs with information on new drugs. However, if 
policymakers want to influence the uptake of new drugs, whether new 
compounds to the market or generics of existing compounds, additional means of 
conveying information to geographically isolated GPs and GPs who do not 
prescribe from a large portfolio of drugs should be considered. Therefore, to 
encourage prescribing of specific drugs, measures which facilitate learning both 
within (learning-by-using effects) and outside (epidemic learning effects) the 
practice need to be considered. A possible means of communicating such 
information to GPs, who are unlikely to obtain such information due to location 
or limited experience, is through e-learning; whereby, GPs can access webinars 
or on-line tutorials which provide them with information on specific drugs. Such 
policy initiatives need to be considered, however, both in the light of the 
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potential benefits of the adoption of new drugs and their potential risks 
(Florentinus, 2006).
99
 
 
Within our multiple technology adoption framework, which accounts for cross-
technology effects, it is difficult to identify practice or informational factors 
consistently influencing the uptake of medical equipment. However, we find 
compelling support for the influence of learning-by-using effects on the use of 
medical equipment in general practice. Practices with a broader portfolio of 
medical equipment are more likely to use an additional item of medical 
equipment. It is important to note that investments in medical equipment are 
borne by the practice, and while this may explain why some practices are more 
poorly equipped than others, our findings suggest that their limited experience 
with medical equipment negatively affects their subsequent investment decisions. 
If policymakers want to influence investment in medical equipment to ensure 
consistent service provision, they need to consider targeting poorly equipped 
practices who are the least likely to invest in new equipment. A potential targeted 
intervention would be a scheme whereby practices can borrow items of medical 
equipment on a short-term basis. Therefore, practices would have the benefit of 
learning from using such equipment, which according to our findings, would 
positively influence their ensuing medical equipment adoption decisions. 
Another approach could be to develop a practice partnering network, whereby 
                                                 
99
 For instance, rofecoxib was first licensed in Ireland on the 12th November 1999 and by March 
2004; almost three-quarters of GPs in our sample were prescribing rofecoxib to patients (see 
Chapter 4). Merck & Co Inc., who produced rofecoxib under the brand names Voixx and Ceoxx, 
voluntarily recalled the drug on September 30, 2004, amidst evidence that it drastically increased 
users‟ risk of heart attack and stroke. 
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knowledge sharing could occur between practices at various stages of 
development. 
 
The majority of Irish general practices are computerised (Bourke and Bradley, 
2010); however, previous studies have categorised Irish general practices as 
„average‟ users of ICT within a European context (Dobrev et al., 2008), 
indicating that Irish general practices are not utilising ICT to its full advantage.  
In our examination of intra-practice diffusion, the influence of learning-by-using 
and epidemic learning effects on intensity of ICT use in Irish general practices is 
convincing. We also find evidence of more intensive ICT use by practices 
located in the HSE South region. This finding is interesting in light of the ICT 
Strategy previously developed by the Southern Health Board.
100
  
 
In 2001, the Southern Health Board developed an ICT strategy to improve 
service delivery. In order to meet its objective of delivering a higher quality and 
more effective service to its service users, a number of applications were 
developed. These applications include, among others, an Interactive Hospital 
School for school-attending patients, an integrated, interactive staff intranet and 
transmission of x-rays and scans. The European Commission acknowledged the 
HSE South‟s ICT Strategy with a “Best Practices in eService Delivery” award – 
the first time it was awarded to a health care organisation. An evaluation of the 
HSE South‟s ICT strategy demonstrates how a system-level approach to eHealth 
maximises the use of technology (Mathews and Barton, 2002). It is likely that 
this system-level strategy results in knowledge spillovers and, in turn, influences 
                                                 
100
 Prior to January 2005, the Irish health care system comprised of eight regional health boards. 
In 2005, the Southern Health Board was subsumed into the HSE South region.  
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how GPs use ICT in their practices. The implementation of this strategy centres 
on information and education; which is in line with our findings that learning-by-
using and epidemic learning effects positively influence the extent to which 
practices use ICT. Therefore, there may be merit in extending this strategy 
nationwide ensuring that practices have the necessary information and know-how 
to gain proficiency in ICT use and to solve the complex problems that result from 
using numerous ICT applications.  
 
Our research also demonstrates the beneficial influence of research and academic 
involvement on intensity of ICT use, particularly in relation to patient care 
applications. Therefore, academic-practitioner networks, which are primarily 
developed to engage in research and implement research evidence, may also 
positively influence adoption of technologies by practitioners. The Western 
Research and Education Network (WestREN) is a newly established 
collaborative network consisting of the Discipline of General Practice at the 
National University of Ireland (NUI) Galway and 71 West of Ireland general 
practices (Kavanagh et al., 2010). Therefore, consideration should be given to the 
possibility of positive externalities, in the form of adoption decision-making, 
resulting from such university-affiliated general practice research networks.  
 
8.4.2 Potential Policy Implications in the Context of Proposed 
Health Care Reforms in Ireland and the UK 
There are wide-ranging reforms for general practice proposed in the new 
Programme for Government which, if implemented, will have significant 
implications for Irish GPs (Department of the Taoiseach, 2011). The Irish 
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government proposes to develop a universal, single-tier health service which 
guarantees access to medical care based on need, rather than income. Such health 
care reforms propose that more care is delivered in the community, and that 
health care will be paid for through Universal Health Insurance. The Universal 
Health Insurance System will be designed according to the European principle of 
social solidarity: access will be according to need and payment will be according 
to ability to pay. The Irish population will be obliged to purchase insurance from 
a public or private insurer; insurance payments will be related to ability to pay. 
However, the State will pay insurance premia for people on low incomes 
(Department of the Taoiseach, 2011).
101
  
 
In relation to general practice, fees for GP care will be removed and GPs will be 
paid primarily by capitation for the care of their patients. Universal Primary Care 
will be implemented on a phased basis, with the recruitment of additional 
doctors, nurses and other primary care professionals. It is also proposed that GPs 
will work in Primary Care Teams with other primary care professionals. The 
number of practice nurses will also be increased, so that, where appropriate, 
work can be delegated to them (Department of the Taoiseach, 2011). 
 
There is much discussion and debate in Ireland as to the potential impact of these 
health care reforms on general practice, with limited consensus to date. However, 
it is expected that Irish GPs will remain self-employed, private practitioners, and 
that the vertical integration between provider and third-party payer will be 
                                                 
101
 Therefore, it is not expected that this reform will have any financial impact on current GMS 
patients. 
 
253 
 
completely independent. It is uncertain to what extent Universal Primary Care 
will affect the autonomy presently enjoyed by Irish GPs. Therefore, the 
opportunities for innovative behaviour in relation to prescribing and medical 
equipment and ICT use by Irish GPs may continue. However, if the reforms take 
a more systems-level approach, with respect to practice development, the 
opportunities for innovative decision-making may be reduced.  
 
The proposed reforms specifically identify staffing issues within general 
practices. The proposal to increase the number of practice nurses is encouraging, 
particularly, as our research finds nursing support to be a positive influence on 
innovative behaviour across all three areas of adoption decision-making 
examined. Also, in the UK where practice nurses have more established roles 
than in Ireland, there is evidence that appropriate trained nurses provide high 
quality care, and sometimes achieve similar health outcomes for patients to GPs 
(Horrocks et al., 2002; Laurant et al., 2005). The move towards group practices 
may create a setting within which epidemic and learning-by-using effects 
strengthen, thereby, positively influencing innovative behaviour. 
 
In brief, it is difficult to ascertain the future policy implications of this thesis 
within a reformed Irish health care system; particularly given the uncertainty 
surrounding such reforms. Also some aspects of the proposals may facilitate 
innovation, whereas other elements of the proposed reforms may restrict the 
current incentive structures within general practice, thereby constraining 
innovative behaviour. On the one hand, the general practice staffing and 
interaction proposals bode well for GP‟s decision-making concerning adoption of 
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innovations. However, if the introduction of Universal Primary Care results in a 
more restrictive environment than the current system, then there is likely to be 
counter-acting implications for primary care. For instance, if GPs no longer face 
incentives with respect to attracting patients and developing the commercial, 
private aspects of their practice, there are potentially negative implications for 
health care quality in the longer-term. 
 
There are also significant changes planned in general practice in England at 
present. Groups of GPs and other health care professionals, or commissioning 
consortia, will be given budgets to commission health care on behalf of patients 
in their local communities. This will replace the current system where budgets 
are administered by Primary Care Trusts (PCTs), with varying degrees of 
clinician involvement. It is planned that the GP-led commissioning consortia will 
assess the health needs of a population; then plan, secure and monitor the health 
services for that population, given the resources available (Barratt, 2011).  
 
There are clear distinctions between the mandates of the GP-led commissioning 
consortia in the UK and general practices in Ireland. However, the findings of 
this thesis may be a useful lens through which to view these NHS reforms. Our 
research illustrates the innovativeness of GPs and the influence of commercial 
and informational stimuli on decision-making concerning practice development 
and health care provision. Although, the GP-led commissioning consortia will be 
constrained by a pre-determined budget, our findings suggest that placing such 
decision-making in the hands of health care professionals may encourage 
innovative health care provision. 
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8.5 Limitations of this Research 
This section briefly discusses some limitations of this research, primarily 
focusing on data restrictions and the implications of these restrictions on our 
empirical analysis and findings. 
 
As discussed in Section 8.2.3, we do not model stock and order effects in all 
three empirical exercises, essentially due to data restrictions. In relation to 
medical equipment use, we do not include a stock effect in our econometric 
analysis. The primary reason for this is our survey data is cross-sectional. By 
their nature stock effects are time-variant. We do not model either stock or order 
effects in relation to intensity of ICT use. Our survey instrument did not ask 
respondents to indicate when they adopted each of the seventeen ICT 
applications included in the empirical analysis. It was decided that such a task 
would be too onerous for respondents. Ideally, we would like to model all 
elements of our encompassing theoretical model of adoption in all three 
empirical exercises.  
 
In this thesis, we use two datasets to address our research questions. Our 
prescribing dataset provides us with a rich source of data, bringing together 
information of GPs prescribing history over a 4½ year time period with 
information on the characteristics of 625 GPs themselves. Our survey data, cross-
sectional in nature, provides us with a profile of 601 Irish general practices in 
2010, along with information on decision-making concerning practices use of 
medical equipment and ICT. An ideal scenario would be if, firstly, the 
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prescribing dataset was timelier and, secondly, if it were possible to match these 
two datasets. 
 
The prescribing dataset pertains to three of the eight Irish health boards, the 
Southern, South-Eastern and North-Eastern Health Boards, which provide health 
services to 34 per cent health services to of the Irish population (Department of 
Health and Children, 2002). The 625 GPs in this sample represent a third of all 
GPs who hold a contract to treat public GMS patients in Ireland. This dataset, 
which matches GPs characteristics with their prescribing decisions, provides us 
with a unique opportunity to analyse the influences on prescribing innovation by 
GPs. 
 
A key limitation with the prescribing dataset is that it pertains to prescriptions 
dispensed from October 1999 to March 2004. Along with the Departments of 
General Practice and Pharmacy at University College Cork, the Department of 
Economics has asked for the provision of this data from April 2004 to the 
present. Access to more timely data would allow us to explore adoption patterns: 
for the large number of drugs brought to the Irish market since 2004; and also for 
drugs exhibiting slow adoption prior to 2004 which may reach higher adoption 
levels after 2004. Secondly, the structure of Irish general practices has changed 
since 2004 with a move towards group-practices with more support staff 
(O'Dowd et al., 2006; Bourke and Bradley, 2010). It would be interesting to see 
if the consistent and significant influence of stock, order and learning-by-using 
effects on timing of adoption of new drugs continues. In the previous section, we 
discussed the policy implications of our findings in relation to prescribing 
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innovation. Analysis with more timely data would reinforce the importance of 
our policy recommendations. 
 
Our Medical Equipment and IT in General Practice survey, a population survey, 
was administered to all general practices in Ireland; achieving a 42 per cent 
response rate. Geographically, the survey data provides information on practices 
in every county and HSE region in Ireland. As we designed the survey 
instrument ourselves, we were able to ensure that the data suited our needs. For 
instance, we have a wider range of measures of rank and epidemic effects in our 
survey data than in the prescribing dataset. Therefore, if we could match our 
survey data with the prescribing data, we would be able to model additional 
influences on prescribing innovation.  
 
We must also be aware of the implications of the cross-sectional nature of our 
survey data. Our econometric models suggest causality; however, we could 
extend our understanding of adoption decision-making if we had access to 
longitudinal data. Furthermore, our survey data pertains to general practices in 
Ireland. We have discussed at length the unique context of general practice in 
Ireland; which potentially limits the generalisability of our results. In the next 
section, we discuss how issues with the cross-sectional and country-specific 
nature of our analysis could be reduced with additional primary data collection.  
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8.6 Future research plans and possibilities 
Drawing on the theoretical insights from the current study and considering the 
existing primary and secondary datasets and possibly further primary data 
collection, this section outlines six potential opportunities for future research. 
 
First, the prescribing dataset provides a rich source of data in relation to Irish 
GPs and their prescribing patterns. In Chapter 3, a transition matrix (see Table 
3.2), reflects the transitions in the level of prescribing by GPs of all 1,137 drugs 
in the first year of the sample and in the final year of the sample. In our analysis, 
we focus on drugs which saw an increase in the proportion of GPs prescribing 
them over the 4½ year period. However, it may also be interesting to identify the 
determinants of those drugs which are now prescribed by fewer GPs than before. 
Do commercial and informational stimuli also influence de-adoption?  
 
Second, our analysis of the determinants of prescribing innovation focuses on six 
drugs which operate on different physiological organs or systems. Opportunities 
for future research include a similar analysis focusing on a number of drugs from 
the same therapeutic class, to determine if the commonalties reported in the 
adoption of the drugs in this study are evident to the same or a greater extent 
when examining drugs prescribed for similar conditions. It may also be of 
interest to conduct analyses on the adoption of drugs with a relatively high 
degree of pharmacological innovation compared to those with a relatively low 
degree of innovation. We would also like to examine GPs decisions to adopt 
complementary drugs. Such analysis would allow for an investigation for cross 
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drug effects similar to those identified in complementary technology diffusion 
studies.  
 
Third, as discussed in Chapter 4, our prescribing data provides us with only one 
epidemic learning effects measure. However, it may be possible to introduce a 
measure of the impact of advertising in relation to prescribing decision-making. 
Advertising noise or impact could be measured through a citation search in 
medical journals or ranking the market power of the pharmaceutical companies 
which initially released these drugs. 
 
Fourth, in the prescribing innovation study, our focus is on the timing of 
adoption, i.e. the decision to prescribe a new drug for the first time. In the future, 
we would like to extend our analysis to intensity of adoption. Measuring 
intensity of adoption of new drugs is likely to involve identifying the number of 
patients to whom the GP prescribes the new drug. Such an analysis would add to 
our existing evidence in relation to intra-practice ICT diffusion and allow us to 
test the hypothesis that the drivers of adoption and intensity of adoption differ. 
 
Fifth, as previously discussed, our primary dataset was developed to specifically 
address this study‟s research questions relating to use of medical equipment and 
ICT. Therefore, the opportunities for future research with this data are somewhat 
restricted. The purpose of this study is to explore innovative decision-making in 
general practices; and our approach is focused on prescribing behaviour, medical 
equipment use and intensity of ICT use separately. Another approach is to 
construct an innovativeness measure which combines medical equipment and 
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ICT use and determine the influence of equilibrium, disequilibrium and learning-
by-using effects on this encompassing innovativeness behaviour.  
 
Sixth, as mentioned in the previous section, a limitation of this study is the cross-
sectional and country-specific nature of the survey data. A possible avenue for 
future research is to develop a longitudinal dataset, i.e. administer a subsequent 
survey to the Irish GP population, providing us the opportunity to explicitly 
identify the causality relationships in our analysis. Given the unique setting of 
general practice environment in Ireland, the generalisablility of our results 
internationally may be questionable. Therefore, a subsequent European survey 
and analysis of use and intensity of use of medical equipment and ICT would 
strengthen our results.  
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APPENDIX 1: LOCATION OF HEALTH BOARDS AND HSE 
ADMINISTRATIVE REGIONS IN IRELAND 
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Figure A1.1: Location of Health Board Regions (Pre- 2005) 
 
 
 
 
 
Source: www.hse.ie 
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Figure A1.2: Location of HSE Administrative Areas 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: www.hse.ie 
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APPENDIX 2: DURATION MODELS OF TIME TO FIRST 
ADOPTION – BASELINE MODELS 
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Table A2.1: Duration Models of Time to First Adoption – Baseline Models 
 
 
Esciatlopram
1
 
 
mfx/se 
 
Esmoprazole
2
 
 
mfx/se 
 
Rofecoxib
3
 
 
mfx/se 
 
Desloratadine
4
 
 
mfx/se 
 
Nicotine
5
 
 
mfx/se 
 
Drospirenone 
& Estrogen
6
 
mfx/se 
 
     Rank Effects 
Practice 
Nurse 
-0.253*** 0.006 -0.207 -0.08 -0.002 -0.558** 
(0.062) (0.076) (0.188) (0.162) (0.114) (0.236) 
Practice 
Secretary 
-0.108 0.055 0.028 -0.496** -0.241* -0.581* 
(0.078) (0.102) (0.232) (0.217) (0.144) (0.304) 
GP Age 0.012*** 0.003 0.004 0.020** 0.015** 0.044*** 
(0.004) (0.005) (0.011) (0.010) (0.007) (0.014) 
Dispensing 
Practice 
0.036 0.162 -0.434 -0.02 -0.224 0.719* 
(0.093) (0.108) (0.323) (0.258) (0.188) (0.373) 
IDTS50 -0.044 0.013 -0.081 -0.453** 0.069 -0.327 
(0.071) (0.089) (0.226) (0.195) (0.135) (0.277) 
IDTS60 -0.058 -0.135 -0.031 -0.454*** -0.03 -0.267 
(0.064) (0.083) (0.201) (0.176) (0.124) (0.249) 
    Epidemic Effects 
Rural 
Practice  
0.162*  0.277 0.266 0.155 0.908** 
(0.096)  (0.315) (0.258) (0.184) (0.381) 
    Learning-By-Using Effects 
Portfolio 
Breadth 
-3.151*** -5.810*** -8.098** -10.410*** -10.206*** -5.736 
(1.120) (1.862) (3.550) (3.217) (2.193) (4.125) 
Portfolio 
Breadth
2
 
2.938 5.325 -0.659 9.202 9.886** -0.332 
(2.365) (3.651) (7.706) (6.555) (4.632) (8.892) 
Order 
Effects 
-1.698*** -0.277* -6.035*** -8.487*** 0.694*** -1.044*** 
(0.129) (0.153) (0.380) (0.793) (0.130) (0.297) 
Stock 
Effects 
12.374*** 10.530*** 15.969*** 0.347 6.149*** 20.635*** 
(0.208) (0.402) (0.959) (1.726) (0.903) (0.938) 
N 23366 8607 8150 13628 10871 15082 
Chi- 
squared 
666.087 609.906 983.797 430.182 793.79 291.572 
Log-
likelihood 829.06056 294.3939 392.50908 274.69722 714.41184 7.741109 
AIC -1626.121 -558.788 -753.018 -517.394 -1396.824 16.518 
BIC -1497.18 -452.883 -640.926 -397.076 -1280.12 138.458 
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APPENDIX 3: TEMPLATE OF INTERVIEW SCHEDULE 
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Interview Schedule 
 
Q1. Can you tell me a little about your practice?  
 
Prompts:  Age of practice 
  Number of people working in the practice? FT? PT? 
  Purpose Built 
  Training practice 
  Links to other practices/ hospitals 
 
Q2. Does the practice operate as one legal entity or does it operate as a 
number of GPs working out of the same building?  
 
 
Q3. Can you tell me a little about your training and prior experience? 
 
 
Q4. What is the patient profile in the practice? 
 
Prompts:  Number of patients – private – public 
  Age 
  Health Status 
 
Q5. What medical equipment do you use in your practice? 
 
Q6. When did the practice adopt this equipment? 
 
Q7. How did you learn about this equipment? What made you decide to 
adopt it? 
 
Q8. What equipment would you consider adopting in the future? 
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Q9. How do you obtain information on new medical equipment? 
 
Prompts: Suppliers 
 Other primary care providers 
 Internet 
 
 
Q10. Does your practice use Information Technology? If so, for what 
purposes? 
 
Prompts: Accounting purposes 
  Medical research purposes  
  On-line appointment bookings   
SMS appointment reminders     
  Consultation records 
Repeat prescriptions 
 
 
Q11. What benefits do you see in using IT in your practice? What personal 
benefits to you see from using IT? 
 
Prompts: Efficiency 
  Better service for patients  
 
 
Q12. How do you obtain information on new IT applications (ways of using 
IT)? 
 
Prompts: Conferences 
 Other primary care providers 
 Internet 
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Q13.  In general, are you interested in new technology? 
 
Prompts: New mobile phones 
  I-pods 
 
 
Q14. Do GP practices use digital x-ray technologies? 
 
 
  
Q15. Do you prescribe drugs new to the market to your patients? 
 
Prompts: Regularly 
  On recommendation from colleagues  
 
 
Q16. Can you give me some examples of drugs that have come onto the 
market in the last 10 years?  
 
Prompts:  Regularly prescribed drugs 
  Rarely prescribed drugs 
  No longer prescribed 
 
 
Q17. From where do you obtain information on new prescription 
medicines?    
 
Prompts: Suppliers/ Pharmaceutical Companies 
 Other primary care providers 
 Internet 
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Q18. Who makes decisions in your practice, in relation to using new 
equipment, IT and prescribing?  
 
Prompts: GP 
 Practice Mgr 
 Joint decision 
 
 
Q19. So far I’ve focused on the adoption of medical equipment, IT and new 
drugs. Are there any other kinds of things that are adopted in General 
Practices? 
 
 
 
Q20. How often and where do you meet other primary care providers, 
including other GPs? 
 
Prompts: Conferences 
 Email contact 
 Informally, socially 
  
 
 
Q21. I will be distributing a survey to all GPs in Ireland in the coming 
months. Do you think I should email or post it?  
 
 
 
Q22.With an expected outbreak of swine flu in Ireland, do you think it’s a 
bad time to distribute a survey to GPs? 
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APPENDIX 4: COVER LETTER AND QUESTIONNAIRE 
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APPENDIX 5: PROBIT ESTIMATIONS OF MEDICAL 
EQUIPMENT USE - BASELINE MODELS 
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Table A5.1: Probit Estimations of Medical Equipment Use -Baseline Models 
 ECG 
 
24 Hr 
BPM 
Spiro-
meter 
Cryo-
therapy 
Minor 
Surgery 
Foetal 
Monitor 
 
Rank Effects 
Number of GPs 
 
-0.006 0.054*** 0.027 0.009 0.019 -0.017 
(0.015) (0.019) (0.026) (0.016) (0.019) (0.016) 
Log of Patients 
 
0.044 -0.035 0.102* 0.076** -0.024 0.058 
(0.027) (0.034) (0.053) (0.031) (0.041) (0.038) 
Proportion of 
Public Patients 
0.134* 0.144 0.189 0.058 -0.211* 0.074 
(0.074) (0.090) (0.138) (0.077) (0.108) (0.098) 
Nursing Support  
 
0.081 0.289*** 0.104 -0.076*** 0.093 0.028 
(0.050) (0.073) (0.075) (0.028) (0.065) (0.054) 
Administrative  
Support 
-0.012 -0.011 -0.142* 0.032 0.092 0.094 
(0.043) (0.059) (0.080) (0.062) (0.089) (0.083) 
All GPs > 40 
 
0.029 -0.003 0 -0.004 -0.056 -0.054 
(0.029) (0.044) (0.067) (0.038) (0.057) (0.052) 
Male Dominated 
 
0.052* -0.013 0.108** -0.039 0.106*** -0.045 
(0.028) (0.034) (0.050) (0.029) (0.041) (0.036) 
 
Order Effects 
Order 
 
0.046* 0.023 0.149*** 0.041 0.066* -0.06 
(0.025) (0.035) (0.048) (0.030) (0.039) (0.041) 
 
Learning-By-Using Effects  
Portfolio 
 
0.560*** 0.442*** 0.569*** 0.449*** 0.529*** 0.379*** 
(0.107) (0.105) (0.082) (0.100) (0.091) (0.092) 
 
Epidemic Effects 
Town 
 
0.044 -0.069* -0.009 0.014 0.06 0.083** 
(0.028) (0.039) (0.056) (0.033) (0.044) (0.040) 
Rural 
 
0.004 -0.087 -0.026 0.027 0.05 0.071 
(0.040) (0.066) (0.078) (0.039) (0.054) (0.045) 
HSE Dublin 
North East 
-0.03 -0.004 -0.131 -0.029 -0.082 -0.028 
(0.047) (0.056) (0.084) (0.052) (0.070) (0.059) 
HSE South 
 
0.042 -0.077 -0.054 0.022 0.061 0.076* 
(0.029) (0.050) (0.067) (0.037) (0.049) (0.043) 
HSE West 
 
0.084*** 0.042 0.033 0.017 0.05 0.066 
(0.027) (0.043) (0.070) (0.039) (0.051) (0.044) 
Clinic 
 
0.085*** 0.048 0.03 -0.01 0.028 0.033 
(0.028) (0.033) (0.049) (0.030) (0.040) (0.037) 
Training 
Practice 
0.081*** -0.001 0.137** 0.024 -0.036 -0.042 
(0.029) (0.046) (0.057) (0.037) (0.052) (0.048) 
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Table A5.1 (continued): Probit Estimations of Medical Equipment Use  -
Baseline Models 
 ECG 
 
24 Hr 
BPM 
Spiro-
meter 
Cryo-
therapy 
Minor 
Surgery 
Foetal 
Monitor 
Supplier Visits 
 
0.014 0.002 0.001 0.031** 0.005 -0.018 
(0.010) (0.013) (0.017) (0.014) (0.015) (0.012) 
Committee 
Member 
0.017 -0.012 -0.015 0.032 -0.049 0.041 
(0.026) (0.034) (0.049) (0.029) (0.041) (0.035) 
Academic 
Department 
0.029 0.006 0.049 0.028 0.063 0.022 
(0.029) (0.038) (0.054) (0.033) (0.043) (0.040) 
Research Project -0.013 0.097*** 0.055 0.02 0.046 0.031 
(0.037) (0.033) (0.058) (0.036) (0.046) (0.042) 
ICGP Course 
 
-0.008 -0.058 0.081 0.028 0.052 -0.071* 
(0.030) (0.041) (0.051) (0.032) (0.041) (0.042) 
CME  
Meetings 
-0.005 0.016** -0.003 0.002 0.001 -0.003 
(0.005) (0.007) (0.010) (0.006) (0.008) (0.007) 
N 522 522 522 522 522 522 
Chi-Squared 190.723 171.314 152.774 118.909 122.104 76.675 
P-value 0 0 0 0 0 0 
BIC 410.491 482.599 663.683 472.18 574.836 574.346 
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APPENDIX 6: PROBIT ESTIMATIONS OF MEDICAL 
EQUIPMENT USE - PREFERRED MODELS 
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Table A6.1: Probit Estimations of Medical Equipment Use - Preferred Models 
 ECG 
 
24 Hr 
BPM 
Spiro-
meter 
Cryo-
therapy 
Minor 
Surgery 
Foetal 
Monitor 
 
Rank Effects 
Number of GPs 
 
 0.053*** 0.03 0.007 0.02 -0.016 
 (0.017) (0.023) (0.014) (0.019) (0.015) 
Log of Patients 
 
0.037* -0.04 0.095* 0.075** -0.025 0.056 
(0.021) (0.035) (0.052) (0.030) (0.042) (0.038) 
Proportion of 
Public Patients 
0.128* 0.162* 0.164 0.063 -0.217** 0.069 
(0.069) (0.094) (0.135) (0.077) (0.109) (0.097) 
Nursing Support  
 
0.071 0.275*** 0.109 -0.072*** 0.086 0.027 
(0.046) (0.070) (0.073) (0.028) (0.064) (0.054) 
Administrative  
Support 
  -0.127 0.035 0.093 0.096 
  (0.081) (0.062) (0.090) (0.083) 
All GPs > 40 
 
0.033    -0.05 -0.054 
(0.026)    (0.057) (0.051) 
Male Dominated 
 
0.058** -0.033 0.103** -0.039 0.106*** -0.045 
(0.027) (0.034) (0.047) (0.029) (0.041) (0.036) 
 
Order Effects 
Order 
 
0.037 0.029 0.136*** 0.043 0.063 -0.06 
(0.025) (0.036) (0.046) (0.030) (0.040) (0.041) 
 
Learning-By-Using Effects  
Portfolio 
 
0.569*** 0.527*** 0.547*** 0.453*** 0.561*** 0.379*** 
(0.103) (0.092) (0.079) (0.098) (0.084) (0.091) 
 
Epidemic Effects 
Town 
 
0.045* -0.047   0.065 0.084** 
(0.025) (0.040)   (0.044) (0.040) 
Rural 
 
 -0.08   0.052 0.073 
 (0.065)   (0.055) (0.045) 
HSE Dublin 
North East 
  -0.116 -0.033 -0.066  
  (0.081) (0.052) (0.068)  
HSE South 
 
0.053** -0.062 -0.05 0.024 0.079* 0.085** 
(0.024) (0.043) (0.065) (0.037) (0.048) (0.038) 
HSE West 
 
0.092*** 0.05 0.05 0.021 0.065 0.074* 
(0.023) (0.040) (0.066) (0.039) (0.050) (0.039) 
Clinic 
 
0.077*** 0.045 0.019  0.027 0.031 
(0.026) (0.034) (0.047)  (0.040) (0.037) 
Training 
Practice 
0.083***  0.114** 0.026 -0.043 -0.043 
(0.026)  (0.056) (0.036) (0.053) (0.048) 
288 
 
Table A6.1 (continued): Probit Estimations of Medical Equipment Use -
Preferred Models 
 ECG 
 
24 Hr 
BPM 
Spiro-
meter 
Cryo-
therapy 
Minor 
Surgery 
Foetal 
Monitor 
Supplier Visits 
 
0.014   0.030**  -0.018 
(0.010)   (0.014)  (0.012) 
Committee 
Member 
 -0.03  0.032 -0.061 0.04 
 (0.035)  (0.028) (0.041) (0.035) 
Academic 
Department 
0.029  0.044 0.026 0.063 0.021 
(0.027)  (0.052) (0.033) (0.043) (0.040) 
Research Project 
 
 0.093*** 0.054 0.023 0.054 0.03 
 (0.034) (0.056) (0.036) (0.046) (0.042) 
ICGP Course 
 
 -0.06 0.088* 0.03 0.06 -0.072* 
 (0.042) (0.049) (0.032) (0.041) (0.042) 
CME  
Meetings 
-0.005 0.019***     
(0.005) (0.007)     
N 530 541 531 522 531 522 
Chi-Squared 190.986 184.867 149.177 118.3 130.06 76.366 
P-value 0 0 0 0 0 0 
BIC 372.768 463.001 641.486 441.501 571.678 562.139 
 
 
 
 
 
